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This thesis reports on the implementation of methods to optimise the MARS
scan settings and conduct a novel material-specific dosimetry simulation
using the MARS small-bore scanner. This thesis was undertaken because
no guideline exists on how to optimise MARS scan settings and conduct
material-specific dose simulation. The MARS photon-counting spectral
computed tomography (CT) scanner is at the stage of conducting the first
MARS human clinical trials. Therefore, the need to perform the clinical
trials with optimal MARS scan settings are crucial. Also, the MARS scanner
provides material-specific information without knowing their radiation dose
deposition. Hence, it is important to characterise their dose depositions and
reduces the patient’s exposure while maintaining the image quality.
This study aims to use the As Low As Reasonably Achievable (ALARA)
principle of radiation protection to determine the absorbed dose for spectral
imaging of small animals that have sufficient image quality and material
differentiation to meet clinical needs. Custom-built Perspex phantoms
were used to measure signal-to-noise ratio and spatial resolution, and to
measure radiation dose using thermoluminescent dosimeters. A multi-
contrast calibration phantom was used to assess material identification.
Small animal imaging and dosimetry were then performed to demonstrate
the study aim. The results suggest that the energy resolving capability of
photon-counting CT maintains diagnostically relevant image quality with
high levels of material discrimination at reduced radiation dose.
The material-specific dosimetry methods were established through developing
and implementing the Geant4 Application for Tomographic Emission
(GATE) Monte Carlo (MC) simulation program based on the MARS small-
bore scanner. The simulated MARS scanner was verified with physical
measurements. Further, a method for preparing spectral attenuation CT
data for three-dimensional MC dose simulation has been established. Lastly,
a method for demonstrating the potential use of the spectral material image
for MC dose simulation has also been developed.
The methods employed in this thesis can also be applied to optimise MARS
large-bore and body-parts scanners scan settings and build a strong basis
for personalised dosimetry.
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CT. Engineering and the Physical Sciences in Medicine conference,
EPSM 2017. Australia.
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1.1 The MARS research project
The MARS photon-counting spectral computed tomography (CT) scanner is an advanced
CT imaging modality project funded by the Ministry of Business, Innovation and
Employment (MBIE) to take spectral imaging of small animals to humans. MARS
spectral CT offers new imaging information beyond traditional CT and opens up new
ways to improve diagnosis and treatment (Anderson and Butler, 2014). The long term
goal of the MARS scanner novel project is to deliver minimum radiation dose, provide
robust and fast spectral imaging for research and clinical health care use.
Several versions of the MARS small-bore spectral CT are now operational in various
collaborative institutions such as the University of Canterbury (New Zealand), the
University of Otago (New Zealand), Charles University (Prague), Virginia Polytechnic
Institute (Virginia), Rensselaer Polytechnic Institute (United States of America), Joint
Institute for Nuclear Research (Russia), University of Notre Dame (United States
of America), and Chinese University of Hong Kong (Hong Kong). The successful
deployment of the MARS scanner goal will bring economic and health benefits to New
Zealand. The work done by the MARS team members falls in the various sections
of the MARS imaging chain illustrated in figure 1.1. The MARS imaging chain is a
process that is followed to acquire, process and store MARS spectral images. The
MARS imaging chain includes controller software, the Image Processing System (IPS)
server and the MARS vision workstation (Mandalika et al., 2018; Chernoglazov, 2016).
Each component of the MARS imaging chain is discussed as follows;
(i) Controller software is used for the scanner operation, scanner calibration, scan
data acquisition and dosimetry.
1
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(ii) Image Processing System (IPS) Server serves as a Picture Archiving and
Communication System (PACS) server to store acquisition data and a server for
reconstruction and material decomposition.
(iii) MARS vision workstation is used for three-dimensional (3D) volume rendering,
image analysis, and 3D visualisation of material images through zSpace
(stereoscopic space). The data obtained from the MARS vision are also transferred
to the IPS server to be stored.
The content of this thesis falls in the areas italicised, as shown in figure 1.1. The
present work was conducted at the University of Otago (Christchurch campus) in
collaboration with partners of the MARS Bioimaging Limited, such as the European
Organization for Nuclear Research (CERN) Dosimetry Service and the Institute of
Radiation Physics at Lausanne University Hospital.
Through my PhD program at the University of Otago, I joined the MARS dosimetry
team to undertake my thesis work. The vision of the dosimetry team is dubbed the
“overarching project”. This vision aims to provide MARS spectral human imaging
where the safety of the radiation source and protection of the patients are insured. In
addition, the vision aims to estimate a radiation dose per patient called personalised
dosimetry.
Figure 1.1: A schematic diagram of the MARS imaging chain. My work focuses on the
italicised area.
2
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1.2 Statement of problem
Prior to the start of my thesis work, there have been past dosimetry studies conducted.
The first MARS dosimetry studies were conducted in 2012 during the authors work
on vulnerable atherosclerotic plaque (Zainon et al., 2012). Later on, further dosimetry
studies focused primarily on implementation of a dose measurement procedure for the
MARS scanner (Ganet, 2014; Ganet et al., 2015). The radiation dose measurements were
performed using thermoluminescence dosimeters (TLDs), pencil ionisation chambers
and three homogeneous 30 mm diameter cylindrical Polymethyl methacrylate (PMMA)
phantoms (Ganet, 2014; Ganet et al., 2015). The established dose measurement
procedure was then used for subsequent Monte Carlo (MC) dosimetry simulation
studies. The MC dosimetry simulation was based on Tool for Particle Simulation
(TOPAS) (Lu, 2016; Lu et al., 2017).
Although, all the dosimetry studies were useful in understanding the dose distribution
in the MARS scanner none of them fully characterised the MARS scanner dosimetry.
In addition, none of these studies has looked at the effect of radiation dose (scan
parameters/settings/protocols) on the MARS image quality. My thesis seeks to extend
their research and fill the knowledge gap provided. Thereby, establishing dosimetric
methods for MARS spectral imaging which can also be apply to spectral technology in
a whole.
1.3 Thesis goals
This thesis work aims to establish methods to optimise the MARS scan settings and
conduct a novel material-specific dosimetry simulation. The work in this thesis are in
line with the long term goal of the MARS project.
Firstly, the As Low As Reasonably Achievable (ALARA) principle of the radiation
protection (Valentin, 2007; OECD, 2011) is used to determine absorbed dose for spectral
imaging of small animals that have sufficient image quality and material differentiation
to meets clinical needs (discussed in chapter 3).
Secondly, novel material-specific dosimetry methods were established through
developing and implementing the Geant4 Application for Tomographic Emission (GATE)
MC dose simulation program based on the MARS scanner (discussed in chapters 4 to
6).
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1.4 Significance of research
Radiation protection is a very serious concern on both national and international
forefront starting from the beginning of CT scanner development to its commission.
This is because the X-rays in CT scanners have the potential to damage tissues either
directly or indirectly (Papadimitroulas et al., 2015) and interfere with experimental
outcomes (Hupfer et al., 2012). Thus, makes the understanding of the absorbed dose in
a medium and its associated risk a particular interest for imaging applications involving
ionising radiation.
Furthermore, no guideline exists on how to optimise MARS scan settings to reduce
the radiation dose for preclinical and human imaging while maintaining the spectral
image quality. Lastly, the MARS scanner provides material-specific information without
knowing their radiation dose deposition.
1.4.1 Preclinical imaging
The MARS spectral CT project has begun preclinical research where the investigation
into small animal and excised biological samples are being done. The ethics approval
number for this investigation is URB/07/02/001. I have presented some applications of
the MARS spectral imaging systems, as shown in figures 1.2, 1.2 and 1.3, to illustrate
the importance of my thesis. This is because none of these MARS studies presented
and other related MARS work took into account the radiation dose except Zainon et al.
investigations. Hence, it is important to investigate the effect of radiation dose (scan
settings) on MARS image quality. The information obtained will help to reduce the
dose during imaging without affecting the image quality. In essence, the radiation dose
risk will be reduce during imaging.
Multi-contrast imaging
Figures 1.2 (a) and (b) show the differentiation and quantification of different materials
concentrations in a multi-contrast phantom and in a mouse, at the same time,
respectively. This study proves the ability of the MARS system to identify and quantify
many contrast agents in one scan.
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Figure 1.2: Differentiation and quantification of four high atomic number (Z) materials
in (a) a multi-contrast phantom and (b) a mouse. The different colours were applied to
each material for easy identification. The water in the mouse image has been partly
removed to indicate four contrast materials: calcium (bone), gold (in the heart and
blood vessels), gadolinium (in the stomach), and iodine (in pelvis and bladder). Image
courtesy of (Mahdieh et al., 2016)
Soft tissue imaging
The findings presented in figure 1.3 shows a clear separation of fat, meat and bone
in a chopped lamb. This demonstrates that the MARS scanner provides better soft
tissue contrast than standard CT. This also shows that pathological features, such as
cardiovascular disease, can be imaged at high spatial resolution.
Figure 1.3: An image slice of lamb meat. Clear visualisation of fat (beige), meat, and
bone (white) can be seen in the meat structure. Image courtesy of (Aamir et al., 2014).
1.4.2 Human imaging
The MARS spectral scanner is at the stage of conducting the first MARS human clinical
trials, after the success in demonstrating human imaging, as shown in figure 1.4 (3D
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material images of a person wrist and ankle) (Panta et al., 2018). These trials will
require optimal MARS scan settings. The first MARS human images were obtained
in May 2018 using the MARS-14 (MARS large-bore scanner) and later made public
in July 2018. This breakthrough of the MARS-14 acquired images proves the success
of scaling up the MARS small-bore scanner to scan live patients, although my thesis
work focuses on the MARS small-bore scanner. The knowledge can be applied to the
MARS large-bore and the body-part scanners being built. Also, we seek to use the
material-specific information provided by the scanner for MC dosimetry simulation.
The dose information will help to improve the scanner, to assess and optimise radiation
dose risk during patient imaging.
An ethics approval is needed prior to starting the MARS human clinical trials. The
trial goal is to demonstrate the use of MARS human scanner for clinical applications.
This includes showing that the same image quality acquired in the small-bore scanner
can be obtained in the large-bore scanner, across the same range of diseases. Voluntary
patients having theses range of diseases will be scanned and expanded to other different
diseases too. The importance of the ethics approval is to provide the mandate to
scan voluntary patients. An ethics approval (study reference: 18/STH/221 and study
title : Taking MARS Spectral CT to Human Imaging) has been obtained from the
Southern Health and Disabilities Ethics Committee (Southern HDEC committee). The
significance of my thesis to this trial is to establish methods to optimise MARS scan
settings to deliver less radiation dose while maintaining the image quality.
Figure 1.4: MARS human images. (a) MARS 3D image of a person’s wrist with a
watch. Gray depicts bones (high dense areas) and red shows soft tissues. (b) A 3D
MARS ankle image. The yellow colour inside the ankle shows lipid-like material, soft




This thesis is structured as follows:
Chapter 2 provides a general introduction and talks about the scientific background
relevant to this thesis. Also, it highlights on the physics of spectral imaging and
introduces the MARS spectral CT system along with the dosimetry methods used.
Chapter 3 describes a method that is used to optimise MARS scan settings. It
reports on the use of the As Low As Reasonably Achievable (ALARA) principle of
the radiation protection (Valentin, 2007; OECD, 2011) to determine absorbed dose
for spectral imaging of small animals that have sufficient image quality and material
differentiation to meets clinical needs.
Chapter 4 reports on the initial step by step development of MC simulation package
for MARS small-bore scanner using the GATE toolkit. Validations of the simulation
were done by comparing with physical measurements.
Chapter 5 examines the potential application of using spectral CT attenuation image
for MC dosimetry simulation. The procedure for converting spectral CT image into a
material image for dose simulation was discussed.
In the chapter 6, the potential use of spectral material decomposed density images
for MC dosimetry simulation was reported. A detailed procedure for converting the
material images into a suitable format for MC dosimetry simulation was established.





Whilhem Röntgen discovered X-rays in 1895. His discovery opens up many medical
imaging fields such as X-ray radiography. The X-ray radiography produces two-
dimensional images using X-ray radiation.
In 1972, Röntgen’s discovery led to a breakthrough in medical imaging which
resulted in the first computed tomography (CT) scanner been built by Hounsfield and
Cormack (Patrik et al., 2009). A CT scanner consist of an X-ray source and an X-ray
detector (Hendee et al., 2003; Cember and Johnson, 2008). The X-ray source and the
detector are located inside a circular gantry which rotates around an object to form
three-dimensional (3D) images. The X-ray source emits X-rays which interact with the
patient’s body to form images of patient anatomy (Hendee et al., 2003; Cember and
Johnson, 2008). This innovative technology has opened up a world of opportunities
in the medical field (Hendee et al., 2003), Hence offering more options in terms of
diagnostic and treatment abilities.
This chapter reviews the production and interactions of X-rays with matter, spectral
CT, and the MARS spectral scanner, and the X-ray dosimetry. An understanding of
this chapter helps to understand the ideas developed in the remainder of the chapters
in this thesis.
2.1 X-ray photon generation
An X-ray tube works by converting high-speed electrons to X-ray photons. The X-ray
tube basic components are the cathode (which is negatively charged) and the anode
(which is positively charged). More detail on the operation of an X-ray tube are
discussed in relevant physics textbooks (Khan and Gibbons, 2014; Cember and Johnson,
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2008; Hendee et al., 2003). The generated X-ray spectrum consists of Bremsstrahlung
and characteristic photons. Bremsstrahlung photons are produced with a wide range
of energies. Characteristics X-rays, on the other hand, are specific to the material the
X-rays interact with. The strength of X-ray energies are affected by factors such as
tube potential, filtration, the anode material, tube current (mA) and exposure time (s)
(Khan and Gibbons, 2014; Cember and Johnson, 2008; Hendee et al., 2003; OpenGATE,
2016).
2.1.1 X-ray photons interaction mechanism with matter
The interaction of X-ray photons with matter depends on the incident energy possessed
by the X-ray photon. The strength of X-ray photon energy largely influences the type
of interaction. When X-ray photons strike matter, they either get absorbed or scattered
(Khan and Gibbons, 2014; Cember and Johnson, 2008; Hendee et al., 2003). This thesis
work focuses on the X-ray photon interaction in the clinical energy range (20 to 140
keV).
Coherent (Rayleigh) scattering, incoherent Compton scatter and photoelectric effect
are the main interactions occurring in X-ray computed tomography imaging (Cember
and Johnson, 2008; Hendee et al., 2003). Figure 2.1 shows the mass attenuation
coefficients of coherent and incoherent scattering for X-ray photons in air, relevant to
this thesis.
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Figure 2.1: The mass attenuation coefficients for X-ray photons in air were generated
from the XMuDat software (Robert, 1998) in the energy range of 1 to 140 keV, showing
the major interactions. The total attenuation coefficient includes attenuation coefficients
from the photoelectric effects and the Compton scatter. The atomic cross section for
the photoelectric attenuation reduces sharply as the incident photon energy rises. The
mass attenuation coefficient of air reduces steadily with rising photon energy. This
explains why CT scans exposed to high energy photons have poor contrast (Khan and
Gibbons, 2014; Cember and Johnson, 2008; Hendee et al., 2003; OpenGATE, 2016).
Even though Rayleigh attenuation is normally neglected in medical imaging, it is
important in simulating low energy photons (Hendee et al., 2003).
2.2 Conventional CT to Spectral computed
tomography imaging
The images formed by conventional CT detectors contain the data of the total loss
of X-ray beam intensity travelling through the object. However, they fail to capture
energy information in the X-ray spectrum. The energy information helps to improve
the accuracy of separating and quantifying materials (Shamshad, 2017; Bateman et al.,
2018; Fornaro et al., 2011).
This challenge of getting the energy information led to the development of dual-
energy CT (DECT). DECT imaging is achieved by quantifying and separating different
materials using two energy windows (also referred to as bins or channels or thresholds)
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information from the scanned object (Shechter et al., 2012). DECT is possible through
different imaging techniques such as rapid voltage switching (Dilmanian et al., 1997;
Johnson, 2012), dual detector layers (Johnson, 2012; Dilmanian et al., 1997), dual-source
CT (DSCT) (Flohr et al., 2006; McCollough et al., 2015) and sequential acquisition
(Dilmanian et al., 1997). Several studies have highlighted on some of the disadvantages
associated with DECT imaging (Martin et al., 2008; Johnson, 2012; Dilmanian et al.,
1997; McCollough et al., 2015). These disadvantages include the scattering of X-rays
due to the simultaneous use of two X-ray tube sources, a high chance of X-ray spectral
overlap and different noise intensities may be observed from low and high energy images
in the case of dual layer detector.
Currently, energy resolving photon counting detectors are available to address most
of the DECT disadvantages. A typical example is the Medipix3RX detector (Ballabriga
et al., 2013) used by MARS Bioimaging Limited for spectral CT. These detectors
discriminate X-ray absorption into multiple energy windows in a single scan. Hence,
providing the potential to differentiate multiple tissue components and contrast agents
simultaneously (Zhao et al., 2012). These detectors make spectral imaging superior to
single X-ray CT and DECT.
2.2.1 Physics of spectral imaging
The physics behind X-ray photon interactions with matter discussed in section 2.1.1
apply to spectral CT imaging as well. The attenuated spectra in a spectral scanner are
measured with a photon-counting detector, such as the Medipix3RX (Ballabriga et al.,
2006, 2011, 2013). The Medipix3RX detector is used in the MARS scanner.
The Medipix3RX measures the X-ray spectra at different energy windows. This
enables the separation of different materials at different energies. The outcome of
this mechanism is the ability to detect different materials and evaluate their densities,
at different energies. A clear example is figure 2.2, where different material total
attenuation coefficients are shown. The different total attenuation coefficients of bone,
soft tissue, iodine, gadolinium, gold and adipose captured by the Medipix3RX detector
enhances the material separation. Hence, the mass attenuation coefficients of different
materials vary according to the incident X-ray energies.
The mass attenuation coefficients are used by a material decomposition (MD)
algorithms (Knight, 2015; Bateman, 2014; Bateman et al., 2018) to characterise different
material concentrations. The current MARS-MD algorithm (Knight, 2015; Bateman,
2014; Bateman et al., 2018) is developed for post reconstruction of image data. The
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MARS-MD algorithm uses a statistical segmentation technique to separate the low
attenuating soft tissue materials from the high attenuating dense material. The MARS-
MD algorithm can easily achieve a reasonable six material decomposition using four
energy windows in the human imaging range of 20-140 keV.
Figure 2.2: Different materials total attenuations. The setting of energy thresholds
(Th) of Th1 to Th4 in charge summing mode was done using the Medipix3RX detector.
Unsubtracted energy thresholds is depicted by the double arrows over the entire energy
range. Image courtesy of (Anjomrouz, 2017)
2.3 MARS small-bore scanner
The MARS small-bore scanner is a spectral imaging system that uses the photon
processing abilities of the Medipix detector. The Medipix detector is developed at the
European Organization for Nuclear Research (CERN). The MARS scanner is suitable
for preclinical spectral imaging of small animals that have a maximum size of 80 mm
diameter and 200 mm length (Butler et al., 2008) and human samples of diseased
tissue. The MARS scanner used for this study is MARS-11. It is equipped with a
single Medipix3RX detector and later upgraded to three Medipix3RX detectors during
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the course of this study. The former was used in chapter 3 studies whiles the latter
was used in chapters 4 to 6. Apart from the detector upgrade, the rest of the scanner
components remain the same.
The MARS small-bore scanner consists of a single rotating gantry, which contains a
micro-focus X-ray tube, the Medipix3RX energy resolving detector (Ballabriga et al.,
2013) (More information on the Medipix3RX detector is found in subsection 2.3.2), and
a sample bed for sample placement which can be adjusted in the x and y directions
(Butler et al., 2008), the cabinet controller, the computer hardware and the scanner
software (Aamir et al., 2014; Rajendran et al., 2014; Ronaldson et al., 2011; Walsh
et al., 2011; de Ruiter et al., 2017), as seen in figure 2.3. The scanner is situated in a
1.8 mm lead shielded box placed between 0.5 mm aluminium and 0.5 mm stainless steel.
The box has interlocks and shielded ports for cable entry and ventilation (Butler et al.,
2008).
Figure 2.3: (a) MARS small-bore scanner. (b) Inside view showing a phantom mounted
on a sample holder between the X-ray source and the Medipix detector. (c) The MARS
gantry removed from the scanner.
2.3.1 X-ray tube
The position of the X-ray tube connected to the base plate can be varied to ensure total
coverage of a sample. To ensure the continuous scanning for long hours, a cooling fan
was used to reduce the X-ray tube temperature (Butler et al., 2008). The micro-focus
X-ray source features a 20◦ pure tungsten (W) anode with an effective focal spot size of
50 µm and intrinsic filtration of 1.8 mm Al, and a 120 kilovolt tube potential (kVp). The
X-ray tube operates in the tube current range of 10-350 µA and tube potential range
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of 60-120 kVp. The maximum tube power is 39 Watts. More detailed specifications
of the X-ray tube can be found in the operating manual (Manez, 2012). Additionally,
the MARS scanner employs two external filtration scan settings (0.375 mm brass and
two mm Aluminium) to remove low energy photons. This reduces the absorbed dose to
patient that does not contribute to image formation.
2.3.2 The Medipix detector
The Medipix detector is attached to a plate that enables a fine angular adjustment and
vertical translation to ascertain that the detector pixels cover the whole sample (Butler
et al., 2008). The main components of the Medipix detector are a semiconducting sensor
layer and application-specific integrated circuit (ASIC) (the detector readout chip). In
this thesis, the term “Medipix chip” and “Medipix detector” are used interchangeably.
The sensor layer is bump-bonded to the readout chip. Both the sensor layer and the
readout chip are divided into very small units called detector pixels. Each pixel of the
sensor is connected to its own electronics in the ASIC, as seen in figure 2.4 (a). The
sensor layer usage is to convert X-ray photons to electron-hole pair which are then read
by the ASIC. A schematic diagram showing the operation of the Medipix detector is
presented in figure 2.4 (b).
Three generations of the Medipix detectors have been used successfully (More detail
on the history of the Medipix detector can be found in (Anjomrouz, 2017; Shamshad,
2017)). The Medipix3RX detector (Ballabriga et al., 2013) used in this thesis is from
the third generation Medipix family. The sensor layer used is two mm cadmium zinc
telluride (CdZnTe also known as CZT). CZT was used because of its higher absorption
efficiency for photons in the clinical energy range (10-120 keV) (Koenig et al., 2013).
The Medipix3RX chip has an active area of 256 × 256 pixels with each pixel having
a pitch of 55 by 55 µm2. The total sensitive area covered by the chip is 14.08 × 14.08
mm2. The regular structure in the matrix is grouped in clusters of 2 by 2 pixels, forming
one readout pixel of pitch 110 µm (128 by 128 pixels) in the Medipix3RX chip (Butler
et al., 2008; Ballabriga et al., 2013). Only one of four pixels is connected to the sensor.
The circuitry in the pixels that were not bump-bonded is used to provide more energy
thresholds (Butler et al., 2008; Ballabriga et al., 2013).
The Medipix3RX detector has eight counters (four charge summing mode (CSM),
three single pixel mode (SPM) and an arbitration counter) with adjustable thresholds
(de Ruiter et al., 2017). The arbitration counter is set just above the noise floor.
Currently, the three SPM counters are not used in MARS imaging (Butler et al., 2008;
14
2.4. X-ray dosimetry
Ballabriga et al., 2013).
Figure 2.4: (a) Medipix detector showing the sensor layer bump-bonded to the ASIC.
Image courtesy of (CERN, 2012). (b) An X-ray photon strikes the semiconductor sensor
layer to produce an electron-hole charge. An external bias voltage is applied to drive
the charge carriers through the bump-bonded contact to the ASIC. The outcome is the
separation of X-ray energies.
2.4 X-ray dosimetry






the same unit as absorbed dose. But, kerma can be different from absorbed dose,
depending on the energies involved. For low energy photon beams (below 60Co beam












of energy loss due to bremsstrahlung by secondary electrons is less than 0.3% (Ma et al.,
2001b; Bushberg, 2003). This scenario is depicted in figure 2.5. Also, assuming that
charged particle equilibrium (CPE) exit, the kerma is then the same as the absorbed
dose (Attix, 2007; Bushberg, 2003). Absorbed dose to a material/tissue can then be
written mathematically, as seen in equation (2.1). Absorbed dose is defined for all
ionizing types of radiation (Valentin, 2007; Bushberg, 2003; Cember and Johnson, 2008).
The radiation component in the MARS scanner is an essential part of this thesis.
Section 2.1.1 provides information on X-ray interactions with matter. This leads to
image formation, however, they can also affect biological tissues or organs. Biological
radiation health effects may appear in the form of stochastic (cancer and genetic effect)
or/and deterministic effects. Due to this radiation health effects, it is imperative
to practise radiological protection and its principles. In addition, to quantify the
15
2.4. X-ray dosimetry
radiation dose risk. More information on radiation protection, radiation health effects
and protection quantities can be found in (IAEA, 2014; Cember and Johnson, 2008;
Bushberg, 2003; Valentin, 2007; Hendee et al., 2003) medical physics textbooks and
publications. Ionisation chamber, thermoluminescence dosimeters and MC dosimetry
simulations were used to assess the MARS scanner radiation dose.
Figure 2.5: The total mass energy absorption coefficients and total mass energy transfer
coefficients of water and adipose tissue were generated from the XMuDat software
(Robert, 1998) in the energy range of 1 to 120 keV. The total coefficient includes
coefficients from the photoelectric effect, Rayleigh scattering and the Compton scatter.













= the mass energy absorption coefficient of a tissue t at energy E
ψ = the photon energy fluence
2.4.1 Ionisation chamber
Ionisation chambers are classified as active radiation detectors. They are widely used
to assess radiation dose in CT scanners. Hence, we used it to carry out most of the
dose measurements in this thesis.
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Principle of ionisation chamber operation
When an uncharged particle (X-ray photon) interacts with a medium (for example, a
gas) shown in figure 2.6, it ionises the medium creating ion pairs. The ion pairs migrate
from their point of production to charge electrodes (anode and cathode), causing the
flow of current. The current flow is then measured to determine the total number of
ions collected. More information can be found in Cember and Johnson (2008); Hendee
et al. (2003) physics textbooks.
Figure 2.6: Schematic diagram of a simple representation of an ionisation chamber. The
X-ray photon causes the formation of ion pairs within the gas container. The ionised
gas moves due to applied potential difference resulting to a measurable current.
Computed tomography dose index
Computed tomography dose index (CTDI) is a quantity that estimates the radiation
dose given by a CT scanner. This quantity helps to compare the scan settings radiation
dose between CT scanners and against a national diagnostic reference level (DRL) for
safety purposes. CTDI phantoms are used together with ionisation chambers. CTDI
measures the radiation dose in the axial direction or z-axis at one rotation during
CT imaging. Traditionally, CTDI measurements are performed using two standard
cylindrical polymethyl methacrylate (PMMA) phantoms. The two phantoms are 16
and 32 cm in diameter for the head and the body, respectively. Equation (2.2) is used








N = number of tomographic slices scanned in one axial rotation.
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T = thickness along the z-axis of a tomographic slices.
D(z) = radiation dose profile along the z-axis.
For relatively large bodies such as that of a human, the CTDI at the peripheries are
not the same as the CTDI at the centre. This is corrected for by a weighted measure,
CTDIw, which includes 5 measurements made within the CTDI phantom: 4 near the
outer peripheries and 1 at the centre. CTDIw is calculated by equation (2.3), where









CTDI100,c = dose measured at the centre of the CTDI phantom.
CTDI100,p = average of the doses measured at the outer peripheral positions of the
CTDI phantom.
2.4.2 Thermoluminescence dosimeter
Thermoluminescence dosimeters (TLDs) are classified as passive radiation detectors.
TLDs are much smaller than ionisation chambers and can be made into different shapes
and sizes. They are used for point dose measurements in phantoms and biological
specimens. In this thesis, we used small TLDs to record point dose in a mouse cadaver
(chapter 3). In addition, TLDs were used to cross-check our ionisation chamber and
simulation dose results.
Principle of TLD operation
The lithium fluoride (LiF) crystals make-up of TLD possesses a similar effective atomic
number as soft tissue. This makes the LiF crystals suitable for clinical dosimetry (Khan
and Gibbons, 2014). Radiation striking on a TLD causes the crystal atom to be excited
producing electron-hole pair. The introduction of doping material such as copper (Cu),
magnesium (Mg), and phosphorus (P) in the TLD called doping, causes electron-hole
to be trapped. The dose information is obtained by further heating the exposed TLD
to cause the excited electrons to drop in energy. The photon energy released by the
electron is directly proportional to the absorbed dose expressed in milligray (mGy)
18
2.5. Summary
(Cember and Johnson, 2008; Khan and Gibbons, 2014). Examples of such TLD crystals
are LiF, CaF2:Mn, CaSO4:Tm, Li2B2O7:Cu, and LiF:Mg,Ti.
2.5 Summary
 CT scanner consists of an X-ray source and a detector.
 The X-ray spectrum consists of the Bremsstrahlung and the characteristic photons.
 The main physics interaction of X-ray photons with matter in the clinical range
are the Rayleigh scattering, the photoelectric effect and the Compton scatter.
 Spectral CT imaging is an advanced imaging modality compared to the single
X-ray CT imaging. It has the potential to differentiate multiple tissue components
and contrast agents simultaneously. Spectral CT can separate incoming X-ray
photons based on their energies.
 The MARS small-bore scanner is a spectral imaging system that uses the photon
processing abilities of the Medipix chip developed at the CERN.
 Radiation dosimeter such as the ionisation chambers and the TLDs were used for





indicators and radiation dose using
photon-counting spectral CT
3.1 Overview
This chapter presents a method to optimise the MARS spectral computed tomography
(CT) scan settings. In this study, we aim to use the As Low As Reasonably Achievable
(ALARA) principle of the radiation protection (Valentin, 2007; OECD, 2011) to
determine absorbed dose for spectral imaging of small animals that have sufficient
image quality and material differentiation to meets clinical needs.
Firstly, we assess the quality of images using objective measures such as signal-to-
noise ratio (SNR) and modulation transfer function (MTF). To this end, we apply
varying imaging parameters common to any form of CT that will modify dose and
investigate how this affects image quality. We then assess specific image quality measures
provided by photon-counting CT, that is material identification and quantification.
The research was conducted because no guideline exists to optimise the MARS scan
settings, MARS spectral image quality and radiation dose. Also, the MARS spectral
CT is at a stage of conducting human clinical trials. It is imperative to know the
effects of scan settings on the radiation dose of the images produced by the MARS
scanner. This information allows us to deduce optimal scan settings which produces
images that reveal as much detail as possible with reduced radiation dose. Moreover,
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the performance of the spectral system’s algorithm for material decomposition could be
compared using this procedure. Lastly, the method in this thesis serves as a guideline
in optimising radiation dose for different MARS scan settings while keeping the spectral
image quality.
The MARS-11 scanner, with one Medipix3RX detector was used for this study. The
scanner is located at the University of Otago (UO), Christchurch campus.
Section 3.2 briefly reviews the knowledge gap in literature. Next, a description of
materials and processes used are presented in sections 3.3 and 3.4. The crucial findings
are discussed in section 3.3. In section 3.6, the significance and limitations of the studies
are discussed. A summary of the entire study is given in section 3.7.
I was the principal investigator. I would like to thank Chiara Lowe, Dr Joe Healy,
Dr Mahdieh Mogiseh, Arron Dyer, Dr Aamir Raja, Eng.Pierre Carbonez and Dr Jérôme
Damet for their help in the mice preparation. Also, I thank Nicole Meyer and Marie
Nowak for calibrating and reading the radiation doses on the thermoluminescence
dosimeters. Lastly, I thank Dr Alex Chernoglazov for preparing the mice images.
3.2 Introduction
Photon-counting spectral CT imaging is on the horizon of clinical radiology (Kim et al.,
2018; Panta et al., 2018). It measures the energy of every detected X-ray photon with
high spectral resolution and contrast sensitivity. In principle, photon-counting CT
divides the broad X-ray spectrum into user-set multiple energy channels where photons
with specific energy are accounted for and processed individually. In this way it not
only excludes electronic noise but also improves the signal-to-noise ratio and spectral
separation at a high spatial resolution (Willemink et al., 2018).
Spectral CT was first theorised by Alvarez and MacOvski in 1976 using their proposed
material decomposition (MD) algorithm to decompose spectral clinical attenuation data
into material-specific density images (Alvarez and MacOvski, 1976). A plethora of MD
algorithms had since been applied either in the raw data (Hu and Zhao, 2016; Schlomka
et al., 2008) or/and image data (Butler et al., 2011; Knight, 2015) domain by spectral
systems.
Multiple energy channels, their appropriate selection and bin size play a key role
in improving the accuracy and precision of detected photons and therefore give lower
noise in the resulting material specific images. For instance, wider energy bin widths
provide lower noise levels however, the reconstructed spectral image may suffer from
21
3.3. Materials
poorer image contrast. Thus, information regarding the multiple energy photons, as
well as the characteristics of material specific X-ray attenuation, results in the highly
specific identification and quantification of multiple materials simultaneously.
The assessment of image quality and material identification in spectral photon-
counting CT is a new area of research with only a few relevant studies (Ehn et al.,
2017; Curtis and Roeder, 2019; Rajendran et al., 9000; Curtis and Roeder, 2017b;
Pourmorteza et al., 2017; Kappler et al., 2014; Raja et al., 2018). From a clinical
perspective especially when photon-counting CT imaging is clinically available, its
purpose would be to accurately display materials and their concentrations so that
disease processes tagged with high atomic number materials such as gadolinium (Curtis
and Roeder, 2019; Rajendran et al., 9000), hafnium (Ostadhossein et al., 2020), iodine
(Si-Mohamed et al., 2018) and gold (Clark et al., 2013; Mahdieh et al., 2016; Cole et al.,
2015) can be measured in the presence of soft tissue, lipid and bone found in animals
(Si-Mohamed et al., 2019) and humans (Gutjahr et al., 2016). This imaging needs
to be performed at the lowest achievable radiation dose. Various studies show that
photon-counting CT will result in ∼30-85% radiation dose reduction while providing
highly specific imaging at high spatial resolution (Giersch et al., 2004; McCollough
et al., 2015; Anderson and Butler, 2014; Symons et al., 2017; Rajendran et al., 2019).
This is made feasible by the small pixel size of photon-counting detectors (Ballabriga
et al., 2016), which is designed to provide better visualisation of fine structures (Becce
et al., 2019; Stamp et al., 2019) whilst operating under low X-ray flux (Baek et al.,
2013).
3.3 Materials
The components of MARS small-bore spectral CT scanner are discussed in chapter 2
section 2.3.
3.3.1 Thermoluminescence dosimeters, four-hole and MTF
phantoms
The thermoluminescence dosimeters (TLDs) used were TLD-100s, calibrated and
provided by CHUV (Institute of Radiation Physics at Lausanne University Hospital,
Switzerland). The purpose of the TLDs was to conduct in vitro radiation dose
measurement at different tube currents. Also, to conduct mice dosimetry for the
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optimised tube current. The specifications of the TLD-100s (LiF: Mg, Ti) are 3.2 ×
3.2 × 0.9 mm3. The results of the measurements done with TLDs-100 are expressed in
terms of absorbed dose in water.
A Perspex phantom called “four-hole phantom” in this study, as shown in figure 3.1,
is a custom-built 26 mm diameter phantom used by the MARS team. This phantom is
used for SNR and in vitro X-ray radiation dose measurement at different tube currents.
It is a 7.0 mm length cylindrical rod with four holes (2 mm diameter each). The four
holes form a square of 13 × 13 mm2 on the phantom’s surface.
Another Perspex phantom known as “MTF phantom” in this study is a custom-built
25 mm diameter cylindrical rod with a polished surface, as shown in figure 3.2. It is
used to check the CT system’s ability to differentiate small adjacent objects expressed in
spatial resolution. The spatial resolution of the MARS system was assessed at different
tube currents.
Figure 3.1: (a) Picture of the four-hole phantom. (b) Image slice of the four-hole
phantom with five ROIs for the SNR measurements, and the four TLD-100s attached
to the outer periphery for the radiation dose measurements.
Figure 3.2: MTF phantom for spatial resolution measurements.
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3.3.2 Gadolinium and hydroxyapatite calibration phantom
The calibration phantom used for this study is made of polymethyl methacrylate
(PMMA), containing gadolinium and hydroxyapatite (Gd/HA) vials called Gd/HA
calibration phantom. The purpose of the calibration phantom is for material
identification and quantification at different tube currents. The Gd/HA calibration
phantom contains twelve 6 mm diameter holes, to allow for insertion of different
material vials. The HA vials used are solid rods of calcium hydroxyapatite at 0, 54.3,
104.3, 211.7, 402.3 and 808.5 mg/mL (0, 271.0, 520.5, 1056.4, 2007.6 and 4034.6 mM,
respectively); manufactured and calibrated by Quality Assurance in Radiology and
Medicine (QRM), GmbH, Moehrendorf, Germany. The remaining vials were filled with
gadolinium solution at 1, 2, 4 and 8 mg/mL (6.4, 12.7, 25.4 and 50.9 mM, respectively)
(Gadobenate dimeglumine, Bracco Diagnostics Inc, Princeton, NJ, USA), along with
water and lipid (vegetable oil), as shown in figure 3.3. The HA represents bone-like
tissue, water represents soft tissue and lipid as a proxy of fat. Gadolinium based contrast
agents had been studied and applied in CT imaging probably due to its K-edge (50.2
keV) absorption falling within human diagnostic X-ray imaging (Schmitz et al., 1995;
Mahdieh et al., 2016; Raja et al., 2018; Bonvento et al., 2006; Gierada and Bae, 1999;
Koelblinger et al., 2011; Curtis and Roeder, 2017a; Rajendran et al., 9000; Si-Mohamed
et al., 2019).
Figure 3.3: (a) Gd/HA calibration phantom containing multiple Gd and HA




3.3.3 Mice imaging and dosimetry
Three mice of average weight 26.5 ± 2.1 g standard deviation were used. The purpose
of using mice is to demonstrate animal dosimetry for part of monitoring material
differentiation with the optimised scan settings. Also, to compare the absorbed dose
to doses obtained from conventional micro CT scanners. Table 3.1 shows the mice
descriptions.





Date of Birth 31-08-16 31-05-16
Age (week) 16 29
Parentage SB12/22/4 R2/1
Mass (g) 28 25
Gadolinium injection Yes No
3.4 Methods
3.4.1 Experimental set-up
Our MARS scanner has previously been described in detail (Raja et al., 2018; de Ruiter
et al., 2017; Aamir et al., 2014). The study was performed with a small-bore MARS
scanner (MARS-11 v5, MARS Bioimaging Ltd., Christchurch, New Zealand), comprised
of a micro focus X-ray tube and a single CdZnTe assembled Medipix3RX chip (Ballabriga
et al., 2013) incorporated MARS camera. Multiple vertical positions of the MARS
camera were used to create a virtual detector of the greater area to cover the 31 mm
field of view. The X-ray tube, a Source-Ray SB-120-350 (Source-Ray Inc, Ronkonkoma,
NY), had a tungsten target with an effective focal spot size of ∼50 µm, and included
1.8 mm aluminium (Al) equivalent intrinsic filtration. Additional external filtration of
0.375 mm brass was used to cut off low-energy photons below ∼26 keV to minimise the
beam hardening effect and also to mimic the clinical CT X-ray energy range. In this
study, four charge summing counters were used to set low energy thresholds at 30, 45,
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60 and 78 keV. Fig. 3.4 is a representation of a simulated X-ray spectrum (SpekCalc)
(Poludniowski et al., 2009) at 120 kVp with 0.375 mm external brass filter together with a
1.8 mm Al (equivalent) intrinsic filtration. Vertical dotted lines show user specific energy
thresholds used for the characterisation of gadolinium, calcium, lipid and soft tissue.
These energy threshold settings were adopted from one of our previously published
studies (Raja et al., 2018) to characterise spectral response of gadolinium, calcium,
lipid and soft tissue. Four tube current settings (24, 34, 44 and 54 µA) were selected
to assess the effect of X-ray doses on the image quality and material identification
errors while keeping the tube voltage fixed at 118 kVp with an exposure time of 220
ms. The 118 kVp broad X-ray spectrum not only benefitted the application of low
energy thresholds in the diagnostic energy range but also helped in using diagnostically
relevant contrast agents. The tube currents were selected upon careful consideration to
avoid the probability of the pile-up effect while providing high X-ray flux (Aamir et al.,
2011). The 24 µA tube current was selected as a suitable starting point because better
identification and quantification of Gadolinium has previously been reported (Raja
et al., 2018) with this setup. The source-to-object, and object-to-detector distances
were 200 mm and 50 mm, respectively. The 720 circular projections over 360◦ were
acquired with a pitch of 0.92.
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Figure 3.4: The simulated X-ray spectrum from SpekCalc, selected energy bins and
mass attenuation coefficient for gadolinium, calcium, adipose (lipid) and soft tissue as a
function of X-ray energy. Vertical dotted lines show user applied energy thresholds set
at 30, 45, 60 and 78 keV.
3.4.2 Thermoluminescence dosimeters, Four-hole phantom
and MTF phantom analysis
The radiation dose measurements were performed by placing TLD-100s on the phantom
surface at 90◦ interval around the circumference. The TLD-100s were then read on a
Harshaw 5500 reader in accredited dosimetry service in CHUV. The TLD-100s absorbed
dose results against the four different tube currents are seen in table 3.2. In all, 43
TLD-100s were used and analysed.
The reconstructed images of the four-hole phantom were sorted into four energy bins
(30-45, 45-60, 60-78 and 78-118 keV) using the ImageJ software (Rueden et al., 2017).
The image slices showing no TLD-100s images were selected and a MATLAB code
(MathWorks, 2017) was used to calculate the SNR. Selecting image slices with no TLD-
100s removes any potential interference of the TLD-100s attenuation on the outcome of
the calculated SNR. The same selected image slices were used for all the four energy bins.
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The mean SNR calculated from the four energy bins were used to make it equivalent to
standard CT settings. This is because the spectral image quality indicators such as
SNR and MTF are energy bin dependent. This is due to the difference in the number
of photon counts within each bin.
The SNR calculations was done by selecting five regions of interest (ROIs) seen as
squares (centre, top, bottom, left, and right) in figure 3.1 (b). The SNR was calculated
as the ratio of average pixel values to the standard deviation of the pixel values for each
image slice. Mean SNR was then computed over the four energy bins. The SNR results
against the four different tube currents are seen in table 3.2.
The MTF measures system’s ability to transfer the contrast information of a
sample/phantom to the image plane at an exact spatial frequency or resolution usually
expressed in units of line pairs/mm (Verdun et al., 2015). For a given frequency, the
more contrast information transferred the higher the MTF. The MTF values ranges
from 0 to 1, where a value of 0 suggests that 0% of contrast information is transferred
and a value of 1 indicates that 100% is transferred. The 10% MTF represents the spatial
resolution at which there is 10% modulation of the transferred contrast information. A
higher spatial resolution is indicated by a larger 10% MTF value (Tang, 2013).
In this study, the MTF was calculated based on the method described in the ASTM
International standards (ASTM E1695-95, 2013). The annulus mask applied around
the image slice shown in figure 3.5 (a) was used to analysis the edge response function
(ESF) of the air/phantom boundary of the phantom. A MATLAB code (MathWorks,
2017), written by a MARS team member, was used to calculate the 10% MTF, as
shown in figure 3.5 (b). This procedure was repeated for the same number of image
slices in the four energy bins, for each tube current. The mean MTF values calculated
from the four energy bins were used to make it equivalent to standard CT settings.
This is because spatial resolution measurements in photon-counting detectors such as
the Medixpix3RX depends on the energy bin (Koenig et al., 2014). The MTF results
against the four different tube currents are seen in table 3.2.
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Figure 3.5: (a) The MTF phantom image slice with an annulus mask applied around
the edge for spatial resolution measurement. (b) A graphical representation for the
calculation of 10% MTF. The vertical axis is modulation transfer function displayed in
relative percentage.
3.4.3 Mice imaging and dosimetry
The male mouse was injected with 32 mg in 200 µL of pure Gadovist (604.72 mg/mL
of Gadobutrol) through the tail while anaesthetised. It was euthanised using CO2
approximately 15 minutes after injection to allow the Gd concentration to accumulate
in the kidneys and bladder. The other two mice without Gd contrast injection were
also euthanised using CO2.
All the mice (presented in table 3.1) were euthanised according to the Christchurch
Animal Research Area (CARA) standard operating procedure and Gd injection protocol
adopted from the University of Otago, Christchurch Animal Ethics approval number
C19-13/601.
Nine TLD-100s were inserted into each of the three mice and sutured to maintain
fixed positions. Each mouse was placed inside a 50 mL conical polypropylene centrifuge
tube (Corning Falcon 50mL Conical Centrifuge Tubes) and 80 mm length was scanned.
To prevent motion of the mice during scanning, cotton balls were placed inside the
50 mL Falcon tube at the feet and tail end. Figure 3.6 shows the mouse and orange
squared TLD-100s, and the non-contrast mouse material image.
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Figure 3.6: (a) The mouse with orange squared TLD-100s ready to be inserted. (b)
The non-contrast mouse material image showing the HA and TLD-100s channels (in
red colour).
3.4.4 Image processing and reconstruction
The MARS imaging system standard procedure for image acquisition and reconstruction
(Mahdieh et al., 2016; Aamir et al., 2014; Raja et al., 2018) was used to scan the phantoms
and mice. This procedure involves acquiring flat field measurements (720 images for
each camera position and energy bin) after scanning the mice and phantoms. This is
used to correct for fixed pattern variation in individual pixel responses (Aamir et al.,
2011). The flat field measurements contributed no dose to the mice and phantoms. The
raw data in Digital Imaging and Communications in Medicine (DICOM) format was
transferred to the inbuilt Picture Archiving and Communication System (PACS) where
an automated image reconstruction was done. An in-house iterative reconstruction
algorithm produced three dimensional linear-attenuation images over the energy ranges
of 30–45, 45–60, 60–78 and 78–118 keV, simultaneously. In one step, the algorithm
solves a non-linear system of equations based on a low-resolution polychromatic version
of the Beer Lambert law to map the four energy ranges of the result onto the four
measured counters. There is no regularisation as part of the reconstruction. The cubic
voxels were 90 µm wide.
3.4.5 Spectral and linearity response
The spectral response of the detector was assessed to know the detector’s ability to
capture all the different materials used in this study. Linearity response determines
the relationship between the spectral X-ray attenuation and the material concentration.
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The spectral and linearity information are important for the material identification
and quantification. I assessed this information using the Gd/HA calibration phantom
attenuation images.
Spectral HU were calculated by normalising linear attenuation coefficients of each
of the energy bins to the corresponding attenuation values to water and air, as shown







µmat(E) is the linear attenuation coefficient of the given material in a given energy bin.
µwater(E) and µair(E) are the linear attenuation coefficients of water and air respectively
at the given energy bin.
MATLAB code developed by a MARS team member was used to calculate the
linear attenuation, HU, standard error and MD basis for water, lipid, Gd and HA
for each energy bin, and for each tube current. This was done by selecting ROIs of
approximately 1076 voxels over each solution of the Gd/HA calibration phantom. The
HU value for each material at a given energy bin for all tube currents were plotted to
determine the K-edge of materials. The determination of material K-edges helps to
distinguish material types by comparing their spectral CT responses. This procedure is
reported in (Mahdieh et al., 2016; Raja et al., 2018).
The linearity relationship between material HU and concentration (mg/mL) was
explored by graphically plotting the HU as a function of material concentration (mg/mL).
This relationship is important in that it helps to determine the concentrations of unknown
materials. The Pearson correlation coefficient (r) was used to find the relationship of
each material linear response as a function of the concentration.
3.4.6 Material decomposition, identification and
quantification
The purpose of conducting material decomposition is to breakdown the spectral
attenuation (energy information) into information about the different materials
contributing to that attenuation. An in-house constrained linear least squares MD
algorithm (Knight, 2015; Bateman et al., 2018) was applied in the reconstructed image
domain for the Gd/HA calibration phantom and the mice. The Gd/HA calibration
phantom (figure 3.3) data were decomposed using the mass attenuation information
obtained from the Gd/HA calibration phantom. The material basis of Gd, HA, fat and
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water obtained from the Gd/HA calibration phantom were applied to decompose the
mice dataset. This procedure has been reported in (Raja et al., 2018; Mahdieh et al.,
2016).
The effects of different tube currents on the material identification and
misidentification was assessed. To quantify the amount of identification and
misidentification, a post-MD quantitative metric (Raja et al., 2018) written in MATLAB
was used to assess the level of misidentification between different material concentrations
in MD images. In summary, a quantitative metric of the calibration phantoms’ MD
images provides sensitivity (true positive rate) and specificity (true negative rate) for the
correct material identification at various material concentrations. Material identification
evaluation also provides information on how different radiation doses using one image
reconstruction and material decomposition method affect the measurement of material
identification.
Finally, the relationship between the known and measured concentrations of
gadolinium and hydroxyapatite was analysed in the material images domain. This was
done to investigate how the MD algorithm accurately measures the known material
concentration at different tube currents.
3.5 Results
3.5.1 Thermoluminescence dosimeters, Four-hole phantom
and MTF phantom analysis
Table 3.2 shows the assessment of the SNR, the MTF and the absorbed dose results with
their standard deviations as a function of the four different tube currents. In addition,
the table 3.2 also shows the respective percentage change normalised to the results
obtained at 24 µA. The results at 24 µA is used to monitor the effect of increasing
the tube current on the SNR, the MTF and the absorbed dose. The mean SNR and
the MTF values were calculated from the four energy bins. The reason is to make the
analysis of the results concise. Also, to make it equivalent to the calculation of SNR
and MTF in the standard CT settings.
In table 3.2 it is noticeable that as the X-ray exposure increases the SNR and
the MTF value improved by less than 10%, but the absorbed dose rises by > 160%.
The MTF and SNR been weakly affected by tube current could be due to pulse pile-




Table 3.2: Mean SNR, 10% MTF over the four energy bins and absorbed dose
measurements at the four different tube currents. The percentage changes were
calculated using the results at 24 µA as the reference.
Tube current Mean SNR Mean 10% MTF Mean Absorbed dose
µA Pixel value(SD) % change lp/mm(SD) % change mGy(SD) % change
24.0 16.27(0.013) - 2.26(0.11) - 23.05(1.23) -
34.0 16.62(0.012) 2.2 2.30(0.13) 1.7 33.97(2.11) 47.4
44.0 17.52(0.012) 7.7 2.43(0.16) 7.3 46.08(4.24) 99.9
54.0 17.68(0.012) 8.7 2.46(0.13) 8.8 61.92(6.58) 168.6
lp = Line pairs, SD = Standard deviation
3.5.2 Spectral and linearity response
The detector’s ability to detect different materials was evaluated by plotting the spectral
response (in HU) against the energy bins used, as presented in figure 3.7.
The relationship between the signal intensities (HU) and the material concentrations
were assessed via the linear equation, as shown in figures 3.8 and 3.9. The established
linear equation is used to calculate the concentrations or spectral response of unknown
materials.
In figure 3.7, it was demonstrated that for each tube current the increase in the
energy causes a decrease in attenuation value (HU) of HA and Gd. However, higher
attenuation was observed for Gd at 50.2 keV (K-edge of Gd) for all exposure settings.
Also, from figure 3.8 and 3.9, there is a strong Pearson correlation of r in the range
of 0.92 to 0.99, respectively, for all the tube currents. However, when the material
concentration is zero the HU is not zero. This was observed in all the linear equations
of all the graphs plotted, as seen in figures 3.8 and 3.9. Poor linearity means a poor
quantification of material density in the MD images. The non-zero CT number at zero
concentration could be related to the possibility of some intrinsic noise in the detection
system, bump bond effect between the detector and the sensor layer, and imperfections
of the photon-counting detectors.
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Figure 3.7: The spectral response for the four different tube currents are plotted. (a)
Spectral response at 24 µA for the four energy bins. (b) Spectral response at 34 µA
for the four energy bins. (a) Spectral response at 44 µA for the four energy bins. (d)
Spectral response at 54 µA for the four energy bins. The spectral response indicates




Figure 3.8: Linear graphs are used to assess the relationship between the signal intensities
(HU) and the different Gd concentrations. (a) HU against Gd concentrations at 24 µA.
(b) HU as a function of Gd concentrations at 34 µA. (c) HU against Gd concentrations
at 44 µA. (d) HU as a function of Gd concentrations at 54 µA. A strong correlation of
r in the range of 0.92 to 0.99 were observed for all the tube currents. The standard
errors for (a), (b), (c) and (d) range from ± 2.56 to 5.62 HU. However, the standard
error bars were not shown to make the graphs concise.
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Figure 3.9: Linear graphs were plotted to assess the relationship between the signal
intensities (HU) and the different HA concentrations. (a) HU against HA concentrations
at 24 µA. (b) HU as a function of HA concentrations at 34 µA. (c) HU against HA
concentrations at 44 µA. (d) HU as a function of HA concentrations at 54 µA. A strong
correlation of r ≥ 0.99 was observed for all graphs plotted. The standard errors for (a),
(b), (c) and (d) range from ± 3.14 to 12.79 HU. However, the standard error bars were
not shown to make the graphs concise.
3.5.3 Material decomposition, identification and
quantification
Material decomposition of the Gd/HA calibration phantom provided material
concentration map of Gd and HA, as shown in figure 3.10. Some misidentification
at lower concentrations Gd and HA material image were observed, for all the tube
currents. Even though, from the spectral response (figure 3.7), all the concentrations
of HA and Gd were detected. The phantom body (PMMA) was also misidentified as
gadolinium. Since it is difficult to visually assess the effect of higher X-ray flux on the
misidentification, the post-MD quantitative metric (Raja et al., 2018) was applied to
the material images in figures 3.10 (b) and (c), to assess the level of identification and
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misidentification between the different material concentrations. The results are shown
in figures 3.11 and 3.12.
Based on the MARS team advices and on my study, a subjective diagnostic quality
reference threshold of ≥ 80% (shown with orange horizontal lines) was used for correct
identification of material concentration, as shown in figures 3.11 and 3.12. This is
because there is currently no acceptable threshold for correctly identified material. From
observation in figures 3.11 and 3.12, only Gd1 and Gd2 mg/mL did not meet the stated
threshold for all the tube currents.
The quantification assessment of the HA and Gd compared the measured
concentration against the known concentration for the four different tube currents,
as presented in tables 3.3 and 3.4. This assessment was influenced by the level of
material misidentification associated with the low material concentrations (shown in
figures 3.10, 3.11 and 3.12). The percentage change was used to assess the accuracy
of the measured material concentrations to the known concentration for all the tube
currents. The negative sign shows the measured concentration underestimate the known
concentration.
In addition, the Bland-Altman plots (Giavarina, 2015) in figures 3.13 and 3.14
show the agreement between the known and measured concentrations for Gd and HA,
respectively. For all tube currents, mean differences were within ± 1.96 SD (standard
deviation), indicating good agreement between both results. Root mean square error
(RMSE) values show the quantitative accuracy between the known and measured
concentrations. For varying imaging parameters, the RMSE of Gd ranges between 0.3
to 0.8 mg/mL (2 to 5 mM, respectively); for HA, RMSE values between from 14 to 27
mg/mL (70 to 134 mM, respectively).
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Figure 3.10: (a) Representative CT image slice of Gd/HA calibration phantom from
30-45 keV. (b) and (c) Quantitative material decomposition map of HA and Gd at
different tube current (24, 34, 44 and 54 µA). A cross talk between phantom body
(PMMA) and Gd is visible in (c).
Figure 3.11: (a), (b), (c) and (d) Quantitative assessment of material identification as a
function of tube currents for all concentrations of gadolinium. The green colour shows
the material identified as Gd, grey as HA, yellow as lipid and blue as water. Orange
horizontal lines show a subjective diagnostic quality reference threshold at 80% under
which material is considered not correctly identified for this study.
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Figure 3.12: (a), (b), (c), (d) and (e) Quantitative assessment of material identification
as a function of tube currents for all concentrations of hydroxyapatite. The green colour
shows the material identified as Gd, grey as HA, yellow as lipid and blue as water.
Orange horizontal lines show a subjective diagnostic quality reference threshold at 80%
under which material is considered not correctly identified for this study.
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Measured HA concentration (mg/mL) at the four tube currents
24 µA 34 µA 44 µA 54 µA
Measured(SD) % change Measured(SD) % change Measured(SD) % change Measured(SD) % change
54.3 36.5 (22.3) -32.8 43.6 (32.9) -19.8 38.5(28.1) -29.2 40.0(30.0) -26.4
104.3 82.1 (34.5) -21.3 103.5 (34.5) -0.8 82.3(36.9) -18.2 86.2(33.1) -17.4
211.7 186.9(40.7) -11.7 211.4 (39.9) -0.1 198.2(36.2) -6.4 198.4(41.8) -6.3
402.3 357.2(84.2) -11.2 372.7 (67.4) -7.4 383.0(49.2) -4.6 384.8(44.4) -4.3
808.5 797.6(100.8) -1.3 775.5 (77.4) -4.1 783.6(78.0) -3.1 808.7(72.6) 0.0
SD=Standard deviation





Measured Gd concentration (mg/mL) at the four tube currents
24 µA 34 µA 44 µA 54 µA
Measured(SD) % change Measured(SD) % change Measured(SD) % change Measured(SD) % change
1.0 0.7(1.0) -32.3 0.9(1.2) -11.4 0.9(1.3) -12 0.8(1.0) -13.8
2.0 1.4(1.3) -29.8 2.5(1.5) 22.9 1.9(1.4) -6.7 2.0(1.4) -0.5
4.0 3.2(1.7) -20.3 3.5(1.9) -11.8 3.6(1.5) -9.7 3.4(1.3) -13.2




Figure 3.13: Bland-Altman plots showing difference between known and measured
concentrations of Gd as a function of mean of known and measured Gd concentrations
for 24, 34, 44 and 54 µA. The black line denotes the bias and the dashed lines correspond
to upper and lower limits of the mean (confidence limits ± 1.96 SD). The RMSE between
known and measured Gd concentrations of Gd were calculated to be 0.8, 0.4, 0.3 and
0.4 mg/mL (4.9, 2.5, 1.8 and 2.8 mM, respectively) for varying tube currents.
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Figure 3.14: Bland-Altman plots showing difference between known and measured
concentrations of HA as a function of mean of known and measured HA concentrations
for 24, 34, 44 and 54 µA. The black line shows the bias and the dashed lines denote
upper and lower limits of the mean (confidence limits ± 1.96 SD). The RMSE between
known and measured HA concentrations were calculated to be 26.8, 20.4, 18.7 and 14.2
mg/mL (133.7, 101.8, 93.3 and 70.9 mM, respectively) for varying tube currents.
3.5.4 Mice imaging and dosimetry
The aim of this study is to use the ALARA principle of radiation protection to determine
dose for spectral imaging of small animals that has sufficient image quality and material
differentiation to meet clinical needs. Results in tables 3.2, 3.3 and 3.4 show that
increased tube current has no significant effect on material characterisation. Thus, with
the application of ALARA principle, the mice scans were performed with the tube
current of 24 µA while keeping the all other scan settings the same. Figure 3.15 shows
axial, coronal and sagittal views of the three mice, normalised into Hounsfield unit
using the water reference from the Gd/HA calibration phantom. The images are free
from obvious artefacts and regions of fat are clearly visible against soft tissue. No streak
or beam hardening artefacts were observed around highly attenuating region such as
the contrast mouse and bones. Figure 3.16 also shows the material component images
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for Gd concentration in bladder and kidneys, and bones obtained from the MD analysis
of the contrast mouse at high spatial resolution. Measured TLD-100s absorbed dose
results of different mice body parts are presented in the table 3.5.




(mGy ± standard deviation)
Mouth 20.4±2.3
Brain 26.4±2.1
Left front leg 29.4±2.9
Left kidney 30.8±2.7
Left rear leg 27.5±2.4
Right front leg 27.9±2.0
Right kidney 29.1±1.4





Figure 3.15: Selected axial, coronal and sagittal reconstructed image slices of the 30-45
keV energy channel for mice 1 to 3, displayed in Hounsfield units. The scans were
acquired using the scan settings of 118 kVp tube voltage, 24 µA tube current, 220 ms
exposure time and 80 mm scan length.
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Figure 3.16: (Left) A reconstructed coronal image of mouse 3 with gadolinium contrast
and TLD-100s. (Right) A sagittal view of the 3D volume rendering of the contrast
mouse material image using MARS Vision (Mandalika et al., 2018). The orange squares
show the TLD-100s in the mouse and the green shows Gd concentration deposition in
the bladder and the kidneys.
3.6 Discussion
In this chapter, the effects of tube currents on standard image quality indicators (SNR
and MTF), material identification and radiation dose were assessed. This was done by
applying the ALARA principle of radiological protection (Valentin, 2007; OECD, 2011).
The ALARA principle was used to optimise the absorbed dose delivered during spectral
imaging of small animals that have sufficient image quality and material differentiation
to meet clinical needs.
The tube current 24 µA was used as the reference to 34, 44 and 54 µA to assess
the effect of the tube current on the SNR, the MTF, the absorbed dose and material
identification.
From the table 3.2, the mean SNR rises as the tube current increases. The reason
is, as the tube current increases more X-ray photon interactions are recorded. This
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decreases the statistical deviation (noise) in the image. According to the Rose SNR
criterion, if an SNR is at least 5 there is a high assurance of spotting an object in
an image (Cunningham and Shaw, 1999). The calculated SNR was at least about 16,
for all the tube currents. The percentage changes in SNR of 2.2%, 7.7% and 8.7%,
corresponding to 34, 44 and 54 µA, respectively, were calculated.
Furthermore, the mean 10% MTF value at the tube current range of 24 to 54 µA is
at a spatial frequency range of 2.2 – 2.5 line pairs/mm, equal to a resolution range of
455.0 – 400.0 µm. The 10% MTF values show an increasing trend with the tube current,
as seen in table 3.2. CT spatial resolution depends on factors such as size of X-ray focal
spot, pixel size of the detector, reconstruction algorithm, reconstructed voxel size and
number of circular projections per single rotation. All such factors were kept constant
in this study. Although radiation dose may have no direct implications on CT spatial
resolution, statistical variation in the number of incoming photons can directly affect the
overall measurements. A similar increasing spatial resolution trend with respect to tube
current is reported by others using iterative reconstruction algorithms (Richard et al.,
2012). In table 3.2, the percentage changes of 1.7%, 7.3% and 8.8% were calculated for
34, 44 and 54 µA, respectively, using 24 µA as the reference.
Lastly, increasing the number of X-ray photons (tube current) comes at the cost of
increasing the radiation dose (table 3.2). The absorbed dose measured for all the tube
currents falls within the range of typical medical imaging procedures (10-100 mGy)
(Pernicka et al., 2007). It is also below the radiation dose range of small animal imaging
(100-300 mGy) (Boone et al., 2004). The percentage changes of the absorbed dose using
24 µA as the reference to 34, 44 and 54 µA were calculated to be 47.4%, 99.9% and
168.6%, respectively. The increase in percentage difference is expected.
The spectral responses (figure 3.7) show that all the materials used for this study
were captured. This information is necessary for the material decomposition algorithm
to separate the individual materials accurately. Generally, it was observed that HA and
Gd attenuation decreases with increasing energy for each tube current. This could be
attributed to the decreasing influence of the photoelectric effect and the increase of the
Compton scatter. However, a higher attenuation is observed in the region of 45 to 60
keV at each tube current (figure 3.7). This is the results of Gd K-edge impact at 50.2
keV. This result agrees with similar studies (Mahdieh et al., 2016; Raja et al., 2018).
Figures 3.8 and 3.9 show the system’s linearity response over a given range of
concentrations for the four energy bins, for each tube current. The linearity response
is a factor that determines the relationship between X-ray attenuation and material
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concentration. A good linear response indicates a strong relationship. There is a strong
correlation of ≥ 0.98 for all the material concentrations plotted at different tube currents.
This information is crucial for material quantification and identification. We observed
that the slope of HU versus material concentrations in all linear equations at different
tube currents to be relatively constant. The reason is, as the tube current increases
the number of photons increase which decrease the statistical image noise, thereby
improving the SNR and material identification. Furthermore, it was observed from the
linear equations in all the graphs in figures 3.8 and 3.9 that when we assumed zero
concentration, the HU is not zero. Some of the potential reasons for this occurrence
are the variation associated with the random features of X-ray photon interactions, the
random noise and the electronic noise from the detection system (Raja et al., 2018).
An unknown concentration of a specific material in the calibration phantom can be
calculated from the linear equations (figures 3.8 and 3.9).
The figure 3.10 (b) and (c) show the level of material concentration for the HA and
the Gd material image. We observed that the calibration phantom body (PMMA) has
been misidentified as gadolinium. Also, especially at the lower concentration of the
HA and the Gd, some misclassification was observed for all the tube currents. The
PMMA phantom body appearing on the Gd channel is likely due to the fact that
PMMA (density = 1.18 g/cm3; relative electron density = 1.147) has slightly higher
signal intensity than water (density = 1 g/cm3; relative electron density = 1) which
could make PMMA to be grouped under the dense material category during the MD
segmentation process. Bateman et al (Bateman et al., 2018) also reported similar
observations. However, we have not encountered similar problem of PMMA being
misidentified with other high-Z elements such as iodine and gold in one of our earlier
studies (Panta et al., 2018). The other reason could be around the similarities in the
elemental composition that is Perspex ((C5O2H8)n) is composed of elements which
are also present in Multihance (C22H28GdN3O11  2C7H17NO5). Despite capturing all
the materials attenuation profiles in the energy images (figure 3.7). This leads to the
quantification of material identification and misidentification.
The key aim of every spectral system is to identify materials correctly and to
measure their concentrations accurately. The effects of the tube currents on the
material identification and misidentification (figures 3.11 and 3.12) were assessed. Based
on the stated condition (correct material is when ≥ 80% of the material’s concentration
is identified), it was observed from the figures 3.11 and 3.12 that ≥ 80% of the HA and




The Gd1 and Gd2 mg/mL were further investigated to assess the effect of increasing
the tube current on the material identification and misidentification. The rise in the
tube current increases the 30% and 70% material identification of Gd1 and Gd2 mg/mL
at 24 µA to 56% and 88% at 44 µA and then drops to 52%, 82% at 54 µA (figure 3.11
(a) and (b)), respectively. Even though, Gd1 and Gd2 mg/mL were identified from the
system’s spectral response (shown in figure 3.7) for all tube currents. Similar trends
were also observed in the material concentrations that met the stated condition (correct
material is when ≥ 80% of the material’s concentration is identified). Lastly, it was
observed that more misidentification occurred in the lower Gd material concentrations,
as shown in the figure 3.11 (a) and (b), for all the tube currents.
This suggests there could be other factors that are likely to influence the material
identification and misidentification. Pulse pile-up is one of the factors known to affect
the material identification in photon counting detectors (Taguchi et al., 2010; Atharifard,
2017). Pulse pile-up occurs when two or more X-ray photons hit the same detector
area within the same readout chip processing time. The readout chip, therefore, sees
these hits as a single hit leading to loss of energy resolution and counts. Increasing
the tube current enhances the potential of pulse pile-up effects in photon counting
detectors (Panta et al., 2015). The decrease in the material identification of Gd1 and
Gd2 mg/mL from 44 to 54 µA could be attributed to the pulse pile-up effects. Another
factor is image noise, due to photon statistics. Noise plays a crucial role in detecting
low atomic number (Z) materials and identification of low concentrations of high Z
materials. Lastly, semiconductor detector inhomogeneity (Raja et al., 2018) could also
affect the identification of materials.
Protocol optimisation is a key to improving material identification such as optimal
energy threshold and energy bin size to capture all material signatures and improve
the SNR. Optimising the material decomposition algorithm could also improve the
material identification at lower concentrations. For instance, the MD algorithm should
be more specific to the imaging protocol. The pulse pile-up issue in the detection system
modelled by Atharifard (2017) should be implemented. Increasing the number of energy
bins in the charge summing mode could decrease the pulse pile-up effects too.
In spectral imaging, material identification plays a major role in quantifying the
correct material concentrations. From tables 3.3 and 3.4, the measured Gd and HA
concentrations for all the tube currents in most cases underestimate their known
concentrations. However, the Bland-Altman plots between the measured and known
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Gd and HA concentrations showed good agreement for all the tube currents. The
spatial accuracy obtained in our study was consistent to that of previously reported
studies using similar image acquisition and material decomposition methods Raja et al.
(2018); Mahdieh et al. (2016). Another study conducted by Curtis et al (Curtis and
Roeder, 2019), using different image acquisition parameters and material decomposition
methods, reported quantitative accuracy of Gd as RMSE ≈ 2 mM or 0.3 mg/mL. The
measured RMSE of Gd in our study was found between 0.38 to 0.8 mg/mL (2 to 5
mM, respectively) across four different tube currents. Despite the close correlation of
measurements it is important to highlight that different image acquisition settings could
have a major impact on spectral image quality in terms of image contrast, noise levels
and material differentiation.
In summary, the results showed that, as tube current increased from 24 to 54 µA,
the SNR improved by < 10%, gadolinium identification improved by < 55% for 1 and
2 mg/mL (6.4 and 12.7 mM, respectively), whilst the radiation dose increased by >
160%, with respect to 24 µA. The measured Gd and HA concentrations for all tube
currents underestimate in most cases the known concentrations due to some material
misidentification. However, the Bland-Altman plots between the measured and known
Gd and HA concentrations in Figs. 3.13 and 3.14 showed good agreement for all tube
currents. Therefore, by applying the ALARA principle, the tube current 24 µA was
chosen as the optimised tube current. The tube current (24 µA) gives similar material
differentiation quality compared to the rest of the tube currents. These phantom results
show a high potential for clinical photon counting CT systems to use lower tube current
to achieve a significant decrease in radiation dose with only minor losses in image quality.
Photon-counting CT detectors make this feasible by measuring the energy of every
detected photon thereby providing equal weighting to low and high-energy photons,
which ultimately results in good contrast even at reduced radiation dose levels.
The images of scanned mice were obtained at high energy resolution (3.5 keV) and
high spatial resolution using the optimised tube current (24 µA), as shown in figure 3.15.
The mean SNR, mean 10% MTF and mean absorbed dose obtained for the optimised
tube current (24 µA) were 15.5, 2.2 line pairs/mm (454.5 µm) and 23.0 mGy (table 3.2),
respectively. On the MARS Vision imaging processing software (Mandalika et al., 2018;
Chernoglazov, 2016), superior and almost noise-free images of the mice can be visualised
(figure 3.16). The mean absorbed dose of the mice with the standard deviation was 27.3
± 2.4 mGy, falling below the absorbed dose range of small animal imaging (100-300
mGy) for conventional micro CT (Boone et al., 2004). This value represents the average
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whole-body irradiation of the mice. This result show the potential to identify and
quantify antibodies, liposomes, or micelles labelled with gold, iodine, gadolinium or
other high-Z metals in living mouse models at a reduced dose, before moving to large
animal studies with a larger MARS scanner currently under construction and testing.
More recently, a study conducted in the MARS group showed that the MARS photon
counting scanner technology can be translated to scan living humans at a similar spatial
resolution (Panta et al., 2018).
There are various limitations to our study which need to be considered while
interpreting their implications. One of the major limitations is sample size i.e., number
of contrast materials. Only one contrast agent (Gd) was used in this study, however, a
more robust evaluation could be performed in a phantom with potential high-Z elements
that can be developed for photon counting CT imaging. Another limitation was using
an older version of the MARS scanner with a single Medipix3RX chip (14 mm × 14
mm) camera which required multiple vertical translations to cover a 31 mm FOV size.
This limitation has now been addressed for future studies at the time of writing this
thesis by the expansion of the detector array. We now have three versions of MARS
scanners incorporating a 3-chip (42 mm × 14 mm), 5-chip (70 mm × 14 mm) and
7-chip (98 mm × 14 mm) cameras which has significantly reduced the overall scanning
time. Lastly, another shortfall could be due to using only tube current to assess the
material identification, standard image quality indicators and radiation dose. Further
studies can be conducted to assess the effect of standard image quality indicators on
material identification, using other scan settings.
In conclusion, these results may suggest the inability of standard image quality
indicators (SNR and MTF investigated in this thesis) to evaluate the performance of
current MD algorithm developed for the MARS spectral imaging. Furthermore, it was
observed that the assessment of material identification can be used as an additional
quality control tool to characterise lower detectable limits of any given material in
spectral CT. Moreover, the results show the energy-resolving capability of photon-
counting CT maintains image quality, with correct material identification at reduced
radiation dose. The tube current deduced in this chapter can be used to further optimise
the MARS scan settings. The established method could also be used to evaluate the
material decomposition algorithm performance. Lastly, a method for optimising MARS
spectral CT scan settings has been established. This method will be used to optimise
MARS scan settings for the MARS human clinical trials.
The work presented in this chapter aligns with the MARS project goal (providing
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economic and health benefits to New Zealand) by assessing and optimising the MARS
scan settings. This is achieved by ensuring the MARS scan settings provides a minimum
absorbed radiation dose with good material differentiation quality for research and
clinical health care use. In addition, it enhances customer’s confidence to patronise the
MARS scanners thereby generating income for New Zealand.
3.7 Summary
The main points in this chapter are summarised:
 This chapter presents a method to optimise MARS scan settings. The aim of
this study is to use the ALARA principle of radiation protection (Valentin, 2007;
OECD, 2011) to determine dose for spectral imaging of small animals that have
sufficient image quality and material differentiation to meet clinical needs.
 A method for optimising MARS spectral CT scan settings has been established.
This method will be used to optimise MARS scan settings for preclinical studies
and the MARS human clinical trials. In addition, the method could be used to
evaluate the material decomposition algorithm performance.
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Chapter 4
GATE Monte Carlo modelling and
simulation of MARS
4.1 Overview
This chapter demonstrates the initial steps taken for a full dosimetry simulation package
for the MARS imaging system based on the Geant4 Application for Tomographic
Emissions (GATE) Monte Carlo (MC) simulation toolkit1.
The MARS simulation package will be used with the method established in chapter 3
to optimise MARS scan settings and perform material-specific radiation dose simulation.
In addition, this chapter seeks to build a solid foundation to quantify an accurate
three-dimensional (3D) material-specific dose. The essence is to assess and quantify
accurate radiation risk to simple (phantom) and complex geometries (spectral CT data
and material density image). This, in turn, will lead us to our overall objective of
personalised dosimetry. Moreover, the simulation package could provide a convenient
and quicker way to assess and optimise the MARS scanner radiation dose. Finally,
the dosimetry simulation package could serve as a prototype to carry out dosimetry
simulation for the MARS human and body-part scanners.
This study uses the MARS-11 scanner with three Medipix3RX detectors located in
the University of Otago, Christchurch campus.
In section 4.2, the need for the MARS scanner dosimetry is discussed. The procedure
for developing and implementing the MARS small-bore spectral scanner in the GATE
toolkit are discussed, in sections 4.3 and 4.4. Section 4.5 validates the simulation of




MARS small-bore spectral scanner. The results of these validations are discussed in
section 4.6. Finally, a summary of the chapter is presented in section 4.7.
I was the principal investigator. I would like to thank Robert Thirkettle for
fabricating the phantom holder for the radiation dose in air measurements. Lastly, I
thank Dr Marzieh Anjomrouz and Dr Steven Marsh for their useful discussions in the
X-ray energy spectrum generation.
4.2 Introduction
The use of small animal computed tomography (CT) systems for preclinical examinations
and excised biological specimens are increasing (Ritman, 2004; Lee et al., 2016, 2013).
This is due largely to small animal studies serving as a platform for optimisation of
image reconstruction algorithms, image quality and scan settings for clinical usage
(Deak and Kalender, 2009).
Small animal imaging is normally done at higher resolution typically ranging from
50-100 µm. Hence, requiring imaging at high signal-to-noise ratio and contrast-to-noise
ratio to clearly visualise small organs of interest (Deak and Kalender, 2009). This
imaging procedure comes at the expense of high radiation dose to the sample/specimen.
Hence, increasing the potential of the radiation detriment to live specimen and interfering
with experimental results. Typical preclinical radiation dose reported by other small
animal systems ranges from 17 to 300 mGy depending on the scan settings (Deak and
Kalender, 2009; Boone et al., 2004; Taschereau et al., 2006; Carlson et al., 2007).
Small animal imaging is associated with a large radiation doses, therefore, it is
imperative to quantify the radiation dose in order to evaluate the radiological detriment.
The radiation health detriment could be minimised by reducing the radiation dose using
phantoms and MC simulations without involving the actual animal. Several researchers
have conducted radiation dose measurements either through physical measurements
(using an ionisation chamber and thermoluminescence dosimeters) or MC simulations.
However, the use of ionisation chambers and thermoluminescence dosimeters (TLDs)
has some limitations. For instance, ionisation chambers and TLDs fail to account for
accurate tissue dosimetry (Hupfer et al., 2012). MC simulations, on the other hand,
is an easy and quick method for conducting accurate tissue dose measurements. MC
simulation allows scoring of 3D dose to either unvoxelised phantoms (mathematically
defined phantoms) or voxelised phantoms (patient CT image) specific to scanner
geometry and scan settings (Sarrut et al., 2014; OpenGATE, 2016; Hupfer et al., 2012).
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MC simulations are often used to solve physical and mathematical problems, which
other approaches may find it difficult to resolve. There are plethora of MC simulations
which depend on repeated random sampling to obtain numerical outcomes. The basic
concept is using randomness to work out problems that might be deterministic in
principle (Kroese et al., 2014).
MC simulation plays a major role in many medical fields such as imaging and
radiotherapy. For instance, MC simulation for imaging applications are employed
to design new equipment, investigate the effect of various scans settings on image
quality, assess and validate image reconstruction techniques, study imaging detectors
and radiation dose (Reuillon et al., 2008; Jan et al., 2011). Lastly, MC simulations are
also employed in radiotherapy to implement fast dose deposition algorithms and to
define beam properties.
4.3 Materials
The components of the MARS small-bore scanner necessary for the simulation studies
were discussed. Additional equipments such as the Unfors Raysafe Solo CT ionisation
chamber and a 30 mm diameter custom-built CT dose index (CTDI) phantom used for
this chapter were discussed. The CTDI phantom is used to mimic a real mouse.
4.3.1 Experiment
MARS-11 with three Medipix3RX detectors (Ballabriga et al., 2013) was used for this
study. The main components of the MARS scanner considered for the simulation
are rotating gantry and X-ray tube. For more information on the MARS scanner
specifications, see chapter 2.
Rotating gantry and X-ray tube specification
The gantry contains the X-ray tube and the Medipix3RX detector. The X-ray source unit
currently used in the MARS small-bore scanner is the model M-SB-120-350 manufactured
by Source-Ray, Inc (Manez, 2012) with the specification shown in table 4.1. The X-
ray tube specifications in table 4.1 were used to model and simulate the X-ray beam
geometry in the simulation.
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Table 4.1: Physical specification of the source unit model SB-120-350
Parameter Value
Focal spot 0.07 mm Nominal
Target material 1 mm thick Tungsten (W) anode
Filament material Tungsten
Anode body Copper (Cu)
Inherent filtration 1.8 mm aluminium (Al)
Target Angle 20◦
Tube potential range 60-120 kVp
Tube current range 10-350 µA maximum
Glass frame Borosilicate 0.085 thick
Unfors Raysafe Solo CT ionisation chamber
The Unfors Raysafe Solo CT ionisation/ion chamber is a cylindrical pencil chamber. It
is designed to measure the CT dose to determine units and indexes such as dose length
product (DLP) (mGy.cm) and CTDI (Gy). The CT ionisation chamber dimensions
are 100 mm in height as the active length, 3 mm3 in volume, and 6.2 mm in diameter.
Automatic correction of temperature and pressure is applied to all dose measurements
with an uncertainty below 2%. The radiation dose measuring range is about 1 to 9999
mGy with expended uncertainty (k = 2) on dose (at a reference beam RQT9; 120 kV,
3.7 mm Al and 0.25 mm Cu) below 5%. The calibration certificate ensures energy
dependence below 5% between 80 kV and 150 kV (RQA, RQR and RQT qualities). The
calibrated CT ionisation detector has a slice width of 1 cm. The ionisation chamber has
a base unit for displaying results. The CT ionisation chamber reading is calibrated by
the Physikalisch Technische Bundesanstalt (PTB), traceable to the National Institute
of Standards and Technology (NIST). The ionisation chamber was calibrated in terms
of air kinetic energy released per unit matter (air kerma) in free air. The reading is
displayed on the base unit of the CT ionisation chamber. Figure 4.1 shows a picture of
the Unfors Raysafe Solo ionisation chamber.
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Figure 4.1: The Unfors Raysafe Solo CT ionisation detector with cabling and a base
unit for displaying result.
CTDI PMMA phantom
The standard cylindrical CTDI polymethyl methacrylate (PMMA) phantom for the
head (16 cm) and the body (32 cm) used in clinical settings cannot be used in the
MARS small-bore scanner. This is because the size is bigger compared to the internal
size of the gantry. In the clinical CT domain the measured CTDI100 is done at the
edges of the outer peripheral and in the centre of the PMMA phantom to compute
weighted CTDI. However, considering the relatively large size of the standard CTDI
phantoms, a modified version was custom-built suitable for dose measurement in the
MARS scanner, as shown in figure 4.2. The specifications of the custom-built CTDI
PMMA phantom are 30 mm diameter, 12.5 mm inner hole diameter, 100 mm in length
and mass density of 1.195 g/cm3. Due to the relatively small size of the custom-built
CTDI phantom compared with the ionisation chamber makes a measurement of the
CTDI100 (equation (4.6)) close to the outer peripheral impractical. For the purposes of
this study, we will call it “CTDI” phantom. The density of PMMA makes it suitable for
tissue-equivalent dosimetry. The inner centre hole of the phantom is where the Unfors
Raysafe CT ionisation chamber is inserted.
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Figure 4.2: CTDI PMMA phantom
4.3.2 Simulation
The programs used for the simulation are discussed as well as how the experimental
materials were modelled.
Geant4 Monte Carlo simulation platform
Geant4 (for GEometry ANd Tracking) (Agostinelli et al., 2003) is a general purpose
MC simulation code developed at the European Organization for Nuclear Research
(CERN) (Geneva, Switzerland). Geant4 plays a crucial role in this study since it is
the backbone of the GATE MC simulation toolkit. Geant4 is a free software package,
composed of tools which can be used to accurately simulate the transport of particles
through matter. Geant4 is capable of handling the modelling of modern particle and
nuclear physics for high energy physics experiments. Its major areas of application are
high energy, nuclear and accelerator physics, medical and space science (Agostinelli
et al., 2003).
GATE MC simulation toolkit
GATE toolkit, developed by the international OpenGATE collaboration is an open-
source software like Geant4 dedicated to numerical simulations in medical imaging
and radiotherapy, first publicly released in 2004 (Jan et al., 2011). Currently, it
supports simulations such as the Emission Tomography (Positron Emission Tomography
(PET), the Single Photon Emission Computed Tomography (SPECT)), CT, Optical
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Imaging (Bioluminescence and Fluorescence) and radiotherapy experiments (Ne and
Lazaro, 2006). GATE combines a powerful simulation core, the Geant4 toolkit, with
newly developed software components dedicated to nuclear medicine. GATE is also an
object-oriented simulation platform with the intention to provide a long-term versatile
solution for a large range of problems (Agostinelli et al., 2003). GATE provides a
platform for accurate and precise MC simulations for a large range of PET, SPECT, and
CT applications that include scanner design, statistical image reconstruction, scatter
correction, and scan settings optimisation (Agostinelli et al., 2003).
GATE makes use of the benefits of Geant4 toolkit such as well validated physics
models, complex geometry description, powerful visualisation and 3D rendering tools.
It has mechanisms to manage time, geometry, and radioactive sources from a core
layer of C++ classes close to the Geant4 kernel. Furthermore, it makes use of an
application layer which allows the implementation of user classes derived from the
core layer classes. For instance, building specific geometrical volume shapes and/or
specifying operations on these volumes like rotation or/and translation. The user layer
makes the use of GATE very easy and simple through a dedicated scripting mechanism,
called macro language. The function of the macro language is to extend the native
command interpreter of Geant4. This makes it possible to perform MC simulations
of realistic set-ups. Hence, does not require one to know C++ programming prior to
using GATE (OpenGATE, 2016; Jan et al., 2004). Figure 4.3 illustrates the structure
of the GATE toolkit.
Figure 4.3: Structure of the GATE MC simulation toolkit. Reproduce from (OpenGATE,
2016; Jan et al., 2004)
Reasons for using the GATE MC toolkit
Numerous MC simulation tools have been developed for imaging and dosimetry.
Currently, GATE is the only open-source MC simulation platform supporting the user-
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friendly simulation of imaging, radiation therapy and dosimetry in the same environment
(OpenGATE, 2016). GATE is potentially useful for a spectrum of simulations such as
PET, CT and SPECT studies (Sarrut et al., 2014) as well as boosting on widely validated
physics settings. Furthermore, one does not need to know C++ programming to run a
simulation in GATE (OpenGATE, 2016). Moreover, GATE is quickly becoming the
standard MC simulation toolkit used by the Medical Physics division at the University
of Canterbury and boasts on dedicated user support and active online user-forum.
As a beginner in MC simulation, the description of GATE toolkit makes it more
suitable to use. Lastly, GATE fulfils our simulation tool requirement for conducting
accurate tissue/material-specific dosimetry using mathematically defined phantoms,
computerised digital phantoms, mesh volumes and patient CT images.
4.4 Methods
4.4.1 Statistical analysis of data
In this study, various statistical approaches were employed to assess the difference
between the physical measurement and the simulation. The percentage change
equation 4.1 was used to investigate the difference in the dose measurements (physical
measurement and simulation), the beam collimation width difference between physical
measurement and simulation, and the first half value layer difference. The symmetric
mean absolute percentage error (SMAPE) equation 4.2 (Schnaars, 1986; Chen et al.,
2017; Anjomrouz, 2017) was used to calculate the accuracy of the simulated X-ray
energy spectrum compared with other spectrum within 0-100%. The energy bin of 1 keV
was considered for the error calculation between the spectra. The Pearson correlation
was used to find the relationship between the simulation and the physical measurement.
Lastly, the ImageJ software (Rueden et al., 2017) was used to analyse the radiation








Ds is the simulated dose (calculated value) and












n = number of energy bins used
TE = counts at each energy bin for this study simulated X-ray energy spectrum.
OE = counts at each energy bin for other X-ray energy spectrum.
4.4.2 CT ionisation chamber experimental procedure
The experimental procedure took into account some precautions to ensure the measured
radiation dose is of high accuracy and precision. The two main processes that are known
to affect the physical measurements are initial X-ray warm-up and the acquisition
of flat-field projection data. The X-ray warm-up phase prepares the X-ray tube to
attain stability prior to the sample scan. Precaution was taken to avoid the irradiation
of the chamber selecting an option on the MARS scanner console which allowed the
chamber to be removed before initial X-ray warm-up and during flat-field projection
data acquisition (after sample scan).
The ionisation chamber (figure 4.1) was placed inside the MARS scanner to record
real-time dose, and a readout unit was placed outside the gantry. A universal serial bus
(USB) cable was carefully connected through the gaps in the gantry from the readout
unit outside to the ionisation chamber inside. The radiation dose measurements were
conducted with the ionisation chamber suspended in free air and inserted into the centre
hole of the CTDI phantom (figure 4.2), using the scan settings presented in the table 4.2.
All the physical measurements were performed at a single axial rotation. The value
measured by the ionisation chamber is the air kerma to the entire sensitive volume.






(Gy), the same unit as absorbed dose. Nevertheless, kerma can be different from
absorbed dose, depending on the energies involved. For low energy photon beams











since the fraction of
energy loss due to bremsstrahlung by secondary electrons is less than 0.3% (Ma et al.,
2001b; Bushberg, 2003). Also, assuming that charged particle equilibrium (CPE) exit
(Attix, 2007; Bushberg, 2003), the air kerma equals the absorbed dose in air. If an air
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kerma is measured or calculated at a point in soft tissue, the absorbed dose to the soft
tissue is approximately the same as the air kerma. Hence, the reason why we used the
absorbed dose in chapters 5 and 6.
4.4.3 Simulation
The modelling and simulating of the MARS scanner, the Unfors Raysafe Solo CT
ionisation chamber, and the CTDI phantom followed the general dosimetry steps in the
GATE user’s guide:
(i) MARS scanner geometry
(ii) Unfors Raysafe Solo CT ionisation chamber and CTDI phantom
(iii) Simulation output




4.4.4 MARS scanner geometry
The components of the MARS scanner were modelled based on volumes. The volume is
characterised by shape, size, position, and material composition. The default volume
in GATE is the mother, defined as 70 × 70 × 70 cm3 composed of air. The MARS
scanner was simplified as a rotating X-ray tube housing and collimator, placed 200
and 160 mm from the centre of rotation, respectively. The X-ray tube housing was
defined as a vacuum box having a width of 2.5 cm, a length of 5.0 cm and a height of
2.5 cm. The X-ray tube housing contained the X-ray source and aided the X-ray source
to rotate around the phantom. The collimator was defined as a lead box (30 × 0.36
× 30 cm3) with a hole at the centre. The hole is defined as a box (9.88 × 3.6 × 2.2
mm3) filled with air, served as the collimation width. Figure 4.4 is a schematic diagram
showing the modelled MARS scanner, the X-ray tube housing and the X-ray source,
the collimator and the ionisation chamber.
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Figure 4.4: Schematic diagram of the modelled MARS small-bore scanner. The ionisation
chamber, the collimator, the X-ray tube housing and the X-ray source. The scanner
was parked with the X-ray tube housing at the 12 o’clock position
.
4.4.5 Ionisation chamber and CTDI phantom
In this chapter, mathematically defined phantoms were used. The Unfors Raysafe Solo
ionisation chamber and mouse size CTDI phantom were modelled, as shown in the
figure 4.5, based on the known specification in chapter 4 subsubsections 4.3.1 and 4.3.1.
The ionisation chamber was modelled as a single cylindrical phantom composed of air.
The ionisation chamber and the mouse size phantom were used for the radiation dose
validation and comparison, respectively.
Figure 4.5: GATE model of the custom-built CTDI phantom (cyan) and the Unfors
Raysafe Solo CT ionisation chamber (red). (a) Longitudinal view of the ionisation




The three actors namely dose, energy spectrum and statistics actor in the GATE toolkit
were used to record the simulation output information. The actor functions like a
detector to record and store the simulation information (Sarrut et al., 2014; OpenGATE,
2016; Chetty et al., 2006). The dose actor was used to randomly store absorbed dose
(Gy) or/and energy (MeV) in 3D images of the specific volume of interest. The dose
actor file format used was metaImage (mhd/raw) (Sarrut et al., 2014; OpenGATE,
2016; Chetty et al., 2006). MetaImage file format was used because it can be handled
by most open-source image processing tools, such as vv (Seroul and Sarrut, 2008), Fiji
(Schindelin et al., 2012) and ImageJ (Rueden et al., 2017). The energy spectrum actor
was used to store the X-ray spectrum information by taking into account the weight of
particles. The energy spectrum actor gives information about the X-ray photon energies
and their associated normalised counts/intensities. The statistics actor was used to
record information about the simulation such as the duration, the number of source
particles simulated, and the start and end date of the simulation.
4.4.7 Physics package set-up
GATE uses the Geant4 models for physics processes and interactions. For simulating
low energy applications such as medical imaging and dosimetry, the low energy physics
package is used. The GATE standard energy package called the emstandard opt3 was
used (OpenGATE, 2016). This is because it can simulate the photoelectric effect and
the Compton scattering at energies above 10 keV. This physics package contains all
the physics processes needed for this study in the human imaging energy range of
30-120 keV. It included the photoelectric effect, Compton scatter, Rayleigh scatter,
Bremsstrahlung, ionisation, and fluorescence. There is also the flexibility of customizing
the simulation by adjusting the production thresholds and the cuts (OpenGATE, 2016).
4.4.8 Simulation initialisation
The first four steps described (MARS scanner geometry, phantoms, simulation actors
and physics package set-up) forms the pre-initialised phase of Geant4. The initialisation
phase activates the cross section tables calculation (OpenGATE, 2016) (more information
on the calculation of the cross section can be found in the GATE user manual). After
the initialisation, the physics processes can neither be modified nor additional volumes
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can be inserted into the already modelled geometry (OpenGATE, 2016).
4.4.9 Source spectrum
The source spectrum was introduced into the simulation after the initialising step.
In this chapter, two X-ray energy spectra have been simulated using two different
approaches. The first approach was using the MARSpec X-ray generated energy
spectrum as an input in the simulation. The MARSpec (Anjomrouz, 2017; Shamshad,
2017; Anjomrouz et al., 2018) is an in-house X-ray spectrum generating program similar
to the SpekCalc (Poludniowski et al., 2009; Poludniowski and Evans, 2007). The second
approach was done by modelling and simulating the X-ray tube in the GATE toolkit,
based on the X-ray source specification, as shown in table 4.1 (more information in
subsubsection 4.4.9).
MARSpec development
The development of the MARSpec was based on the BEAMnrc toolkit (Anjomrouz, 2017;
Shamshad, 2017). BEAMnrc is a dedicated MC simulation toolkit based on the Electron
Gamma Shower National Research Council (EGSnrc) Code system (Kawrakow, 2000).
BEAMnrc is dedicated for modelling and simulating radiotherapy sources (Rogers, 2006;
Rogers et al., 2017). BEAMnrc was used to simulate the MARS scanner X-ray tube
based on the specification in table 4.1 (Anjomrouz, 2017; Shamshad, 2017). They used
the simulated spectrum and a written MATLAB code (MathWorks, 2017) to develop
an MC program called MARSpec. MARSpec is capable of generating an X-ray energy
spectrum based on different scan settings used.
The BEAMnrc toolkit was used to simulate the X-ray source due to its friendly
graphical user interface (GUI) and its dedication to model X-ray tubes and accelerators
(Rogers, 2006; Rogers et al., 2017). The GUI of the BEAMnrc program can be seen
in figure 4.6. The X-ray spectrum generated by the MARSpec was used for all the
dosimetry simulations in this thesis.
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Figure 4.6: BEAMnrc GUI of the X-ray source simulation. White arrow shows the
electron direction striking the tungsten anode (red). The produced X-ray photons pass
through a 1.8 mm Al equivalent inherent filter (orange). Image courtesy of (Anjomrouz,
2017; Shamshad, 2017).
Application of MARS scanner settings to MARSpec
The tube current (24 µA) and other scan settings (such as 120 tube kilovoltage potential
(kVp), inherent filter 1.8 mm Al, additional filter 0.375 mm brass and exposure time
220 ms) in the chapter 3 were used in the MARSpec to generate the X-ray energy
spectrum (seen in figure 4.7). The motive for using the X-ray spectrum generated from
the MARSpec was due to its development based on the MARS small bore scanner
specifications and incorporating on and off-axis X-ray beam fluxes. Unlike other X-ray
spectrum programs such as the SpekCalc (Poludniowski et al., 2009; Poludniowski and
Evans, 2007) and the tungsten anode spectral model using interpolating polynomials
(TASMIP) (Boone and Seibert, 1997) that deals with only central axis X-ray beam flux.
However, the SpekCalc was used as a standard spectrum in this study for comparison.
This is because SpekCalc is internationally accepted and widely used. The commercial
version of the SpekCalc software was purchased. This SpekCalc is capable of generating
X-ray spectrum in the tube voltage ranges of 40 to 300 kVp from a tungsten anode




Figure 4.7: X-ray spectrum generated from the MARSpec
MARSpec X-ray spectrum in the simulation
The X-ray spectrum generated from the MARSpec (seen in figure 4.7) was imported
into the simulation as the source spectrum. In the simulation, the X-ray spectrum was
defined as a point source using the general particle source (GPS) definition handled by
the Geant4. The point source has isotropic emission angle distribution with an angular
span equal to equation (4.3).
0◦ ≤ θ ≤ 7.32◦ 0◦ ≤ φ ≤ 360◦ (4.3)
This means all the X-ray photons have a polar angle (θ) between (0 and 7.32) degrees
and travels along with directions orthogonal to the z-axis. This polar angle helped to
irradiate the standard field of view (FOV) of 32 mm used in the MARS scanner. For
the azimuthal angle (φ) between 0 and 360◦, the X-ray photons are emitted along with
all possible directions. The angular distribution was to simulate cone-beam geometry
and to imitate the 32 mm FOV. Figure 4.8 shows a schematic diagram for calculating
the polar angle (θ) of the 32 mm FOV. The point source description was used as the
MARS X-ray beam model. In order to be as realistic as possible, neither variance
reduction techniques (VRTs) were used in the modelling of the physical processes nor
cuts set on any of the simulated volumes. Variance reduction techniques are used to
reduce the statistical error in the simulation.
The simulated MARSpec X-ray spectrum was recorded on a detection/scoring plane
(1 cm wide by 1 nm thick by 1 cm long) filled with air. The scoring plane was placed at
a distance of 20 cm from the X-ray source. The probability weighting of each X-ray
photon energy was recalculated and normalised by the GATE toolkit. The simulated
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X-ray spectrum was recorded by the energy spectrum actor with an energy resolution
of 1 keV. The simulated MARSpec X-ray spectrum was used for all the dosimetric work
in this study.
Figure 4.8: Schematic diagram of the MARS scanner demonstrating the calculation
of the polar angle (θ) corresponding to 32 mm FOV used in the MARS scanner. The
X-ray photons, the collimator, the ionisation chamber and the detection/scoring plane
are also shown.
Modelling and simulating MARS X-ray tube in GATE
The MARS X-ray tube was modelled and simulated using the GATE toolkit. The
purpose of this simulation was to cross-check the spectrum generated from the MARSpec.
In addition, to show the potential of using it for future studies. A script was written
in GATE based on the specification presented in table 4.1 to conduct the simulation.
In the simulation, an assumption was made by considering all the inherent filtration
including the glass casing and surrounding oil coolant to be equivalent to 1.8 mm Al
filter.
In the MARS scanner, two additional filtrations (0.375 mm brass and 2 mm Al)
are used for daily imaging and dosimetry purposes. The additional brass filtration was
modelled as 0.375 mm thick Cu because Cu has the same attenuation characteristics
as brass. The additional aluminium filtration was modelled as 2 mm Al. The anode
target was modelled as 1 mm thick tungsten while the cathode filament was modelled
as a 120 keV mono-energetic electron source with the isotropic distribution. The GPS
definition in GATE toolkit was adopted. The electron source type was modelled as a
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plane with a circular shape of 70 µm focal spot.
A VRT was applied to split the number of Bremsstrahlung X-ray photons by 1000.
The VRT application decreases the statistical deviation and improves the probabilities of
the X-ray photon interactions, especially for the Bremsstrahlung X-ray photons, without
affecting the magnitude of the deposited radiation dose. The GATE default standard
electromagnetic physics package called the emstandard opt3 was used (OpenGATE,
2016). This physics package contained all the physics processes (photoelectric effect,
Compton scattering, Rayleigh scattering, Bremsstrahlung, ionisation, and fluorescence)
needed for my investigations. Cut thresholds were applied on the modelled anode, for
the electron (10 µm) and gamma (0.1 µm). These cut thresholds were obtained based
on multiple simulations and were then converted internally into energy thresholds in
the simulation to limit the productions of electron and gamma below the specified
thresholds. In addition, the cuts helped to increase the computational speed.
The simulation was run with 1×109 primary source particles (electrons) with GATE
default random seed engine called the Mersenne Twister. Mersenne Twister is used
because it is recent, fast and passes almost all the test of the test battery TestU01
(Reuillon et al., 2008; OpenGATE, 2016). The scoring plane composed of air with
dimensions (70 mm × 1 nm × 70 mm) was used to record the X-ray energy spectrum.
The scoring plane was placed at a distance of 10 cm from the X-ray source. The
scoring of the X-ray spectrum was done in the air. The computing system used has the
specifications Intel (R) Core (TM) i7-6200U CPU @ 3.40 GHz, ≈ 3.40 GHz and 16.0
GB RAM.
The GUI of X-ray tube modelling and simulation is shown in figure 4.9. Figure 4.9
(b) illustrates the transport of the X-ray photons and electrons. The few photons
observed are due to the 10000 electron histories (10000) simulated.
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Figure 4.9: (a) GATE GUI of the MARS scanner X-ray tube source, the additional
filtration (copper or aluminium) and the scoring plane. (b) Simulation of the X-ray
photons and the electrons from the X-ray tube source. The few photons observed are
due to the 10000 electron histories simulated.
4.4.10 Acquisition parameter
The acquisition parameter is the final step of the simulation. The acquisition parameter
was used to define the start and the end of acquisition, to imitate a real-life experiment.
Equation (4.4) from the GATE User’s guide was used to calculate the runs or number
of projection frames. For example, the interpretation of a “setTimeStop” of 90 s and
“setTimeSlice” (slice duration) of 2 s is that the duration of acquisition is 60 s with
slices of 2 s. The geometry is updated every 2 s. In this acquisition duration, 90
number of projection frames were acquired. Throughout this chapter I used the terms
“runs” and “number of projection frames” interchangeably. Figure 4.10 shows the GUI
of the complete simulation of the MARS small-bore scanner.
Nruns =




Nruns = runs or number of projection frames
setTimeSlice = slice duration
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Figure 4.10: GUI of the simulated MARS small-bore scanner
4.4.11 Validation of simulated MARS small-bore scanner
All MC simulation packages need to be validated to ensure the simulation delivered
the expected result or performs close to satisfaction. The validation can be achieved in
different ways, either by comparing the known standard/result or experimental work
to the simulation outcome. In this study, several methods of validation were explored.
Successful validation of the simulated MARS scanner is a vital step towards conducting
material-specific dosimetry. To achieve this objective, the mathematically modelled
Unfors Raysafe Solo CT ionisation chamber and custom-built CTDI PMMA phantom
in figure 4.5 were used.
MARS X-ray beam collimation width
The MARS X-ray beam collimation width or the z-axis field of view (zFOV) was one of
the factors considered for the validation of the simulated MARS scanner. The essence
of having the same zFOV in the simulation is to mimic the MARS scanner collimation
geometry.
The physical measurement was done by attaching a self-developing
Gafchromic XRQA2 film to a 30 mm diameter custom-built PMMA phantom. The
Gafchromic film was wound around the outer surface of the PMMA phantom with
the reactive side facing outward to measure the beam collimation width. Using a
measuring ruler, the beam collimation width was measured along the zFOV to be 11.0
mm. Figure 4.11 is irradiated Gafchromic film showing the beam collimation width.
The irradiated film was digitised onto the work computer as a 32-bit colour image
in JPEG format using an office scanner at a resolution of 600 by 600 dots per inch
(dpi). ImageJ software was to analyse the intensity profile using a rectangular region of
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interest (ROI) of 400 by 700 pixels. The 700 pixels was scaled to 30 mm.
For the simulation, due to the simplification of the X-ray source in the MARS scanner
as a point source with a 32 mm FOV (figure 4.8), the MARS scanner collimation width
was adopted and adjusted until the required 11.0 mm zFOV was achieved. The collimator
has a hole which is defined as a box composed of air with the specification of 9.88 ×
3.6 × 2.2 mm3. The collimator is situated at a distance of 16.08 cm from the centre of
rotation. The beam collimation profile was generated by exposing a 30 mm diameter
PMMA phantom, with an image matrix/resolution of 200 × 200 × 553. The results
are shown in the figures 4.17 and 4.19.
Figure 4.11: Gafchromic film was wound around the PMMA phantom and placed at
the MARS scanner centre of rotation to measure the beam collimation width.
Half value layer
Half value layer (HVL) of a material is the thickness of the material needed to reduce
the X-ray beam intensity by half. HVL measurement is a quality control test conducted
to check if an X-ray tube source has sufficient filtration to attenuate the low energy
radiations. The low energy radiations are harmful to tissues/organs under preclinical
or clinical examinations (Lavoie and Martel, 2008) without contributing to the imaging.
HVL assessment is an accepted method for measuring the quality of X-ray beam (Ma
et al., 2001a; Bushberg, 2003). Different thicknesses of Al and Cu are mostly used
for calculating HVL in kilovoltage X-ray tubes (Ma et al., 2001a; Bushberg, 2003).
The X-ray beam quality/intensity relies on factors such as filtrations (inherent and
additional), anode angle, anode material and tube potential (Bushberg, 2003).
For mono-energetic X-ray beam, Beer-Lambert law equation 4.5 can be used to
calculate the HVL with known linear attenuation coefficient for a specific tube potential
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HVL = half value layer
µE = linear attenuation coefficient of a material
In this study, the HVL measurement was based on only Al material since HVL is
mostly expressed as mm Al. The first HVL from the SpekCalc (Poludniowski et al.,
2009; Poludniowski and Evans, 2007) was compared with the first HVL of the simulated
MARSpec spectrum (discussed in subsubsection 4.4.9). The two spectra (SpekCalc and
simulated MARSpec X-ray spectrum) are shown in figure 4.21.
The first HVL set-up in the simulation is shown in figure 4.12. The motivation
behind the range of Al thickness chosen was based on the calculated HVL obtained
from the SpekCalc. Initially, the exposure was done with 0 mm Al thickness and after
that, each subsequent exposure from 6 to 13 mm Al thickness, with an increment of
0.5 mm. All the exposures were recorded with an ionisation chamber, by simulating
1×109 source particles (photon histories). The transmission curve in figure 4.22 shows
the transmission percentage against the thickness of Al. The simulation of the first
HVL was compared to the SpekCalc first HVL, along with their computed percentage
change, as shown in table 4.3.
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Figure 4.12: Simulation set-up for the first HVL measurements. The X-ray source tube
(magenta), the collimator (green), the Al material (ash) and the ionisation chamber
(red).
Symmetric mean absolute percentage error and Pearson correlation
Symmetric mean absolute percentage error (SMAPE) (Chen et al., 2017; Schnaars, 1986)
was used to calculate the percentage error between the simulated MARSpec spectrum
and the SpekCalc spectrum. To estimate the SMAPE and the Pearson correlation, the
photon counts from the SpekCalc and simulated MARSpec spectrum were converted
into probability counts. In this sense, a common platform for data manipulation was
obtained.
Initial dosimetry analysis
The simulated MARS scanner was investigated to assess the radiation dose with three
different number of projection frames/runs (360, 720 and 980) at one rotation position
using equation (4.4). The aim was to understand the dosimetric simulation set-up. The
expectation was that increasing the number of circulation projection frames should
increase the dose scored. In all, 1× 109 photons histories were tracked. The dose was
recorded using the modelled ionisation chamber placed at 20 cm from the X-ray source.




The normalisation factor (NF) is a calculated value used to convert the simulated dose
to absolute or actual absorbed dose for the particular beam collimation width or zFOV.
This is done by taking into account the total scan time and any scatter irradiation
during the physical dosimetry.
The scan settings used for the physical measurement were tube current (80 µA),
tube potential (120 kVp), exposure time (220 ms), 200 mm source to isocenter (SIC)
and 360 number of projection frames. The tube current (80 µA) was used as it is above
the detection threshold of the ionisation chamber. The detection threshold was deduced
to be above 60 µA. The ionisation chamber was used to record dose for a slice thickness
width or beam collimation width at one axial rotation in the air, as shown in figure 4.13.
This needs to be corrected for slice thickness to determine what the scan dose would
be. The ionisation chamber raw readings at isocenter was converted to CTDI100 in free
air using equation (4.6). The CTDI100 (mGy) is used to deduce an NF to convert the
simulated dose to the absolute absorbed dose. The purpose of using the steel plate was
to protect the Medipix3RX detector from high radiation fluxes.
In the simulation, the modelled ionisation chamber was used to generate the radiation
dose map (with an image matrix of 200 × 200 × 553) by simulating 1×109 photons
histories. The simulated dose distribution map was analysed by measuring the region of
interest (ROI) containing 25459 pixels from an average of 20 image slices, as shown in the
figure 4.14. The analysis was repeated for two subsequent simulations. For each of the
three simulations, 20 image slices within the beam collimation width were chosen. This
is because some of the image slices contained noise. A simulated dose map per photon
history for each of the three simulations was deduced. An average of 60 image slices was
assessed to reduce the statistical uncertainties associated with dose map distribution.
The average duration for the simulation was 3.73 hours. Equation (4.7) was used to
derive the photon histories per µAs for the beam collimation width (11.0 mm). The
result is presented in the table 4.5. Equation (4.7) used for this study has been used by




Figure 4.13: Set-up of the Raysafe Solo CT ionisation chamber free in air radiation dose
measurements. The steel is attached to the Medipix3RX detector surface to protect it
against high X-ray flux.
Figure 4.14: Photon histories (1×109) were tracked generating dose distribution map







R = Ionisation chamber raw reading (mGy)
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L = length of ionisation chamber (100.0 mm)









NF = normalisation factor
MDair = measured dose in air
SDair = simulated dose in air
CTDI100 validation between physical measurement and simulation
The validation of the simulated MARS scanner dose was based on three scan settings
(tube current, SIC and number of projection frames), as shown in table 4.2. The three
scan settings were used because they are known to affect radiation dose and image
quality.
From table 4.2, the measurement of each scan settings was repeated to reduce the
statistical uncertainty. A total of 22 physical measurements and 16 simulations were
performed. The total number of simulations is less than the total number of physical
measurements since some of the simulation results were deduced from their base/initial
result. For instance, the other results of the tube current (µA), SIC and the number
of projection frames were deduced from their base results. The average simulation
duration lasted 4.28 hours for simulating 1× 109 photon histories.
The physical measurement radiation doses using table 4.2 were compared to the
simulated doses in air, as shown in figure 4.23. Using the same table 4.2, the radiation
doses scored on the CTDI phantom were compared to the modelled CTDI phantom
doses, as shown in 4.24. The CTDI phantom has a central hole of 12.5 mm in diameter
for the ionisation chamber insertion. The CTDI phantom was used to imitate a real
mouse with 30 mm in diameter and 100 mm in length.
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Table 4.2: Scan settings for comparing the physical measurements to the simulated
doses. Label (a), (b) and (c) show the scan settings that are kept constant and the ones
varied.
Scan settings
Label Tube current (µA) SIC (mm) Number of projection frames Exposure time (ms)
(a) 65, 70, 75 and 80 200 360 220
(b) 65 180, 190, 200 and 210 360 220
(c) 65 200 360, 720 and 980 220
4.5 Results
4.5.1 Modelling and simulating MARS X-ray tube in GATE
The X-ray spectrum in the GATE was simulated with no additional filter, with 0.375 mm
Cu and 2 mm Al additional filters, respectively, as shown in figure 4.15 (a). Figure 4.15
(b) shows its counterpart from the SpekCalc using the same X-ray tube specification
with no additional filter, with 0.375 mm Cu and 2 mm Al additional filters, respectively.
Visual inspection revealed that the spectra generated by the SpekCalc and the GATE
simulated spectra characteristics are the same. All the spectra are normalised to their
peak value. The 0.375 mm and 2 mm additional Cu and Al filters, respectively, were
used to attenuate the low energy X-ray photons that contribute to patient radiation
dose instead of diagnostic imaging. The X-ray tube simulation without additional filter,
with additional 0.375 mm Cu and 2 mm Al filters lasted 1.77, 2.18 and 1.63 days,
respectively.
In this study, the dosimetry work was focused solely on using the additional
0.375 mm copper filtration. In figure 4.16, comparison among the spectra shape
of the GATE simulated spectrum, the X-ray spectrum generated from the MARSpec
(Anjomrouz, 2017; Shamshad, 2017) and the X-ray spectrum generated from the
SpekCalc (Poludniowski et al., 2009; Poludniowski and Evans, 2007) are presented. The
SpekCalc generated spectrum was used as a reference spectrum to validate the shape of
the other two spectra (GATE simulated and MARSpec spectra). The importance is to
let you know if you are using the correct physics definition and also a good model of
your system. The splits characteristics peaks of MARSpec spectrum at 57 and 59 keV
X-rays photons comes from tungsten target electron transitions from the L-shell to the
K-shell. Generally, a good agreement exists among the three spectra.
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Figure 4.15: (a) X-ray energy spectrum generated by 120 keV mono-energetic electrons
impinging on 1 mm thick tungsten with no additional and with additional filtrations (2
mm Al and 0.375 mm Cu). (b) X-ray energy spectrum generated from the SpekCalc
(Poludniowski et al., 2009; Poludniowski and Evans, 2007) without additional and with
additional filtrations (2 mm Al and 0.375 mm Cu)
Figure 4.16: Comparison of the GATE simulated X-ray spectrum to the X-ray spectrum
generated from the SpekCalc (Poludniowski et al., 2009; Poludniowski and Evans, 2007)
and the MARSpec (Anjomrouz, 2017; Shamshad, 2017). The additional filter used was
0.375 mm Cu. The three X-ray spectra are normalised to their highest intensity value.
The splits characteristics peaks of MARSpec spectrum at 57 and 59 keV X-rays photons
comes from tungsten target electron transitions from the L-shell to the K-shell.
78
4.5. Results
4.5.2 Validation of simulated MARS small-bore scanner
The validation of the simulated MARS small-bore scanner includes: spectrum shape,
X-ray beam collimation width, first HVL measurement, SMAPE, Pearson correlation
and radiation dose deposition.
MARS X-ray beam collimation width
ImageJ was used to generate the dose profiles from the irradiated self-developing
Gafchromic film and the 30 mm diameter PMMA phantom, as shown in figures 4.17 and
4.19, respectively. The generated dose profiles are exported to Microsoft Excel and
plotted. Using the Microsoft Excel, the edges of the umbra region of the dose profiles
were identified. Scatter dose contribution towards the two end tails in the penumbra
region approaches zero in the simulation (figure 4.20) and the physical measurement
(figure 4.18). The percentage change of the beam collimation width between the physical
measurement and the simulation was estimated to be less than 1%.
Figure 4.17: Picture of the exposed self-
developing Gafchromic film showing 11
mm zFOV.
Figure 4.18: Normalised dose profile on
the irradiated Gafchromic film.
Figure 4.19: The PMMA phantom with
11 mm zFOV.




Comparison among the simulated MARSpec spectrum, X-ray spectrum
generated from the MARSpec and SpekCalc
The X-ray energy structure shape validation of the simulated MARSpec spectrum
compared to the X-ray spectrum generated from the MARSpec and the SpekCalc was
assessed qualitatively, as shown in figure 4.21. All the three spectra were filtered by 1.8
mm inherent aluminium and 0.375 mm Cu additional filtrations from a 20◦ tungsten
anode at a tube voltage of 120 kVp, recorded at energy resolution of 1 keV.
Visual inspection in figure 4.21 reveals that the simulated MARSpec spectrum and
the X-ray spectrum generated from the MARSpec agrees very well. This implies the
GATE toolkit can reproduce the same spectrum imported in it. This plays a vital
initial step in conducting a successful dosimetry simulation. When the two spectra are
compared to the X-ray spectrum generated from the SpekCalc, differences in spectra
shape in the energy range of 45 to 70 keV were observed.
Figure 4.21: Comparison of the simulated MARSpec spectrum to X-ray spectrum
generated from the SpekCalc (Poludniowski and Evans, 2007; Poludniowski et al.,
2009) and the MARSpec (Shamshad, 2017; Anjomrouz, 2017). All three spectra are
normalised to their maximum intensity value.
Half value layer
The transmission curve in figure 4.22 shows the percentage transmission against the
thickness of Al. The first HVL obtained was compared to the first HVL calculated from
SpekCalc along with their computed percentage change, as presented in table 4.3.
In figure 4.22, it was observed that the transmission curve illustrates an exponential
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trend with strong Pearson correlation between the percentage of intensity transmitted
and its corresponding thickness. Table 4.3 shows the percentage change between the
simulation and the SpekCalc to be 10% for Al. The simulated first HVL is greater
than the SpekCalc first HVL. This disparity agrees with the initial assessment of the
energy spectra shapes, as shown in figure 4.21. The HVL layer comparison is a way of
validating the simulated MARSpec spectrum.
Figure 4.22: Transmission curve for 120 kVp with the filtrations (1.8 mm Al inherent
and 0.375 mm Cu additional filtrations) generated from the simulated MARSpec
spectrum. The red line depicts the Al thickness required to attenuate 50% of the
intensity transmission.
Table 4.3: First HVLs calculated from the simulated MARSpec spectrum and the
SpekCalc spectrum along with their percentage change for beam filtrations (1.8 mm




First HVL (mm) Percentage
changeSpekCalc Simulated MARSpec spectrum
120 Al 8.98 9.88 10.0
Symmetric mean absolute percentage error and Pearson correlation
The accuracy between the simulated MARSpec spectrum and the X-ray generated from
the SpekCalc was assessed by calculating the SMAPE. The calculated SMAPE was
about 13%. The Pearson correlation between the two spectra was estimated to be 0.90.
The SMAPE (about 13%) and the correlation (r = 0.90) agree with the differences
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in the spectra shape and the first HVL results, as presented in the figure 4.21 and
table 4.3, respectively. It is possible the highlighted differences in figure 4.21 played
a role in the first HVL difference (within 10%), the accuracy of about 13% and the
correlation of 0.90. These differences were expected as different simulation procedures
were used to generate both spectra.
Initial dosimetry analysis
Table 4.4 shows the simulation results using three different number of projection frames
(360, 720 and 980). The dose distribution map was recorded in a 3D image dimension
of 200 × 200 × 553. The average radiation dose and standard deviation are obtained
from analysing 30 image slices.
Table 4.4: CTDI in free air for the number of projection frames by simulating 1× 109
photon histories
Number of projection Time-stop CTDI100 in free air Standard deviation
frames (s) (Gy)
360 1.0 1.10×10−5 3.82×10−7
720 2.0 1.08×10−5 6.31×10−7
980 2.7 1.07×10−5 4.01×10−7
It is known that increasing the number of projection frames increases the radiation
dose. Interestingly, from the results in table 4.4, it was deduced that irrespective of
the different number of projection frames used, the radiation dose recorded is relatively
the same. The reason is that the number of photon histories (1×109) simulated is
distributed evenly according to the number of projection frames completing the 360◦
circle. In addition, the difference in the radiation dose from the different number of
projection frames could be due to the photon statistics. The importance of this current
section is the development of the normalisation factor idea which was used to convert
the simulated dose to absolute absorbed dose.
Normalisation factor calculation
The NF in table 4.5 was deduced in air based on the scan settings 200 mm SIC, 80 µA
tube current, 220 ms exposure time, 360 number of projection frames and 120 kVp.
The NF (6.48×108) photons histories per µAs) was simulated covering 360 exposure
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angles of 1.8×106 X-ray photons. This completes a 360◦ with 1◦ step and a time step
of 0.0028 s to achieve an almost continuous movement of the X-ray source.
Table 4.5: Deriving NF using CTDI100 in air at 200 mm SIC, 80 µA, 220 ms, 360
number of projection frames and 120 kVp.
Energy Measured Simulated NF
(kVp) (mGy/µAs) (mGy/photon history) (photon history/µAs)
120 6.94×10−3 1.07×10−11 6.48×108
CTDI100 validation between physical measurement and simulation in air
From the graphs in figure 4.23, there is a strong Pearson correlation of ≥ 0.96, ≥ 0.97
and ≥ 0.99 between the simulation and the physical measurement for the tube currents,
the SIC (mm) and the number of projection frames, respectively. The standard error
bar was calculated taking into account expended uncertainty (k = 2).
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Figure 4.23: CTDI100 free in air comparison between the physical measurements and
the simulations. The error bars are standard errors. (a) Different tube currents (µA).
The tube currents error bars range from 0.20 to 2.47 mGy and 0.90 to 1.10 mGy for the
measurements and simulations, respectively. (b) Different SIC. The SIC error bars for
measurements and simulations are in the range of 0.46 to 1.66 mGy and 0.82 to 1.00
mGy, respectively. (c) Number of projection frames. The error bars for the runs range
from 0.15 to 1.63 mGy and 0.90 to 2.45 mGy for the measurements and simulations,
respectively. However, the error bars are too small to visualize.
CTDI100 comparison between the physical measurement and the simulation
in CTDI mouse size phantom
The CTDI100 outputs are shown in figure 4.24. From figure 4.24, the calculated standard
error takes into account the expended 5% uncertainty (k = 2) associated with the
ionisation chamber. The standard errors were too small to be shown clearly in all the
graphs for the measured and the simulated dose. From the three graphs in figure 4.24,
strong Pearson correlation of ≥ 0.99, 0.97 and ≥ 0.98 exist between the simulation




Figure 4.24: CTDI100 phantom comparison between the physical measurements and
simulations. The error bars represent the standard errors. (c) Different tube currents.
The tube currents error bars range from 1.55 to 1.90 mGy and 0.80 to 1.02 mGy for
the measurements and simulations, respectively. (b) Different SIC. The SIC error bars
for measurements and simulations are in the range of 0.76 to 1.90 mGy and 1.03 to
1.71 mGy, respectively. (c) Different number of projection frames. The error bars for
the runs range from 1.55 to 2.97 mGy and 0.84 to 2.27 mGy for the measurements and
simulations, respectively. Nonetheless, the error bars are very small to see.
4.6 Discussion
In this chapter, initial steps were taken towards developing a full dosimetry simulation
package for the MARS imaging system based on the GATE toolkit. The developed
simulation package will be used with the method established in chapter 3 to assess
and optimise MARS scan settings. In addition, this chapter sought to build a solid
foundation to quantify an accurate 3D material-specific dose.
The modelling and simulating of the MARS X-ray tube employed the two main
MARS additional filtrations (0.375 mm Cu and 2 mm Al) together with no additional
filtration. The results of the simulated X-ray tube spectra characteristics in figure 4.15
(a) were similar to the SpekCalc spectra characteristics in figure 4.15 (b). Furthermore,
as observed in the figure 4.15 (a) and (b), among the three spectra (no additional, 0.375
mm Cu and 2 mm Al filter) the Cu filter tends to have most of the X-ray intensities
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towards the higher energies of the spectra. This could be due to more beam hardening
from the Cu filter.
Generally, for all the spectra, it was observed that the lower energy intensities were
at the anode side and the higher energy intensities at the cathode side of the X-ray
tube. This phenomenon could be explained by the heel effect occurring in the anode
material (tungsten) caused by the anode angling. The anode angle determines the effect
of X-ray photons absorption distribution. X-ray photons travelling straight downward
on the anode side experienced greater self attenuation within the tungsten anode than
X-ray photons travelling towards the cathode side to be recorded by the scoring plane,
as shown in figure 4.9. Hence, lower intensities X-ray beam on the anode side compared
to the cathode. This process is common to all X-ray tubes.
In figure 4.16, visual assessment of the GATE simulated spectrum shape revealed
good agreement compared to the X-ray spectrum generated from the MARSpec. Even
though the MARSpec spectrum splits the characteristics peaks at 57 and 59 keV, as
two individual peaks. Differences in the spectra shape were in the energy range 46 to
70 keV between the GATE simulated spectrum and the X-ray spectrum generated from
the SpekCalc was observed. The overall differences among the three spectral could be
due to the way the inherent filtration was modelled and the physics processes used to
simulate the low energy photons.
From figure 4.21, by visual inspection, the Bremsstrahlung and the characteristics
X-rays of the simulated MARSpec spectrum shape and the X-ray spectrum generated
from the MARSpec (Anjomrouz, 2017; Shamshad, 2017) shape showed very strong
agreement. The strong agreement was expected, as the GATE toolkit is capable of
reproducing the same energy spectrum shape imported into it. However, it appears
there is a slight difference when both (simulated MARSpec spectrum and the X-ray
spectrum generated from the MARSpec) are compared to the X-ray spectrum generated
from the SpekCalc. This difference occurred at the energy range from 35 to 75 keV. The
Spekcalc spectrum intensities appear to be lower than the two spectra at this stated
energy ranges (35 to 75 keV). Also, the SpekCalc spectrum failed to differentiate the two
characteristics peaks at 57 and 59 keV. Instead, it has combined these two characteristics
peaks making the base bigger, as observed in figure 4.21. The possible reasons for the
difference in the spectra (simulated MARSpec spectrum and SpekCalc spectrum) are
the different physics processes used, the SpekCalc scoring photons only at the central
beam axis, and the assumptions and how the simulation parameters were implemented.
Physics processes and simulation assumptions play a huge role in the way electrons and
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photons are transported. Similar differences comparing SpekCalc spectrum to other
X-ray spectrum models has been reported (Lu, 2016; Anjomrouz, 2017; Shamshad,
2017). Interestingly, the three spectra tungsten characteristics normalised intensity
appeared to match very well.
To summarise, amidst the difference highlighted, there was generally a good
agreement among the three spectra in terms of the shape. The simulated spectrum
from the MARSpec was used for all the dosimetric simulations in this study. This is
because using the simulated spectrum from the MARSpec improves the computational
performance compared to the GATE simulated X-ray spectrum in figure 4.16.
Accurate simulation of the MARS beam collimation width is one of the initial steps
taken to validate the MARS scanner geometry. Self-developing Gafchromic film was
used for that purpose. On the other hand, various researchers have measured beam
collimation width using solid state detectors (Lin and Herrnsdorf, 2010) and TLDs
(Deak and Kalender, 2009; Hupfer et al., 2012).
The percentage change of the beam collimation width between the physical
measurement and the simulation was estimated to be less than 1%. Further observation
revealed that the scatter dose tail appears to be different between the physical
measurement (4.18) and the simulation (figure 4.20) dose profiles. However, they
all reduce to zero. The reason for the difference in the scatter dose effect could be due
to the different procedures used to measure their output. The scatter dose tails are also
reported in related studies (Lin and Herrnsdorf, 2010; Deak and Kalender, 2009; Hupfer
et al., 2012).
HVL is a quality control test taken to ensure an X-ray tube source has sufficient
filtration to attenuate the low energy radiation. The HVL measurements can be used
to validate an X-ray spectrum. According to the Lavoie and Martel (2008) safety code,
the minimum HVL for CT imaging at 120 kVp is estimated to be 4.30 mm Al. In the
simulation, the first HVL was estimated to be 9.88 mm Al. This first HVL (9.88 mm Al)
differs by 10% when compared with the SpekCalc first HVL, as shown in table 4.3. The
difference in the first HVLs could be due to their energy spectra shape, as presented
in figure 4.21. From figure 4.21, it is observed that more low energy X-ray photons
are found in the simulated MARSpec spectrum than the SpekCalc spectrum. This
means that more Al thickness is required to attenuate this low X-ray photons, causing
the 10% change calculated. In addition, the physics package used for both spectra to




Moreover, the calculated SMAPE (about 13%) and the strong correlation (r = 0.90)
between the simulated MARSpec spectrum and the SpekCalc spectrum agrees with the
spectra shape difference and the first HVL difference, as presented in figure 4.21 and
the table 4.3, respectively. The highlighted difference in figure 4.21 might have played
a role in the 13% SMAPE and r = 0.90. These differences were expected as different
procedures were used to generate both spectra.
Finally, the general observations that could have accounted for the differences in the
first HVL, the SMAPE and the Pearson correlation are the number of photon histories
simulated and the beam collimation width used. The number of photon histories and
the beam collimation width may have affected the photon statistics in the simulation.
The fewer photons statistics resulted in more deviations recorded. However, the photon
histories simulated was to balance computation power and simulation time, as the
computing system has a maximum random access memory (RAM) of 16 gigabytes. The
ability to simulate higher photon histories could yield much better results with fewer
deviations. In addition, the beam collimation width employed in the simulated MARS
scanner reduced the number of X-ray photons transported. However, in the SpekCalc
spectrum generation, no collimation was taken into account and a higher number of
source particles were used.
From figure 4.23 (a), a strong Pearson correlation of ≥ 0.96 between the measurement
and the simulation was observed. Also, most of the simulated radiation dose fell within
the measured radiation dose uncertainty. This makes the simulated dose closely match
with the measured dose. Hence, the percentage dose error between the measurement
and the simulation ranges from -3.2 to 3.2%. The negative sign indicates the measured
dose is greater than the simulated dose. The average percentage change in dose between
the measurement and the simulation is 0.23 ± 2.59% standard deviation. The simulated
dose close estimates benefited from the initial normalisation of the simulated dose with
the measurement dose.
For the SIC in figure 4.23 (b), the two results (measured and simulated dose) obeyed
the inverse square law existing between radiation dose and distance, with a strong
correlation of ≥ 0.97. A slight variation was observed between the measured and
the simulated dose at 180 mm. This could be due to the varied SIC effect in the
physical measurement associated with the beam collimation width changes. The beam
collimation width changes to compensate for the required zFOV. For the simulation,
the beam collimation width was kept constant throughout different SIC measurements.
Nonetheless, the simulated dose still lies in the uncertainty of the measured dose. The
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percentage change in dose between the simulation and the measurements ranged from
-1.31 to 3.26%, with an average of 0.58 ± 1.92% standard deviation.
In figure 4.23 (c), while it appears there is a strong correlation of ≥ 0.99 for both
dose results (measured and simulated dose) with an increasing number of projection
frames/runs. The simulated dose appears to overestimate the measured radiation dose
at 720 and 980 runs. The reason is that the simulated dose values at 720 and 980
runs were deduced from 360 runs dose. The simulated dose at 720 and 980 runs was
found to be 2.0 and 2.72 times that of 360 runs dose, respectively. Interestingly, the
measured dose values at 720 and 980 runs were found to be 1.7 and 2.2 times the 360
runs, respectively. It is quite difficult at this stage to pinpoint the exact cause for the
reduced dose at 720 and 980 runs during the measurement. However, this issue may
need further investigation. The percentage change in dose between the measurement
and the simulation were found to be within 3.26 to 26.18%, with an average percentage
change of 16.77 ± 12% standard deviation. This percentage change value has to be
taken into account when using the simulated dose at 720 and 980 runs for calculation.
Figure 4.24 (a) shows that the stimulated dose underestimates the measured dose by
an average percentage change of < 9%. The simple explanation could be attributed to
the simplistic modelling of the RaySafe Solo CT ionisation detector, as a single air-filled
cylindrical phantom. However, a strong Pearson correlation (r ≥ 0.99) was observed
between the simulated and the measured dose.
The observed mismatch in figure 4.24 (b) between the measurements and the
simulations could be due to the static beam collimation width employed in the simulation.
However, in reality, the beam collimation width automatically adjusts its zFOV for
each SIC to keep the same exposure. Notwithstanding the difference in the two results,
a strong correlation (r = 0.99) was observed. The percentage change in dose between
the simulation and the measurement was within 10%.
The simulated doses were less than the measured doses in the percentage change
range from 2.0 to 8.7% in figure 4.24 (c). Also, it appears figure 4.24 (c) demonstrated
more agreement between the simulated dose and the measured dose than in figure 4.23
(c). This is because more low energy X-ray photons were attenuated than high energy
X-ray photons (figure 4.24 (c)). Hence, the ionisation chamber recorded fewer X-ray
photons interactions (radiation dose) in the simulation compared with the physical
measurement. In addition, the simulated doses at 720 and 980 runs were derived by
multiplying the simulated dose of 360 runs by 2.0 and 2.72, respectively. However, the
measured doses at 720 and 980 runs were found to be 1.9 and 2.5 times 360 runs dose,
89
4.7. Summary
respectively. Similar behaviour was observed in figure 4.23 (c).
In general, the contribution to the changes in the simulated dose and the measured
dose could be due to the simplification in modelling the X-ray source as a point source.
This suggests the generation of X-ray photons and its interaction with the matter
may differ between the simulation and the physical measurement. Furthermore, small
animal dosimetry could be a difficult task to do especially considering the size of the
CTDI phantom (30 mm in diameter), the distance involved, the low power X-ray source
(maximum 39 Watts) and the number of source particles simulated. The 12.5 mm
diameter hole in the CTDI phantom enhances the difficulty in conducting accurate
dosimetry. Especially, when comparing two different dosimetry platforms. Finally, the
scattered radiation from the flat metal plate (figure 4.13) could have contributed to the
measured dose being greater than the simulated dose. One of the limitations of this
study is the inability to implement helical dose simulation.
Several researchers have also reported a percentage change between the simulated
dose and the measured dose depending on the scan settings in the range of 2.9 to 11%,
for small animal MC dose simulation (Deak and Kalender, 2009; Lee et al., 2013, 2016).
For MC dose simulation in clinical settings a percentage change in dose within 7% was
reported by (Papadimitroulas et al., 2015).
Even though the percentage change dose (measurements and simulation) being
higher (up to an average of 16.77 ± 12% standard deviation) for the different runs
measurements, the overall absorbed dose measured in air and the CTDI phantom results
in differences lower than 5% and 10%, respectively, between the simulation and the
physical measurement for all the scan settings. The CTDI dose differences in this
study are found to be in agreement with other small animal dose difference reported
(Deak and Kalender, 2009; Lee et al., 2013, 2016). The next thesis chapters explore
the potential of using spectral attenuation images and spectral material decomposed
density images for MC dosimetry.
4.7 Summary
 Step by step procedure for modelling and simulating the MARS small-bore spectral
scanner with the GATE MC toolkit is demonstrated.
 X-ray spectra with table 4.1 specification were simulated using no additional
filtration, 2 mm Al and 0.375 Cu mm filtration. The observed spectra profile
characteristics were also demonstrated in the SpekCalc spectra (using the same
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table specification). The comparison of the GATE simulated spectrum using 0.375
mm Cu compares well with the MARSpec and the SpekCalc spectra.
 The X-ray spectrum generated from the MARSpec was simulated in the GATE
toolkit. The simulated MARSpec spectrum compared to the SpekCalc spectrum
showed good agreement. All the investigation in this study were done with the
simulated MARSpec spectrum.
 The ability to replicate the required z-axis field of view in the MARS small-bore
scanner was implemented in the GATE toolkit. The percentage change of the
z-axis field of view was found to be within 1% between the simulation and the
physical measurement.
 NF was derived to convert the simulated dose to absolute absorbed dose for the
11.0 mm z-axis field of view.
 Generally, the overall absorbed dose measured in air and CTDI phantom results
in differences lower than 5% and 10%, respectively, between the simulation and
the physical measurement for all the scan settings.
 This chapter provides the confidence required for conducting accurate material-
specific dosimetry using the MARS images.
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Chapter 5
Radiation dose assessment using
spectral attenuation image
5.1 Overview
This chapter aims to present a method to demonstrate the potential use of spectral CT
attenuation image as input for the Monte Carlo (MC) simulation.
This study promises numerous benefits as it investigates into the practicability of
relying on spectral CT image for 3D dose distribution map assessment. The benefits of
using spectral CT images for dosimetry could help to account for dose in specific organ
size, structure, position and tissue characteristics. Enabling better characterisation of
radiation dose risk to the different organs/tissues in the body. In addition, the study
will provide a useful platform to assess and optimise radiation dose scan settings during
preclinical and clinical imaging. This study also serves as a proof of concept. The
same approach can be further developed and used for the larger versions of the MARS
scanner.
This study focuses on using the spectral attenuation images in chapter 3 and the
simulated MARS small-bore scanner in chapter 4.
Section 5.2 reviews the knowledge gap in research. The procedure for importing
spectral CT image into the simulated MARS scanner was implemented in sections 5.3
and 5.4. In section 5.5, the radiation dose results generated from the spectral energy
images are presented. Next, the section 5.6 discusses the results of the section 5.5,
outlining the significance and the limitations. Lastly, a brief summary of the study is




Complex phantom geometries such as CT images from single energy CT scanners
(Papadimitroulas et al., 2015; Hupfer et al., 2012; Carlson et al., 2007) and digital
phantoms such as mouse whole body (MOBY) and rat whole body (ROBY) (Lee et al.,
2016) has been used for MC dose simulation. In this case, only a single CT image
or/and digital phantom were used for MC dose simulation. With the emergence of
advanced imaging modalities such as dual energy CT (DECT), dual source CT (DSCT)
and spectral CT systems, the CT images are acquired in two or more defined energy
thresholds. The question is can a single energy image from DECT, DSCT and spectral
CT be used as input into MC simulation packages for dose measurement? In other
words, what is the appropriate procedure to conduct DECT, DSCT and spectral CT
MC dose simulation? To the author’s best knowledge no studies have attempted to
answer this question leaving a knowledge gap in this field of study.
However, quantifying the right simulation dose on spectral CT images requires an
accurate tissue definition. The extraction of the tissue features such as mass or electron
density, weight of elements and effective atomic number are used by the MC programs
for pre-calculation of the physical cross section between the radiation type and the tissue
involved (Schneider et al., 2000; Bourque et al., 2014). Accurate tissue characterisation
helps to reduce the errors associated with the radiation dose calculation (Schneider
et al., 1996, 2000; Bourque et al., 2014; Lalonde and Bouchard, 2016). In addition, in
radiation treatment planning obtaining accurate tissue heterogeneities information is
an essential quality control step to estimate the right exposure to patients.
Accounting for accurate tissue characteristics has been a great challenge faced by
clinicians long before the inception of CT X-ray imaging in 1972 (Schneider et al., 2000).
CT imaging has provided solutions to most of the tissue defining challenges by giving
information on the exact tissue inhomogeneities, geometrical location and attenuations.
Many authors have since conducted studies to derive the exact tissue inhomogeneities
information (Schneider et al., 2000; Bourque et al., 2014; Lalonde and Bouchard, 2016).
They have related CT number to mass density and elemental weights of tissue (Schneider
et al., 2000), electron density (ED) and stopping power (SP) of tissue (Schneider et al.,
1996), ED and effective atomic number (EAN) of tissue (Bourque et al., 2014).
Nonetheless, Schneider et al. (2000) study is the current gold standard stoichiometric
calibration method for relating CT numbers to tissue compositions and mass density.
The stoichiometric calibration method (Schneider et al., 2000) has been adopted by
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most dedicated and general MC simulation packages such as Geant4 Application for
Tomographic Emission (GATE) (Sarrut et al., 2014), Tools for Particle simulation
(TOPAS) (Perl et al., 2012) and Electron Gamma Shower National Research Council
(EGSnrc) (Kawrakow, 2000), for GEometry ANd Tracking (Geant4) (Agostinelli et al.,
2003), respectively.
In this study, the gold standard stoichiometric calibration method (Schneider et al.,
2000) was used to evaluate the radiation dose deposition on the MARS spectral
attenuation images in the preclinical domain.
5.3 Materials
The materials used for this studies are grouped into experimental and simulation
components.
5.3.1 Experiment
The experimental materials used were the MARS small-bore scanner in the chapter 4,
the Gd/HA calibration phantom and the mice in chapter 3 (Table 5.1 shows the
experimental set-up), and mouse size phantom with thermoluminescence dosimeters
(TLDs) inserts.
Table 5.1: Specifications of the experimental set-up
Parameter Value
Scan type Continuous
Exposure time 220 ms
Tube voltage 118 kVp
Source to isocentre (SIC) 200 mm
Tube current 24 µA
Intrinsic filtration 1.8 mm Al
Additional filtration 0.375 mm brass
Energies (charge summing mode) 30, 45, 60 and 78 keV
Number of projection frames 720
Flat-field 720 over 360◦
Voxel size 90 × 90 × 90 µm
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Mouse phantom with TLDs inserts
The 30 mm diameter custom-built cylindrical Polymethyl methacrylate (PMMA)
phantom has five holes labelled A, B, C, D and E for TLDs insertion, as shown
in figure 5.1. The TLD-100s were used to measure absorbed dose to the mouse size
phantom. The specification of the TLDs used are TLD-100 (3.2 × 3.2 × 0.9 mm3, LiF:
Mg, Ti). The TLD-100s dose measurements were used to verify the absorbed dose
scored on the Gd/HA calibration phantom.
Figure 5.1: (a) and (b) are pictures of the mouse size phantom with five holes for
TLD-100s insertion.
5.3.2 Simulation
The simulation materials are the simulated MARS small-bore scanner in chapter 4,
Gd/HA calibration phantom attenuation image (chapter 3), mouse attenuation image
(chapter 3) and mouse size phantom.
Gd/HA calibration phantom
The Gd/HA calibration phantom image shown in the figure 3.3 (b) was imported into
the simulated MARS scanner for dosimetry, as shown in figure 5.2. The absorbed doses
scored on each energy image of the Gd/HA calibration phantom was then investigated.
The use of contrast CT attenuation image for dosimetry is not advisable. This is because
the contrast agent affects the investigation outcome due to enhancing the radiation
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dose deposition. However, in this case, the Gd/HA calibration phantom is composed
of sample vials (hydroxyapatite (HA) concentrations, gadolinium (Gd) concentrations,
water and lipid) separated from each other. Hence, the Gd contrast agent influence on
the other sample vials radiation dose results become impracticable.
Figure 5.2: The red rectangle border line shows the Gd/HA calibration phantom
image imported into the simulated MARS scanner. X-ray tube source (magenta) and
collimator (green).
Mice
The reason for using the mouse attenuation images is to show realistic absorbed
dose distribution simulation compared to the simulated absorbed dose on the Gd/HA
calibration phantom. The absorbed doses scored on the mouse images account for the
true organ/tissue position, size and shape. Also, the purpose of the TLDs inside the mice
is impractical for this study. The three mice images (chapter 3 subsection 3.3.3) were
used by obeying the welfare of animals in research. The welfare of animals in research
is promoted by the National Animal Ethics Advisory Committee (NAEAC) through
the 3Rs which stands for replacement (using different option to live animals such as
computer simulation and modelling), reduction (in this instance the experimental set up
is improved to minimise the number of animals needed) and refinement (minimising pain
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and suffering such as using analgesia). The welfare of animals was taken into account by
adopting the reduction component in the 3Rs. The mouse image shown in the figure 3.6
(b) was imported into the simulated MARS scanner for dose measurements.
Figure 5.3: The red rectangle border line shows the mouse image in the simulated
MARS scanner. X-ray tube source (magenta) and collimator (green).
Mouse size phantom
The mouse size phantom was mathematically modelled as a cylindrical water phantom
for dose purposes. The water is to mimic soft tissue characteristics. The mouse size
phantom has mass density of 1.0 g/cm3, 100 mm in length and 30 mm in diameter.
The mouse size phantom absorbed dose was used as a verification to the absorbed dose
scored on the Gd/HA calibration phantom.
5.4 Methods












if secondary electrons transport can be neglected.
Absorbed dose is thus the photon energy fluence times the mass energy absorption
coefficient. Also, assuming that charged particle equilibrium (CPE) exit (Attix, 2007;
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Bushberg, 2003), the air kerma equals the absorbed dose in air. If an air kerma is
measured or calculated at a point in soft tissue, the absorbed dose to the soft tissue
is approximately the same as the air kerma. Hence, the reason why we used the
absorbed dose in this study and chapter 6. However, we used absorbed dose and dose
interchangeably to mean the same thing.
5.4.1 Experiment
Mouse phantom with TLDs inserts
The calibrated TLD-100s were used to perform radiation dose measurements with the
mouse size phantom. The TLD-100s were read on the Harshaw 5500 reader used in an
accredited dosimetry service in the CHUV (Institute of Radiation Physics at Lausanne
University Hospital, Switzerland). Results of the calibrated TLD-100s are given in
terms of absorbed dose in water.
Experimental set-up and post processing of image data
The experimental procedure and the image data processing in this chapter is the same
as the chapter 3 experimental procedure.
Spectral and linearity response
The spectral response of the MARS scanner was evaluated to know the scanner’s ability
to detect all the materials used for this study. Linearity response is a factor that
determines the relationship between the spectral X-ray attenuation and the material
concentration. This response information is used as a quality control test to ensure that
all the materials under investigation are captured. Also, to check if their attenuation
responses correlate with their concentrations. The spectral and linearity information
determine the accuracy of the MC dose simulation. I assessed this information using
the Gd/HA calibration phantom attenuation images.
The Gd/HA calibration phantom linear spectral attenuation images were
standardised into spectral HU by taking into account water and air linear attenuation
coefficients (More information on the spectral and linearity response can be found in




Preparation of spectral CT image for MC dose simulation
The Gd/HA calibration phantom image consists of four energy thresholds stack (30-45,
45-60, 60-78 and 78-118 keV). The four energy thresholds stack were split into single
individual energy threshold say 30-45, 45-60, 60-78 and 78-118 keV, using the Fiji image
processing tool (Schindelin et al., 2012).
The HU energy dependent conversion method for spectral CT (Hurrell et al., 2012)
was applied on each individual energy threshold of the Gd/HA calibration phantom
linear attenuation image, to quantify each in separate HU dependent energies (keV).
The conversion was necessary because the HU attenuation images are used in the
simulation. An average of the four energy thresholds images was calculated to deduced
the fifth energy threshold. The calculation of the fifth energy threshold makes spectral
CT be equivalent to the conventional CT. Henceforth, for the remaining part of this
chapter, we will call the averaged energy threshold “fifth energy threshold”. Each HU
(keV) image was saved in metaimage format (mhd) and exported into the simulated
MARS scanner for dose simulation, as shown in figure 5.2.
The same procedure was applied to the mice linear attenuation images. The linear
attenuation of water and air obtained from the Gd/HA calibration phantom images
were used to standardised each of the mouse linear attenuation images. The fifth energy
threshold for each of the mouse was calculated. Each of the mouse HU (keV) image was
saved and exported into the simulated MARS scanner (figure 5.3) for dose calculation,
as shown in figure 5.3.
Schneider2000 tables and density tolerance g/cm3
The Schneider2000 material table and Schneider2000 densities table are used to generate
the material database by taking into account the density tolerance. The Schneider2000
material table (presented in table 5.2)is an acceptable calibration text file (Schneider
et al., 2000). The Schneider2000 densities table is a scanner dependent calibration
text file showing the HU and the density (g/cm3), as shown in the tables 5.3 and 5.4.
The mass densities (g/cm3) of HA and Gd were taken from the manufacturer specified
densities while that of lipid and water were taken from the GATE material database.
From the convention of the Schneider2000 material table into the material database
using the Schneider2000 densities table, it is possible a material in the material database
could have multiple material description. This normally occurs due to the density
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variation of the material and the HU variations in the CT image. In other words, a
single material may have a plethora of different HU ranges and densities describing it
in the material database. This places a lot of burden on the computing systems. Hence,
there is the need to limit the number of material definitions to speed up computation.
This is done by the use of the density tolerance value. This defines a single material
for a range of HU values to density ranges differing less than the tolerance value. The
default density tolerance (0.1 g/cm3) used in the GATE was found useful to generate
an appreciable number of materials to avoid lengthy computational time. The 0.1
g/cm3 tolerance means materials with densities differing less than the tolerance value
is classified as the same material for a given HU range (OpenGATE, 2016). The
mechanism behind how the GATE toolkit generates the material database from the
Schneider table is not within the scope of this thesis.
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Table 5.2: Schneider2000 material table with materials definitions
[Elements]
Hydrogen Carbon Nitrogen Oxygen Soduim Magnesium Phosphor Sulfur Chlorine Argon Potassium Calcium
Titanium Copper Zinc Silver Tin
[/Elements]
# HU H C N O Na Mg P S Cl Ar K Ca Ti Cu Zn Ag Sn Material
-1400 0 0 75.5 23.2 0 0 0 0 0 1.3 0 0 0 0 0 0 0 Air
-950 10.3 10.5 3.1 74.9 0.2 0 0.2 0.3 0.3 0 0.2 0 0 0 0 0 0 Lung
-120 11.6 68.1 0.2 19.8 0.1 0 0 0.1 0.1 0 0 0 0 0 0 0 0 AT AG SI1
-82 11.3 56.7 0.9 30.8 0.1 0 0 0.1 0.1 0 0 0 0 0 0 0 0 AT AG SI2
-52 11 45.8 1.5 41.1 0.1 0 0.1 0.2 0.2 0 0 0 0 0 0 0 0 AT AG SI3
-22 10.8 35.6 2.2 50.9 0 0 0.1 0.2 0.2 0 0 0 0 0 0 0 0 AT AG SI4
8 10.6 28.4 2.6 57.8 0 0 0.1 0.2 0.2 0 0.1 0 0 0 0 0 0 AT AG SI5
19 10.3 13.4 3 72.3 0.2 0 0.2 0.2 0.2 0 0.2 0 0 0 0 0 0 SoftTissus
80 9.4 20.7 6.2 62.2 0.6 0 0 0.6 0.3 0 0 0 0 0 0 0 0 ConnectiveTissue
120 9.5 45.5 2.5 35.5 0.1 0 2.1 0.1 0.1 0 0.1 4.5 0 0 0 0 0 Marrow Bone01
200 8.9 42.3 2.7 36.3 0.1 0 3 0.1 0.1 0 0.1 6.4 0 0 0 0 0 Marrow Bone02
300 8.2 39.1 2.9 37.2 0.1 0 3.9 0.1 0.1 0 0.1 8.3 0 0 0 0 0 Marrow Bone03
400 7.6 36.1 3 38 0.1 0.1 4.7 0.2 0.1 0 0 10.1 0 0 0 0 0 Marrow Bone04
500 7.1 33.5 3.2 38.7 0.1 0.1 5.4 0.2 0 0 0 11.7 0 0 0 0 0 Marrow Bone05
600 6.6 31 3.3 39.4 0.1 0.1 6.1 0.2 0 0 0 13.2 0 0 0 0 0 Marrow Bone06
700 6.1 28.7 3.5 40 0.1 0.1 6.7 0.2 0 0 0 14.6 0 0 0 0 0 Marrow Bone07
800 5.6 26.5 3.6 40.5 0.1 0.2 7.3 0.3 0 0 0 15.9 0 0 0 0 0 Marrow Bone08
900 5.2 24.6 3.7 41.1 0.1 0.2 7.8 0.3 0 0 0 17 0 0 0 0 0 Marrow Bone09
1000 4.9 22.7 3.8 41.6 0.1 0.2 8.3 0.3 0 0 0 18.1 0 0 0 0 0 Marrow Bone10
1100 4.5 21 3.9 42 0.1 0.2 8.8 0.3 0 0 0 19.2 0 0 0 0 0 Marrow Bone11
1200 4.2 19.4 4 42.5 0.1 0.2 9.2 0.3 0 0 0 20.1 0 0 0 0 0 Marrow Bone12
1300 3.9 17.9 4.1 42.9 0.1 0.2 9.6 0.3 0 0 0 21 0 0 0 0 0 Marrow Bone13
1400 3.6 16.5 4.2 43.2 0.1 0.2 10 0.3 0 0 0 21.9 0 0 0 0 0 Marrow Bone14
1500 3.4 15.5 4.2 43.5 0.1 0.2 10.3 0.3 0 0 0 22.5 0 0 0 0 0 Marrow Bone15
1640 0 0 0 0 0 0 0 0 0 0 0 0 0 4 2 65 29 AmalgamTooth
2300 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MetallImplants
3450 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MetallImplants
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Table 5.3: The Schneider2000 density table showing the density and the HU of Gd/HA






24.73 0.001 #Gd 1mg/mL
76.93 0.002 #Gd 2mg/mL
128.95 0.0543 #HA 54.3mg/mL
127.53 0.004 #Gd 4mg/mL
230.80 0.1043 #HA 104.3mg/mL
310.95 0.008 #Gd 8mg/mL
500.70 0.2117 #HA 211.7mg/mL
953.51 0.4023 #HA 402.3mg/mL






39.55 0.001 #Gd 1mg/mL
95.13 0.0543 #HA 54.3mg/mL
104.89 0.002 #Gd 2mg/mL
159.92 0.1043 #HA 104.3mg/mL
179.33 0.004 #Gd 4mg/mL
356.77 0.2117 #HA 211.7mg/mL
404.60 0.008 #Gd 8mg/mL
693.171 0.4023 #HA 402.3mg/mL
1416.13 0.8085 #HA 808.5mg/mL
Table 5.4: The Schneider2000 density table showing the density and the HU of Gd/HA






28.25 0.001 #Gd 1mg/mL
79.34 0.0543 #HA 54.3mg/mL
82.67 0.002 #Gd 2mg/mL
123.27 0.1043 #HA 104.3mg/mL
146.32 0.004 #Gd 4mg/mL
256.16 0.2117 #HA 211.7mg/mL
289.56 0.008 #Gd 8mg/mL
471.81 0.4023 #HA 402.3mg/mL






24.15 0.001 #Gd 1mg/mL
60.38 0.002 #Gd 2mg/mL
82.55 0.0543 #HA 54.3mg/mL
107.40 0.004 #Gd 4mg/mL
124.29 0.1043 #HA 104.3mg/mL
196.40 0.008 #Gd 8mg/mL
227.61 0.2117 #HA 211.7mg/mL
399.88 0.4023 #HA 402.3mg/mL
780.23 0.8085 #HA 808.5mg/mL
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Table 5.5: The Schneider2000 density table showing the density and the fifth energy





29.17 0.001 #Gd 1mg/mL
81.217 0.002 #Gd 2mg/mL
96.494 0.0543 #HA 54.3mg/mL
140.145 0.004 #Gd 4mg/mL
159.57 0.1043 #HA 104.3mg/mL
300.375 0.008 #Gd 8mg/mL
335.311 0.2117 #HA 211.7mg/mL
629.591 0.4023 #HA 402.3mg/mL
1267.42 0.8085 #HA 808.5mg/mL
Generating voxelised phantom in the simulation
The Gd/HA calibration phantom image (in HU) and the mice image (in HU) were
imported into the simulation and then voxelised. This means dividing the imported 3D
images (Gd/HA calibration phantom and mice image) into smaller distinct 3D volumes.
The GATE toolkit has this capability of dividing volumes using the parameterisation
methods. The essence of the parametrisation methods is to speed up the simulation
by optimising computational performance and memory swapping. In this study, the
nested parameterisation was used. This is because nested parameterisation method is a
well-validated part of the GEometry ANd Tracking for (Geant4), accurate, precise and
about 3% faster than all other available parameterisation methods (J.Schumann et al.,
2009).
The nested parametrisation method was used to allocate materials from the material
databases tables 5.7, 5.8, 5.9, 5.10 and 5.5) to each HU voxel in the imported image
(Gd/HA calibration phantom and mice image) based on their HU (keV) ranges. The
materials in the material database each have a density, elemental weights and the HU
range allocated to it. The material information is needed by the GATE/Geant4 to




The information about the Gd/HA calibration phantom and the mice image
specifications are presented in the table 5.6. This image specification is the same
as the simulation image specification. Appreciable photon histories (6.48×108 per µAs)
was deduced to balance computational performance and resources. The computing
system used has the specifications Intel (R) Core (TM) i7-6200U CPU @ 3.40 GHz,
≈ 3.40 GHz and 16.0 GB RAM.
Table 5.6: Gd/HA calibration phantom and mice image specifications.
Spectral CT image Number of voxels (nx × ny × nz) Voxel size (mm3) Energy window
Gd/HA calibration phantom 544 × 544 × 328 0.09 × 0.09 × 0.09 4
Mouse (×3) 544 × 544 × 1048 0.09 × 0.09 × 0.09 4
5.4.3 Mouse size phantom
The modelled mouse size phantom was placed inside the simulated MARS scanner to
record absorbed dose to the phantom, as shown in figure 5.4. The dose simulations were
done using the scan settings of 26 µA tube current, 720 number of projection frames
and exposure time (220 ms) and 200 mm SIC at a single rotation. The dose output
images were generated using the image matrix of 200 × 200 × 553. The use of the
image matrix is to speed up the simulations.
Figure 5.4: Schematic diagram of the simulated MARS scanner. Mouse size phantom




The analysis of variance (ANOVA) was used to investigate, if the mean absorbed dose
scored on the four energy thresholds images of the Gd/HA calibration phantom are
significantly different from each other. The ANOVA was performed using the the Open
Source Epidemiologic Statistics for Public Health (OpenEpi) (Sullivan et al., 2009).
The statistical significance test was done based on two hypotheses. The first
hypothesis is the Null hypothesis (Ho) which states that there is no statistically significant
difference among the mean dose scored on the four energy thresholds images of Gd/HA
calibration phantom. The second hypothesis is the Alternate hypothesis (H1) which
states that there is a statistically significant difference among the mean dose scored on
them.
Since the 12 materials in the Gd/HA calibration phantom may have an influence on
one another due to the attenuation of the X-ray photons, the chance of either wrongly
rejecting the Null hypothesis or accepting the Alternate hypothesis is increased. The
Bonferroni correction (Weisstein, 2010) was used to avoid this scenario. The Bonferroni
correction (Weisstein, 2010) was applied to the 12 materials to calculate a significant
threshold of 0.04 (4%). The alpha (α) value used was 5% with 95% confidence interval
(CI). In table 5.12, the calculated probability values (P-values) were compared to the
deduced significant threshold of 0.04 to determine the acceptance or rejection of the
Null hypothesis.
5.5 Results
5.5.1 Spectral and linearity response
The HU response and uncertainty for each region of interest (ROI) over the centre of
each material insert were calculated from the Gd/HA phantom reconstructed images.
The HU was plotted against the four threshold energies, as shown in the figures 5.11
(a) and (c). The relationship between the signal intensity (HU) compared to the HA
and Gd material concentrations (mg/mL) was assessed using the Pearson correlation
coefficient, as shown in the figure 5.5. Pearson correlation coefficient of ≥ 0.99 was
deduced for all the graphs.
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Figure 5.5: The linear response of the scanner was evaluated with a strong Pearson
correlation of ≥ 0.99 for all the plotted data. (a) HU against HA material concentration
with standard error in the range of ± 3.7-12.7 HU. (b) HU versus Gd material
concentration with standard error in the range of ± 3.8-5.6 HU.
5.5.2 Generated material database
In all, five material databases were generated based on the four energy thresholds
and the fifth energy threshold from the Gd/HA calibration phantom. These material
databases were applied on the voxelised phantoms (Gd/HA calibration phantom and
mice image) to generate cross sectional tables. The cross section tables are used by
the dose algorithm engines for dose computation. The tables 5.7, 5.8, 5.9, 5.10 and
5.11 are extracted versions from the full material databases generated in the simulation,
showing only the materials in the Gd/HA calibration phantom.
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Table 5.7: The Gd/HA calibration phantom manufacturer densities and its corresponding






lower limit upper limit mg/mL
Air Air 0 -1400 -950 1.21
Lipid AT AG SI1 10 -120 -82 933.97
Water AT AG SI4 13 -22 8 995.42
Gd1 and 2 SoftTissue 15 19 80 1.47
Gd4 ConnectiveTissue 16 80 120 2.91
HA54.3 Marrow Bone01 17 120 200 66.85
HA104.3 Marrow Bone02 18 200 300 81.23
Gd8 Marrow Bone03 19 300 400 49.92
HA211.7 Marrow Bone05 22 500 600 232.45
HA402.3 Marrow Bone09 26 900 1000 400.82
HA808.5 AmalgamTooth 33 1640 2200 808.41
Table 5.8: The Gd/HA calibration phantom manufacturer densities and its corresponding






lower limit upper limit mg/mL
Air Air 0 -1415 -950 1.21
Lipid AT AG SI1 10 -120 -82 933.97
Water AT AG SI4 13 -22 8 995.42
Gd1 SoftTissue 15 19 80 9.84
HA54.3 ConnectiveTissue 16 80 120 26.26
Gd2 and 4, HA104.3 Marrow Bone01 17 120 200 103.89
HA211.7 Marrow Bone03 20 300 400 203.78
Gd8 Marrow Bone04 21 400 490 63.4
HA402.3 Marrow Bone06 25 676 700 327.09
HA808.5 Marrow Bone14 34 1400 1500 808.5
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Table 5.9: The Gd/HA calibration phantom manufacturer densities and its corresponding






lower limit upper limit mg/mL
Air Air 0 -1388 -950 1.21
Lipid AT AG SI1 10 -120 -82 933.97
Water AT AG SI4 13 -22 8 995.42
Gd1 SoftTissue 15 19 80 23.17
Gd2 and HA54.3 ConnectiveTissue 16 80 120 45.66
Gd4 and HA104.3 Marrow Bone01 17 120 200 28.75
Gd8 and HA211.7 Marrow Bone02 20 249 298 105.107
HA402.3 Marrow Bone04 24 400 455 307.32
HA808.5 Marrow Bone09 31 900 1000 806.02
Table 5.10: The Gd/HA calibration phantom manufacturer densities and its






lower limit upper limit mg/mL
Air Air 0 -1400 -950 1.21
Lipid AT AG SI1 10 -120 -82 933.97
Water AT AG SI4 13 -22 8 995.42
Gd1 and 2 SoftTissue 15 19 80 1.7
Gd4 and HA54.3 ConnectiveTissue 16 80 120 18.98
Gd8 and HA104.3 Marrow Bone01 17 120 200 56.61
HA211.7 Marrow Bone02 18 200 238.4 156.87
HA402.3 Marrow Bone03 22 390.4 400 397.12
HA808.5 Marrow Bone07 29 700 800 776.12
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Table 5.11: The Gd/HA calibration phantom manufacturer densities and its







lower limit upper limit mg/mL
Air Air 0 -1400 -950 1.21
Lipid AT AG SI1 10 -120 -82 933.97
Water AT AG SI4 13 -22 8 995.42
Gd1 and 2 SoftTissue 15 19 80 1.39
HA54.3 ConnectiveTissue 16 80 120 50.26
Gd4 and HA104.3 Marrow Bone01 17 120 200 104.09
Gd8 Marrow Bone02 19 200 300 42.45
HA211.7 Marrow Bone03 20 300 340.72 124.52
HA402.3 Marrow Bone06 25 600 700 415.30
HA808.5 Marrow Bone12 31 1200 1300 797.41
5.5.3 Assessment of the simulation absorbed dose maps
Absorbed dose maps were generated from each of the four energy thresholds and the
fifth energy threshold of the Gd/HA calibration phantom and the mice images. The
absorbed dose maps were deduced by simulating 6.48×108 photon histories per µAs.
The simulation of the Gd/HA calibration phantom and the mice lasted 2.5 and 4.1 days,
respectively. The MARS scan settings 26 µA tube current, 720 number of projection
frames and exposure time (220 ms) and 200 mm SIC used for routine imaging was used
to deduce an appropriate dose distribution map.
The absorbed dose in the four energy thresholds of the Gd/HA phantom was then
average to investigate their dose output. Henceforth, we will call the averaged dose
of the four energy thresholds as “average dose”. Also, the absorbed dose on the fifth
energy threshold was quantified. The average dose was compared with the dose scored
on the fifth energy threshold to investigate if there is any significant difference in their
dose results.
From the absorbed dose images in the figures 5.8 (b) and 5.9 (b), higher statistical
noise variation were observed compared to the energy image in the figure 5.7. The
reason could be attributed to the high spatial resolution (90 µm), a low number of
photon histories simulated and the consideration of mass in the dose calculation. Unlike,
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in the figure 5.7 where no mass was taken into account. With that said the dose map
signal to noise ratio obtained was good for the assessment.
The Gd/HA calibration phantom dose image obtained from the figure 5.6 (b) was
used because it is more homogeneous and easy to measure the dose for each material
compared to the mice dose image. Moreover, the noise levels in the mice dose image
make it unsuitable for any dose assessment. The quantification of the Gd/HA calibration
phantom material dose was done by a selecting region of interest (ROI) comprising of
1020 pixels for each material (Gd, HA, water and lipid), as shown in figure 5.6 (a).
Figure 5.6: (a) ROI selection of the Gd/HA calibration phantom materials. The number
label shows which material dose was measured first up to the last one. (b) Reconstructed
Image slice of the Gd/HA calibration phantom showing the positions of the various
material concentration used for this study.
5.5.4 Spectral Hounsfield unit, mass energy absorption
coefficient and absorbed dose
Figures 5.8 (a) and 5.9 (a) show the Gd/HA calibration phantom and mouse Hounsfield
unit image of the four energy thresholds. Their simulation dose counterpart, as shown
in figures 5.8 (b) and 5.9 (b), respectively. Figures 5.8 (a) and 5.9 (a) show the
decrease attenuation (HU) of the materials as the energy threshold increases. The
simulation counterpart also exhibit the same trend, as shown in figures 5.8 (b) and 5.9
(b). Figure 5.12 shows the fifth energy threshold and the corresponding absorbed dose
map.
Figure 5.10 shows the mass energy absorption coefficients of water, adipose tissue
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(fat), lithium fluoride (LiF), gadolinium and cortical bone in the medical diagnostic
energy range. The importance of figure 5.10 is to help us explain the results in figure 5.11
and table 5.12. This is because the absorbed dose is the product of the photon energy
fluence and the mass energy absorption coefficient.
The spectral characteristics of the materials (Gd, HA, lipid and water) and their
simulation absorbed dose counterpart used for this study, as shown in the figure 5.11.
To make the HA graph concise the HA808.5 mg/mL attenuation was not plotted. Also,
all the HA materials attenuations show a similar pattern.
Figure 5.7: Energy distribution map of energy threshold 30-45 keV. (a) Gd/HA
calibration phantom. (b) Mouse.
Figure 5.8: Gd/HA calibration phantom spectral image (a) Hounsfield unit of each




Figure 5.9: Mouse spectral image. (a) Hounsfield unit of each energy threshold (keV).
(b) Corresponding absorbed dose map due to HU for each energy threshold (keV).
Figure 5.10: The total mass energy absorption coefficients of water, adipose tissue,
gadolinium, lithium fluoride and cortical bone were generated from the XMuDat
software (Robert, 1998) in the energy range of 1 to 120 keV. The total coefficient




Figure 5.11: (a) HU against energy threshold (keV) for Gd concentrations with standard
error ranging from ± (3.8-5.6) HU. (b) Absorbed dose (mGy) versus energy threshold
(keV) for Gd concentrations with standard deviation ranging from ± (20.3-59.2) mGy.
(c) HU against energy threshold (keV) for HA materials, water and lipid. Standard
error of HA ranging from ± (3.7-12.8) HU, lipid ± (3.2-3.4) HU, water ±(0) HU. (d)
Absorbed dose (mGy) versus energy threshold (keV) for HA materials, water and lipid.
Standard deviation of HA ranging from ± (16.6-52.4) mGy, lipid ± (11.5-12.9) mGy,
water ± (19.2-25.6) mGy.
5.5.5 ANOVA
The test for the statistically significant difference among the mean absorbed dose of
the four energy thresholds was assessed using the ANOVA, as shown in table 5.12.
The purpose of the ANOVA test is to investigate if one energy threshold from spectral
energy thresholds can be used for MC dose simulation. Table 5.13 shows the average
absorbed dose of the four energy thresholds.
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Table 5.12: ANOVA test of the four energy thresholds (keV) absorbed dose (mGy) of
the Gd/HA calibration phantom. The absorbed dose was calculated using the scan
settings of 26 µA, 720 number of projection frames, 200 mm SIC and 200 ms.
Materials
(mg/mL)
30-45 keV 45-60 keV 60-78 keV 78-118 keV
P-value
Mean StdDev Mean StdDev Mean StdDev Mean StdDev
HA808.5 1789.58 576.80 404.52 344.28 136.94 27.43 124.94 25.92 P<.04
HA402.3 117.56 34.59 100.36 33.70 83.56 31.15 76.47 28.45 P>.04
HA211.7 87.96 45.42 73.80 48.57 66.40 44.76 63.18 37.04 P>.04
HA104.3 67.80 52.45 54.71 44.87 46.10 40.60 46.63 42.76 P>.04
HA54.3 47.16 43.60 46.88 41.70 41.56 39.18 40.09 42.21 P>.04
Lipid 52.48 12.98 49.19 12.65 47.43 12.41 47.37 11.45 P>.04
Water 30.36 19.25 36.27 23.96 40.29 25.64 32.22 19.44 P>.04
Gd8 84.53 59.20 95.77 55.11 81.41 48.91 69.67 46.95 P>.04
Gd4 43.01 44.06 58.37 43.45 51.42 43.76 32.94 36.88 P>.04
Gd2 29.56 32.89 46.75 41.66 41.34 38.30 26.49 31.21 P>.04
Gd1 23.97 20.33 31.36 29.53 31.41 26.66 24.34 21.95 P>.04
StdDev= standard deviation
Table 5.13: Average absorbed dose of the four energy thresholds (keV).














5.5.6 Comparison between the fifth energy threshold
absorbed dose and the average dose
The calculation of table 5.13 makes the comparison between the fifth energy threshold
absorbed dose and the average dose possible. The essence of the comparison is to decide
on the right approach for MC dose simulation using spectral systems. Table 5.14 presents
the percentage absorbed dose difference between the two dose scoring approaches. The
absorbed dose values were calculated using the scan settings of 26 µA, 720 number of
projection frames, 200 mm SIC and 200 ms.
Figure 5.12 shows the fifth energy threshold and the corresponding absorbed dose
map. The simple application of figure 5.12 is figure 5.13. We have deduced a simple
relationship between the absorbed dose to the materials in the Gd/HA calibration
phantom with their associated attenuations. The linear equation in figure 5.13 will
provide a quicker way to calculate absorbed dose to a material given that the attenuation
of the material is known. The image noise observed in figure 5.12 could be due to low
photon histories simulated.






Fifth energy threshold Average dose
HA808.5 159.88 613.99 117.36
HA402.3 94.84 94.49 0.38
HA211.7 70.98 72.83 2.57
HA104.3 50.81 53.81 5.73
HA54.3 41.55 43.92 5.55
Lipid 50.32 49.11 2.43
Water 31.99 34.78 8.36
Gd8 79.25 82.84 4.43
Gd4 49.95 46.44 7.30
Gd2 34.30 36.04 4.94
Gd1 24.96 27.77 10.66
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Figure 5.12: (a) Mouse HU image slice of the fifth energy threshold. (b) Corresponding
mouse absorbed dose map. (c) Gd/HA calibration phantom HU image slice of the fifth
energy threshold. (d) Corresponding Gd/HA calibration phantom absorbed dose map.
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Figure 5.13: A simple relationship between the absorbed dose and the HU from the
fifth energy threshold of the Gd/HA calibration phantom. The vertical error bar shows
the standard deviation of the absorbed dose which ranges from ± 10.8 to 445 whiles
the horizontal error depicts the standard deviation of the HU ranging from ± 22.4 to
85.0. A strong correlation of 0.96 was observed between the absorbed dose and the HU.
The absorbed doses were calculated using the scan settings of 26 µA, 720 number of
projection frames, 200 mm SIC and 200 ms.
5.5.7 Absorbed dose comparison among Gd/HA calibration
phantom, mouse size phantom and TLD-100s
The absorbed dose of the water from the Gd/HA calibration phantom results in
table 5.13, the modelled mouse size phantom and the TLD-100s were compared, shown
in table 5.15. The essence is to cross-check the accuracy of the absorbed dose scored on
the water vial in the Gd/HA calibration phantom.
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Table 5.15: Comparison among the absorbed dose scored on the water vial, the mouse
size phantom and the TLD-100s. The absorbed doses were deduced using the scan




Water vial Mouse size phantom TLD-100s
Average 34.78 42.09 26.12
Standard deviation 22.25 8.61 1.11
5.6 Discussion
As of today, we do not know how spectral CT image can be used for MC dosimetry
simulation. The aim of this chapter was, therefore, to present a method to show the
potential use of spectral CT attenuation image as input for the MC dose simulation.
The linearity and the spectral response were used as a quality control check on the
MARS system to ensure that the correct information was obtained to conduct accurate
dose simulation. A strong Pearson correlation coefficient of ≥ 0.99 between the HU and
all the material concentrations was calculated for all the graphs. A strong correlation is
important for accurate dose simulation.
The results in figures 5.8 (a) and 5.9 (a) show the HU of Gd/HA calibration phantom
and the mouse, respectively, for the four energy thresholds. By visual inspection, it is
clearly seen that the lowest energy threshold (30-45 keV) has the highest attenuation
compared to the highest energy threshold (78-118 keV). This could be attributed to
the predominant photoelectric effect over the Compton scatter. The photoelectric
effect mainly depends on the EAN or atomic number (Z) of the material, the density
of the material and the energy of X-ray photons. Furthermore, the increase in the
Z and the density of material while reducing the X-ray photon energy increases the
attenuation and the mass energy absorption coefficient (seen in figure 5.10). This means
the material tends to attenuate (absorption and scattering) more X-ray photons, as
seen in figures 5.8 (a) and 5.9 (a). The rise in attenuation automatically increases the
absorbed dose also, as seen in figures 5.8 (b) and 5.9 (b). This explains the main reason
behind the use of filtration in the X-ray tube to cut off some low energy photons that
contribute to radiation dose only.
However, different materials have different responses to the the mass energy
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absorption coefficient because they have different EAN or Z. The EAN/Z of lipid,
soft tissue, bones and Gd are known to be 6.3, 7.6 and 12.3 and 64, respectively.
Moreover, as the energy threshold increases the attenuation and the mass energy
absorption coefficient decreases, as shown in figure 5.11 (a) and (c), and figure 5.10.
In addition, figure 5.11 (a) and (c) show the Medipix3RX detector’s ability to capture
all the materials used for this study. The decrease in the mass energy absorption
coefficient results in the absorbed dose reduction, as shown in figure 5.11 (b) and (d).
The exception to this trend is the higher Gd attenuation and mass energy absorption
coefficient (see figure 5.10) at its K-edge of 50.2 keV. The same situation is seen in the
Gd absorbed dose against energy threshold graph (figure 5.11 (b)). The reason is that
the photoelectric effect also depends directly on the Z of the material.
The water and lipid vials in the Gd/HA calibration phantom were used to represent
soft tissue and fat content, respectively, in the human body. The ANOVA test, as
shown in the table 5.12, reveals no statistically significant difference among the mean
absorbed dose values of the four energy threshold. The reason is the water and the lipid
attenuations and mass energy absorption coefficient remain relatively constant over a
given range of energies. Hence, the absorbed dose changes for lipid and water may have
originated from the random nature of the X-ray photon energies. Nonetheless, in the
table 5.12, the absorbed dose to the lipid appears to be higher than the absorbed dose to
the water. This is something not expected. This is because in all the material database
generated (tables 5.7, 5.8, 5.9 and 5.10), the assigned density of water (0.995 g/cm3) is
greater than that of the lipid (0.933 g/cm3) and the mass energy absorption coefficient
of water being higher than lipid (seen in figure 5.10). The reason could be attributed
to photon statistics and the difficulty in differentiating soft tissue composition based on
the Schneider et al. studies. With that said, it is difficult at this stage to provide a
specific reason to explain the lipid absorbed dose been higher than that of the water.
This aspect may need further investigation.
The ANOVA test (table 5.12) on the Gd materials also reveals no statistically
significant difference among the mean absorbed dose values of the four energy thresholds.
Even though the Gd materials absorbed dose values increases from 30-45 keV to 45-60
keV due to Gd K-edge (50.2 keV) and decreases to 78-118 keV., as shown in the
figures 5.11 (b) and 5.10. However, the absorbed dose values scored on the Gd materials
are not a true reflection of the Gd material dosimetry. This is because in the generated
material database (tables 5.7, 5.8, 5.9 and 5.10), the Gd materials attenuations ranging
from 24 to 300 HU were assigned to the soft tissue, the connective tissue and the bone
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marrow. Hence, the absorbed dose scored are to soft tissue, the connective tissue and the
bone marrow depending on the specified Gd material HU. This proves contrast agents
dosimetry based on the gold standard stoichiometric calibration method (Schneider
et al., 2000) are impractical.
From the table 5.12, the ANOVA test on all the HA materials (402.3, 211.7, 104.3,
54.3 mg/mL) shows no statistically significant difference among the mean absorbed
dose values of the four energy thresholds except the HA808.5 mg/mL. The reason for
HA808.5 mg/mL is due to the abrupt decrease in the absorbed dose, as seen in the
figure 5.11 (b). This starts from the energy threshold 30-45 keV (1789.58 mGy) to
78-118 keV (124.94 mGy), resulting in the percentage absorbed dose decrease of 173.9%.
Different HA material concentrations were used to simulate the different bone densities
in the body. It was found that the use of high HA concentration such as HA808.5
mg/mL may give statistically significantly different absorbed dose outcome across the
four energy thresholds. This implies using only one energy threshold from spectral data
for dosimetry is impractical.
The table 5.13 was deduced by averaging the four energy thresholds absorbed dose.
This is to make it equivalent to the standard CT. Another reason is that we have
shown that using a single energy threshold from a spectral data for dose simulation
is impractical. High standard deviations were associated with the absorbed dose for
each material. This is due to simulating low X-ray photon histories (6.48 × 108 photon
histories/µAs) and scaling using appropriate factors to deduced the scan settings
absorbed dose. The use of high photon histories in the order of about ≈ 1010 could serve
as a potential solution by generating a significant signal to noise ratio. Nonetheless,
this is achieved at the expense of long computation time and high computing power.
The absorbed dose simulation of individual energy threshold of a specimen and
finding their average is time-consuming process. To make this procedure fast, simple and
easy. A comparison was made between the average dose (table 5.13) and the fifth energy
threshold absorbed dose, as shown in the table 5.14. For all the materials compared the
percentage dose difference was within 11%, except HA808.5 mg/mL with percentage
dose difference of 117.36%. The is because from the material database (table 5.7), the
HA808.5 mg/mL is defined as amalgam tooth due to its high attenuation. This makes
the average absorbed dose higher compared to fifth energy threshold absorbed dose.
Based on this deduction I recommend the use of the average energy thresholds from
spectral systems for dose simulation.
The figure 5.12 shows the fifth energy threshold HU image of the mouse and the
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Gd/HA calibration phantom and their absorbed dose maps, respectively. Good image
quality is observed even though the dose calculations were done with high spatial
resolution and low photon histories. Improving the performance of the computing
system and optimising the MC algorithm could even yield better image quality for dose
assessment. The linear equation in figure 5.13 will provide a quicker way to calculate
absorbed dose to a material given that the attenuation of the material is known. What
this means is that in practice CT scans could be converted into absorbed dose in a fast
way. Another benefit is the achievement of personalised dosimetry.
In the table 5.15, the accuracy of the absorbed dose to the water vial in the Gd/HA
calibration phantom was assessed. This was done by comparing it with the absorbed
dose to the modelled mouse phantom and the TLD-100s inserted into the phantom.
The observed absorbed dose differences could be attributed to the different dosimetry
approaches used for measuring the absorbed dose.
The percentage absorbed dose difference between the mouse size phantom and the
water vial was within 19%. The difference could be due to the high standard deviation
associated with the water vial absorbed dose. Also, the attenuation of X-ray photons
caused by the phantom body and the neighbouring materials such as HA and Gd
concentrations could have contributed to the reduced water vial absorbed dose. As the
X-ray source makes a 360◦ rotation around the Gd/HA calibration phantom.
There are various reasons that could have contributed to the TLD-100s absorbed
doses been the lowest among the three dosimetric approaches. The X-ray photons
reaching the TLD-100s could have experienced some attenuations by the phantom body.
Hence, making the TLD-100s records reduced absorbed dose. Another reason is that
irradiated TLDs at low temperatures are capable of releasing trapped excited electrons
to the ground energy state (Cember and Johnson, 2008). This may cause the final dose
reading to be lower than the initial reading, as some of the electrons have lost their
energies already. In addition to the long distance the TLDs were transferred for reading
may have an impact on the final dose reading. This makes TLDs not to truly account
for all the radiation dose deposition. However, all the three absorbed dose values scored
fall within the dose range of typical clinical imaging settings of 10-100 mGy (Pernicka
et al., 2007) and below typical radiation dose range of small animal imaging (100-300
mGy) (Boone et al., 2004).
A shortcoming to this study may be related to the low number of X-ray photons (6.48
× 108 photon histories/µAs) simulated introducing more deviations in the absorbed
dose output. This study also fails to compare the absorbed dose of the fifth energy
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thresholds attenuation data to the arbitration counter data of the spectral system and
the standard CT scanner data. The failure was due to time constraint. The importance
of this comparison helps to decide which spectral system data is a good representation
of a standard CT scanner data to be used for dose simulations. One of the limitations
of this study is the inability to implement helical dose simulation.
In summary, this study has established a method on how spectral CT attenuation
data can be used for the MC dose assessments. In addition, using the fifth energy
threshold data provides the potential of using the spectral image for MC dose simulation.
However, with the notion that spectral CT attenuation image may not be considered
as a standard image of a spectral system. One may find absorbed dose maps generated
from a spectral attenuation image to be a non-realistic representation of the material
decomposed image obtained from a spectral system. Furthermore, we established based
on Schneider material convention method that contrast agent dosimetry is impractical.
One potential and practical solution is the direct use of the material decomposed density
images from spectral scanners for MC dosimetry simulation. The next chapter seeks to
address these concerns. The method developed in this chapter is translatable to the
MARS large-bore scanner.
5.7 Summary
A summary of the main points in this chapter are:
 This chapter aims to present a method to demonstrate the potential use of spectral
CT attenuation image as input for MC simulation dose assessment. This has
provided insights in using an average energy threshold data from spectral CT for
3D dose map assessment. This is the same case as in the use of standard CT
image for MC dose simulation. Further insight is the inability to conduct contrast
agent dosimetry based on Schneider material convention method.
 A set by step procedure for preparing a spectral CT data to be imported into a
GATE MC toolkit simulation been established.
 GATE toolkit capable of scoring a 3D dose distribution map with the use of






This chapter, on the other hand, seeks to establish a method to explore the potential of
using the spectral material decomposed (MD) density image for GATE Monte Carlo
(MC) dose simulation. Also, this study seek to provide a solution to the challenges
raised in using the spectral computed tomography (CT) energy images for MC dose
simulation and contrast agents dosimetry in the chapter 5.
Recent studies have reported on the increase in the radiation dose due to contrast
agents in CT examinations (Pathe et al., 2011; Grudzenski et al., 2009; Piechowiak
et al., 2015; Sahbaee et al., 2017). Given the frequency of contrast agent-enhanced CT
examinations (60% of CT imaging investigations) (Sahbaee et al., 2017; Boone and
Hernandez, 2017; Sahbaee et al., 2017), it is imperative to quantify their associated
radiation dose. The dose information obtained from the contrast agent could help in
the optimisation of CT scan settings and assessment of radiation risk to tissues during
contrast agent-enhanced CT imaging. In this study, we looked at the potential of using
spectral material image to estimate the increase in radiation dose delivered to soft
tissue.
The successful implementation of the material density images for MC dose simulation
will provide numerous benefits such as assessing three-dimensional (3D) radiation dose
to small animals, excised biological samples and human imaging, extend the traditional
use of material images for MC dose simulation, radiation dose optimisation for spectral
CT systems and assessing radiation risk to samples during imaging. This chapter seeks
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to develop a dosimetric method that could be used as a prototype to simulate the
MARS human and body-part scanners dose.
This study focuses on using the MD density image from the chapter 3 and the
simulated MARS small-bore scanner in the chapter 4.
In section 6.2, the knowledge gap in this study is reviewed. Section 6.3 provides
information about the materials used in this study. In addition, the procedure for
generating a material image is briefly discussed. Next, the process of converting the
material image into a format acceptable for MC dosimetry simulation are presented in
section 6.4. Section 6.6 discusses the main findings of the section 6.5. Lastly, section 6.7
summarises the entire chapter.
I was the primary researcher in this investigation. I would like to acknowledge
Maikol Salas Ramirez (PhD student at University of Würzburg (Germany) for sharing
his understanding on the use of mesh volumes for dosimetry simulation. Also, I thank
the GATE collaborators for making mesh volume rotation dosimetry simulation possible.
Lastly, I thank Dr Alex Chernoglazov for preparing the mice images.
6.2 Introduction
Recently, small animal imaging (SAI) systems have being regarded as the stepping
stone to build human-size imaging systems. Lately, the availability of the SAI systems
has risen due to their application in the optimisation of imaging protocols, dosimetry,
reconstruction image algorithm and determining the correct filter protocol for imaging.
Small animal X-ray CT imaging like traditional X-ray CT is also a non-invasive
research tool. Small animal CT uses X-ray photons to obtain detailed information from
small animals such as mice and excised biological samples (Taschereau et al., 2006).
Since X-ray photons are ionising radiations, it is imperative to assess their radiological
dose risk to tissue/organs (Papadimitroulas et al., 2015; Sarrut et al., 2014). Small
animal imaging radiation dose can be assessed mainly through physical experiment
or/and MC simulation (Papadimitroulas et al., 2015; Taschereau et al., 2006; Hupfer
et al., 2012; Thiam et al., 2008; Chetty et al., 2006). MC radiation dose studies in small
animals are limited even though there is a rise in the use of MC dose simulation.
Small animal study is at the stage where researchers are more interested in accounting
for detail dose to tissue/organ of a real mouse. This is because the current dosimetry
procedures such as the thermoluminescence dosimeters (TLDs), the CT dose index
(CTDI) phantom fails to account for the dose to shape, position and size of organ or
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tissue (Hupfer et al., 2012). Accurately accounting for detail dose to organ or tissue
could only be achieved through MC dose simulation.
In MC dose simulation, there is the privilege of using the mathematically described
phantom (Boone et al., 2004), the computerised mathematically defined phantom such
as four-dimensional (4D) digital mouse whole body (MOBY) phantom for small animal
imaging (Segars et al., 2004) and 4D NURBS-based Cardiac-Torso (NCAT) for human
imaging, and the voxelised phantom (patient CT data) for dosimetry (Papadimitroulas
et al., 2015; Hupfer et al., 2012). However, the use of spectral material image has not
been explored for MC dose simulation.
Spectral CT imaging based on energy resolving photon-counting detectors (PCDs)
such as the Medipix3RX (Ballabriga et al., 2013) possesses the ability to distinguish
between multiple photon energies (McCollough et al., 2015) based on the selection of
energy windows. The Medipix3RX has counts correction signature by operating in
charge summing mode. This aids in decreasing the energy information lost, count loss
and multiple counts observed which could cause pulse pileup effect (Curtis and Roeder,
2017a; Roessl and Proksa, 2007; Ballabriga et al., 2011). The count correction feature
improves the spectral information and the material differentiation of spectral CT (Curtis
and Roeder, 2017a; Roessl and Proksa, 2007; Ballabriga et al., 2011) compared to the
conventional CT and the dual energy CT (DECT) or the dual source CT (DSCT). The
detected multiple photon energies enhance the material decomposition. Spectral CT
also combines the advantages of the anatomic imaging (hard tissue) of CT system and
enhanced soft tissue contrast/molecular imaging comparable to the magnetic resonance
imaging (MRI) (Orlov, 2017; Buchbender et al., 2012). Hence, enabling better diagnosis
and treatment of diseases (Anderson and Butler, 2014; Ashton et al., 2015).
Some of the MARS spectral CT imaging applications are soft tissue imaging (Aamir
et al., 2014; Ronaldson et al., 2012), cancer imaging and multiple high Z atomic imaging
(Mahdieh et al., 2016), atherosclerosis plaque imaging (Zainon et al., 2012; Baturin
et al., 2012), quantitative imaging of vulnerable osteoarthritic cartilage (Rajendran
et al., 2017), decreasing beam hardening effects and metal artefacts using spectral CT
(Rajendran et al., 2014) and drug delivery (Ronaldson et al., 2012; Zainon et al., 2012).
The rise and continuing improvement of spectral material decomposition algorithms
(Hu and Zhao, 2016; Schlomka et al., 2008; Butler et al., 2011; Knight, 2015; Avrin et al.,
1978; Alvarez and MacOvski, 1976; Bateman et al., 2018) had improved the material
separation. The MD algorithms find their application in DECT, DSCT (Lalonde and
Bouchard, 2016; Schlomka et al., 2008) and spectral imaging (Anderson and Butler,
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2014; Bateman et al., 2018; Knight, 2015). However, the potential use of the spectral
material image for MC dosimetry simulation has not been investigated.
6.3 Materials
The experimental materials are the MARS small-bore scanner (discussed in chapters 3
and 4), the Gd/HA calibration phantom (discussed in chapters 3 and 5), the mice
(discussed in chapters 3 and 5) and the mouse size phantom with TLD-100s inserts
(discussed in chapter 5).
The simulation materials are the simulated MARS small-bore scanner (discussed in
chapter 4), the modelled mouse size phantom (discussed in chapter 5) and the Gd/HA
calibration phantom and the mice material images (more details in chapter 3) were
used.
6.4 Methods
6.4.1 Experimental set-up and post processing of image data
The experimental procedure for the mouse size phantom with TLD-100s inserts discussed
in chapter 5 is the same as this study. The Gd/HA calibration phantom and the mice
experimental procedures are discussed in the chapters 3 and 5. The overall image
quality of the Gd/HA calibration phantom and the mice were enough for the dose
simulation studies. No significant artefacts such as X-ray photon starvation and beam
hardening were observed in the images.
Quality control (QC) measures such as the spectral and the linearity response of
the system were conducted on the reconstructed CT images of the Gd/HA calibration
phantom (see chapter 3 subsections 3.4.5 for more information). This spectral and
linearity response information plays a major part in the segmentation process of the
material decomposition, quantification and identification (Barrett and Keat, 2004; Raja
et al., 2018). The correct segmentation, quantification and identification of materials
are important for an accurate MC dose simulation.
6.4.2 Post material image analysis
The MARS in-house constrained linear least squares MD algorithm (Knight, 2015;
Bateman et al., 2018) was applied to decompose the Gd/HA calibration phantom and
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the mice reconstructed image into gadolinium (Gd), hydroxyapatite (HA), lipid and
water base density images (more information in the chapter 3 subsection 3.4.6).
The Gd/HA calibration phantom material image analysis was used as a QC procedure
since the material decomposition ability could be affected by the pulse pileup effect,
the energy resolution of the detector, the calibration phantom and the image noise
(Curtis and Roeder, 2017a; Roessl and Proksa, 2007; Panta et al., 2015). A post-MD
quantitative evaluation metric was used to assess the level of material identification
and misidentification in the material images (Raja et al., 2018). The essence of the
assessment was to determine the suitability of the percentage of materials identified
for the dose simulation. For this study and future dosimetry work, a threshold value
for an acceptable material identification for dose simulation was set to be ≥ 80%. The
threshold value was deduced based on this study and other studies by the MARS team
members (for more information see chapter 3 subsection 3.4.6).
Lastly, Pearson correlation from the linear regression equation was used as an
additional QC measure. This was used to determine the relationship between the known
(manufacturer given concentration) and the measured material concentrations in the
Gd/HA calibration phantom, as shown in figure 6.8.
6.4.3 Procedure for importing material image into the
simulated MARS scanner
The procedure for importing the material image into the simulated MARS scanner was
standardised using the Gd/HA calibration phantom material images. The file format of
the MARS material image is 16 bits Digital imaging and communications in medicine
(DICOM). Tables 6.1 and 6.2 show the material image specifications of the Gd/HA
calibration phantom and the mice material images, respectively.
The 16 bits DICOM was converted to 8 bits DICOM using the Fiji (Schindelin et al.,
2012). Next, the 8 bits DICOM material image was converted to a binary mesh volume
(Standard Tessellation Language or STereoLithography (STL)) using the Isosurface in
the BoneJ (Lorensen and Cline, 1987). The default settings in Bonej was adopted but
the threshold and resampling were adjusted to suit our dosimetry needs. The threshold
and resampling were used to limit the level of material misidentification and improves
on the mesh volume accuracy, respectively, compared to the 8 bits DICOM material
image. The threshold and resampling settings, as presented in table 6.3, were applied
to accept the optimum loss of material information in the correctly identified material
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voxels. In addition, these settings provide the necessary information for identifying all
the voxels containing HA concentration in the HA channel, Gd concentration in the
Gd channel, water in the water channel and lipid in the lipid channel for the Gd/HA
calibration phantom and the mice material image. However, the dose simulation was
done using the mice material images.
Table 6.1: Gd/HA calibration phantom material image specifications





Table 6.2: Mouse material image specifications










Gd/HA phantom Mice Gd/HA phantom Mouse
Gd 6 6 60 60
HA 6 6 10 10
Lipid 8 8 30 30
Water 18 18 42 42
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6.4.4 Mesh volume localisation rectification
FreeCAD image processing software (Riegel et al., 2018) was used for further image
processing on the mice mesh volumes. The mice mesh volumes localisation were affected
after the conversion process. In simple terms, the mice mesh volumes were displaced
from the FreeCAD and the GATE MC toolkit centre of origin when imported. The
importance of using the FreeCAD was to remove some misidentified voxels and to
correct the mesh volume displacement from the centre of origin.
This challenge was solved using the coordinates distances (x y z mm) from the
boundary information (max) in FreeCAD and through repeated practises. The initial x,
y and z mm coordinates distances were each divided by two. Next, five was added to
the divided x and y mm values only. Hence, new coordinates distances (x1 y1 z1 mm)
were deduced. The new coordinates distances (x1 y1 z1 mm) were negated and entered
into the placement menu (Translation field) in the FreeCAD. This process rectifies the
mesh volume localisation or displacement challenge. The mesh volume displacement
from the centre of origin is an area that may need further investigations.
Figure 6.1 (a) is the graphical utility interface (GUI) of the FreeCAD showing the
boundary information (max) and the displayed material mesh volume from the centre
of rotation or origin. The blue sphere is a default shape in the FreeCAD located at the
centre of rotation or origin. The rectified material mesh volume completely hid the
sphere, as shown in figure 6.1 (b).
Next, the mesh volume was exported into the simulated MARS scanner. Also, a
second cross-check was done to verify the correctness of the mesh volume rectification
in the simulated MARS scanner. To do this, a mathematical box phantom of the same
dimension as the imported mesh volume was defined in the simulation. The condition is
that if the defined phantom completely hides the mesh volume, as shown the figure 6.1
(b). Then it means the rectification done in FreeCAD was correct, as shown in figure 6.2.
The displayed mesh volume is the yellow one and the rectified mesh volume is the blue
one. The defined phantom (gray colour) completely hides the blue mesh volume.
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Figure 6.1: (a) GUI of the FreeCAD showing the displayed mesh volume from the origin.
The blue sphere is a default shape in the FreeCAD located at the centre of rotation or
origin. The imported material mesh volume is displayed away from the origin. (b) GUI
of the FreeCAD showing the rectified mesh volume. The sphere is hidden by the mesh
volume after the rectification. This means both are now located at the origin.
Figure 6.2: The magenta is the X-ray box and green is the collimator. (a) The displayed
mesh volume (yellow) and the rectified (blue) are imported into the simulation. (b) The
mathematically defined box phantom (gray) completely hides the blue mesh volume
demonstrating that the FreeCAD rectification is correct.
6.4.5 Simulation
The 3D mesh volumes placed inside the simulated MARS scanner are the direct
representation of the 3D material images from MARS Vision imaging software




Figure 6.3: (a) The mouse HA mesh volume (gray) inside the simulated MARS scanner.
X-ray source (magenta) and collimator (green). (b) The mouse HA channel (gray)
obtained from MARS Vision imaging software (Mandalika et al., 2018; Chernoglazov,
2016).
Figure 6.4: The mouse water mesh volume (gray) inside the simulated MARS scanner.
X-ray source (magenta) and collimator (green). (b) The mouse water channel (gray)




Figure 6.5: The mouse lipid mesh volume (yellow) inside the simulated MARS scanner.
X-ray source (magenta) and collimator (green). (b) The mouse lipid channel (yellow)
obtained from MARS Vision imaging software (Mandalika et al., 2018; Chernoglazov,
2016).
Figure 6.6: The mouse Gd mesh volume (green) inside the simulated MARS scanner.
X-ray source (magenta) and collimator (green). (b) The mouse Gd channel (green)
obtained from MARS Vision imaging software (Mandalika et al., 2018; Chernoglazov,
2016). The majority of the Gd concentrations were collected in the bladder and the
kidneys.
6.4.5.1 Material definition
The use of mesh volumes offers more flexibility in assigning any material from the
GATE material database, the National Institute of Standard and Technology (NIST)
material database (White et al., 1987) and the International Commission on Radiation
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and Measurement (ICRU) (Allisy, 1989). A total of three mice mesh volumes were
used. The mouse mesh volume is composed of HA, water, lipid and Gd mesh volumes.
The mouse mesh volume serves as a true representation of the mouse body.
The rib bone material (the highest bone density in the body) from the GATE
material database (OpenGATE, 2016) was assigned to HA mesh volume. The reason
for using the rib bone was to estimate the radiation dose to the densest bone in the
mouse body. This also serves as the upper limit of dose as far as bone densities dose
calculations are concerned based on the scan settings. Water at 4◦C and adipose taken
from the GATE material database were designated to the water mesh volume and lipid
mesh volume, respectively.
One of the goals in this study was to quantify the radiation dose due to contrast agents
administration during CT imaging. The Gd concentration measured in the Gd material
image channel was used, as shown in figure 6.6. The mice details, preparation and
scanning are discussed in chapter 3 subsection 3.4.3. Specifically, the Gd concentration
in the bladder was used. It was measured to be 22.9 ± 2.9 mg/mL standard deviation
by analysing and averaging of 80 image slices of the Gd material image.
The Gd measured concentration (22.9 ± 2.9 mg/mL) in the bladder is less than
the initial injected concentration. This could be attributed to further dilution of the
Gd solution and its distribution to other mouse body parts. To assign the material
definition to the Gd mesh volume, information on the Gadovist such as the chemical
formula, the mass density, the material composition and the molecular weight are
needed. The Gadovist information was extracted from the National Institutes of
Health (NIH) database. The Gadovist has the chemical formula C18H31GdN4O9 with
the molecular weight of 604.715 g/mol. The Gadovist was defined as a material with
a density of 22.9 mg/mL in the simulation. In addition, as a control to this radiation
dose measurement the Gd mesh volume was defined as soft tissue (water was used
to represent soft tissue). This was done to know the dose difference between the Gd
contrast agent and the soft tissue of the same region of interest.
The table 6.4 shows the material type, the composition assignment and the mass
density. The specifications of the dose image output, as shown in the table 6.5 were
used to increase computational performance and reduces the simulation duration. The
dose simulations on the mice mesh volumes (rib bone, water, adipose and Gd mesh
volumes) were done using one mesh volume at a time.
The primary source particles (6.48×108 photon histories per µAs) were simulated
to cover 360 exposure angles of 1.8×106 photons. This completes a 360◦ with 1◦ step
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and a time step of 0.0028 s to achieve an almost continuous movement of the X-ray
source tube. The computing system used has the specifications Intel (R) Core (TM)
i7-6200U CPU @ 3.40 GHz, ≈ 3.40 GHz and 16.0 GB RAM.
Table 6.4: Mouse mesh volumes and their respective material designation
Mouse mesh volume Composition designation Density/Concentration (g/mL)
Water channel Water from the GATE material database 1
HA channel Rib bone from the GATE material database 1.920
Gd channel Gadovist from the NIH 0.0229
Gd channel (control) Water from the GATE material database 1
Lipid channel Adipose 62 from the GATE material database 0.9504
Table 6.5: Mice mesh volume absorbed dose image specifications






6.5.1 Post MD density image analysis
The post-MD identification and misidentification results are plotted, as shown in
figure 6.7. The results were obtained by analysing image slices (thickness of 90 µm)
and averaging them.
The figure 6.8 shows the linearity trend existing between the known and the measured
material concentrations. For the measured material concentrations, 75 image slices were
analysed and averaged. The Pearson correlation was used to determine the relationship




Figure 6.7: (a) Material identification chart showing the quantitative misidentification
and identification of voxels among Gd, HA, lipid and water. For a known solution of
Gd, the correct identification reduces from 99.95% (8 mg Gd/mL) to 29.56% (1 mg
Gd/mL). For HA vials, even though no misidentification were observed for 808.5, 402.3
and 211.7 mg HA/mL, a total misidentification of 1.31% and 20.42% were observed for
104.3 mg HA/mL and 54.3 mg HA/mL, respectively. (b) A lookup table to show the
individual identification and misidentification value for each material.
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Figure 6.8: The measured and known material concentration relationship at 24 µA was
demonstrated by Pearson correlation. The error bar depicts the standard deviation
of the mean material concentrations. (a) The standard deviation of the measured HA
concentrations ranges from 29.87 to 80.02 mg/mL. (b) The standard deviation of the
measured Gd concentrations ranges of 0.28 to 0.53 mg/mL.
6.5.2 Material images dosimetry
The absorbed dose maps generated on the mesh volumes are shown with their
corresponding mesh volumes. The absorbed dose map demonstrates the ability of
spectral CT material image for MC dose simulation.
The water mesh volume and the absorbed dose map of a sagittal image slice of the
water mesh volume are shown in the figure 6.9 (a) and (b), respectively. Figure 6.10
(a) and (b) also show the lipid mesh volume and the absorbed dose map of a sagittal
image slice of the fat mesh volume, respectively. The absorbed dose map of a sagittal
image slice of the rib bone mesh volume and the rib bone mesh volume, as presented
in the figure 6.11 (a) and (b), respectively. The absorbed dose map shows the 11 mm
z-axis field of view (zFOV). The absorbed dose image slice of the Gd mesh volume (22.9
mg/mL) and the Gd mesh volume, as shown in the figure 6.12 (a) and (b), respectively.
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Figure 6.9: (a) A sagittal plane of the 3D volume rendering of the water mesh volume.
(b) The absorbed dose map of a sagittal image slice of the water mesh volume. The
absorbed dose map shows the 11 mm zFOV. The absorbed dose was deduced from the
routine MARS scan settings 26 µA, 0.22 s, 720 number of projection frames, 200 mm
source to isocenter (SIC) and 120 kVp.
Figure 6.10: (a) A sagittal plane of the 3D volume rendering of the lipid mesh image.
(b) The absorbed dose map of a sagittal image slice of the lipid mesh volume. The
absorbed dose map shows the 11 mm zFOV. The MARS routine scan settings 26 µA,
0.22 s, 720 number of projection frames, 200 mm SIC and 120 kVp were applied to
deduced the absorbed dose.
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Figure 6.11: (a) A sagittal plane of the 3D volume rendering of the rib bone mesh image.
(b) The absorbed dose map of a sagittal image slice of the rib bone mesh volume. The
absorbed dose map shows the 11 mm zFOV. The MARS routine scan settings 26 µA,
0.22 s, 720 number of projection frames, 200 mm SIC and 120 kVp were applied to
deduced the absorbed dose.
Figure 6.12: (a) A sagittal view of the 3D volume rendering of the Gd mesh image. (b)
The absorbed dose map of a sagittal image slice of the Gd mesh volume. The absorbed
dose map shows the 11 mm zFOV. The absorbed dose was deduced from the routine
MARS scan settings 26 µA, 0.22 s, 720 number of projection frames, 200 mm SIC and
120 kVp.
6.5.3 Quantification of material images absorbed dose
The scan settings of a typical MARS protocol (26 µA, 220 ms, 200 mm SIC, 720 number
of projections frames and 120 kVp) were used to deduce the material images absorbed
doses (mGy), as shown in table 6.6. Fiji was used to quantify the mean absorbed dose
in the material images over arbitrary region of interests (ROIs). The material images
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absorbed doses were simulated individually without taking into account the attenuation
from other materials.
For the rib bone mesh volume, a ROI of 325 mean pixels was assessed for 10 image
slices per each of the three rib bone mesh volumes and averaged, as shown in the
figure 6.13 (a). For the water mesh volume, a ROI of 6278 mean pixels was analysed
from an average of 30 image slices per water mesh volume for each of the three water
mesh volumes, as shown in figure 6.13 (b).
The absorbed doses of the three lipid (adipose) mesh volumes were analysed and
averaged, as shown in the table 6.6. A ROI comprising of 489 mean pixels was selected,
as shown in the figure 6.13 (c). The absorbed doses from the Gd mesh (water as control)
and Gd mesh volume (22.9 mg Gd/mL) were calculated. Thirty image slices were
analysed and averaged from a ROI of 4390 mean pixels, as shown in the figure 6.13 (d).
The absorbed dose (mGy) comparison between the dose scored on the Gd mesh
(water as control) and the Gd mesh volume (22.9 mg Gd/mL) is illustrated in figure 6.14.
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Figure 6.13: ROIs selected for the quantification of the absorbed dose for each material.
(a) Rib bone mesh volume absorbed dose deposition map. (b) Water mesh volume
absorbed dose distribution map. (c) Adipose (fat content) mesh volume absorbed dose
deposition map. (d) Gd (contrast agent) mesh volume absorbed dose deposition map.
The calibration bar depicts the absorbed dose (mGy) for the MARS scan settings 26
µA, 0.22 s, 200 mm SIC, 720 number of projection frames and 120 kVp.
Table 6.6: Mean absorbed dose (mGy) scored from the mice mesh volumes over the
selected ROIs using the typical MARS scan settings 26 µA, 220 ms, 200 mm SIC, 720
number of projection frames and 120 kVp.
Material mesh volume Absorbed dose (mGy) Standard deviation
Water 43.31 10.66
Adipose 32.05 39.97
Rib bone 175.21 55.71
Gd (water as control) 45.91 9.86
Gd (22.9 mg/mL) 779.33 199.66
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Figure 6.14: Absorbed dose comparison between the dose scored on the Gd mesh
(water as control) and the Gd mesh volume (22.9 mg Gd/mL). The error bars show the
absorbed dose variations. The absorbed doses were deduced from the typical MARS
scan settings 26 µA, 0.22 s, 720 number of projection frames, 200 mm SIC and 120 kVp.
6.5.4 Absorbed dose comparison
In the table 6.7, the absorbed dose (mGy) due to the water vial (from the Gd/HA
calibration phantom), the TLD-100s and the mouse size phantom taken from the chapter
5 table 5.15 were compared to the absorbed dose scored on the water mesh volume.
The essence is to verify the absorbed dose scored on the water mesh volume.
Table 6.7: Absorbed dose (mGy) due to the water vial (in the Gd/HA calibration
phantom), the mouse size phantom and TLD-100s dose in the chapter 5 table 5.15 and
the water mesh volume using the typical MARS scan settings 120 kVp, 26 µA, 720




Water vial (in the Gd/HA calibration phantom) 34.78 22.25
Water mesh volume 43.31 10.66





This study seeks to establish a method to explore the potential of using the spectral
material image for the MC dose simulation. Furthermore, we seek to provide a solution
to the challenges raised in using the spectral CT energy images for MC dose simulation
and contrast agents dosimetry.
Material identification and quantification depend on material decomposition. The
material decomposition plays a key role in the spectral CT ability to reveal material
signatures and components accurately. However, there are several reported factors
such as the calibration methods (Curtis and Roeder, 2017a), the image noise and
the pulse pileup (Raja et al., 2018; Ehn et al., 2017) that affect the correct material
separation. Hence, affecting the identification and quantification of materials and their
concentrations.
Research has shown that the choice of the calibration phantoms/methods could
affect significantly the material decomposition quantification (Curtis and Roeder, 2017a).
Also, more than two concentrations of a known material in a calibration phantom may
not be necessary for material decomposition in some cases. This implies the number of
material concentrations (HA and Gd) used in this study could have been reduced and
still maintain the needed information for the dose simulation. The benefit of using less
number of material concentrations could improve on the performance of the material
decomposition algorithm.
Furthermore, the image noise is known to inherently affect the imaging of low Z
materials. Also, it affects the separation of high Z materials of low concentrations
(Raja et al., 2018; Lin et al., 1993). From the material identification, as in figure 6.7,
most misidentification occurred at the low concentrations of the 1 mg Gd/mL and 2
mg Gd/mL with a total misidentification of 70.44% and 33.05%, respectively. Similar
results are presented in other related studies (Mahdieh et al., 2016; Raja et al., 2018).
A very strong Pearson correlation of ≥ 0.99 was observed for the HA and Gd measured
against the known material concentrations (mg/mL), as shown in figure 6.8.
Moreover, the percentage of incoming photon energy that is captured by a detector
can be limited by pulse pileup (Atharifard, 2017). Pulse pileup occurs when a single
event represents two or more photons reaching the same detector sensitive area at the
same time frame of the detector readout system. The single event read by the detector
readout systems leads to loss of the energy resolution. Thus, affecting the material
decomposition (Frey et al., 2007; Panta et al., 2015).
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Based on the highlighted challenges faced by the material decomposition and the
objective of using the material image for the MC dose simulation, a threshold value of
≥ 80% was set for the correct material identification. The material image was used
based on the figure 6.7 information for the dose simulation. In addition, the strong
correlation between the measured and the known material concentration for the Gd
and HA concentrations to the known concentrations provides a solid platform for using
a material image for the MC dose simulation. The accuracy of the dose simulation
depends on material identification.
The absorbed dose distribution maps (figures 6.9, 6.10, 6.11 and 6.12) are proof of
concept for the extended use of the material image for dose simulation studies.
The results of the quantified absorbed doses in the figures 6.9, 6.10, 6.11 and 6.12 are
presented in table 6.6. The typical MARS scan settings 120 kVp, 26 µA, 720 number of
projection frames, 200 mm SIC and 220 ms were used. The MARS scan settings were
derived by simulating low number of X-ray fluxes and scaling it by an appropriate factor.
The low number of the X-ray fluxes simulated could have caused the high absorbed
dose deviations observed, as presented in table 6.6.
Contrast agents are used to enhance soft tissue imaging in CT investigation (Sahbaee
et al., 2017). However, research has shown that contrast agent increases the radiation
dose during CT imaging even though they get eliminated from the body shortly after
CT imaging is completed (Pathe et al., 2011; Grudzenski et al., 2009; Piechowiak
et al., 2015; Sahbaee et al., 2017). The likely cause of the radiation dose increase is
photoelectric absorption (Bushberg, 2003). The issue of contrast agents enhancing the
radiation dose to cause single and double deoxyribonucleic acid (DNA) strands to break
(Pathe et al., 2011; Grudzenski et al., 2009; Piechowiak et al., 2015) has to be given
the needed attention. The reasons are in the United States alone, on average, more
than 200000 CT scans are done per day. In addition, to meet the goal of reducing
the effective dose levels less than 1 mSv laid out by the Summit on Management of
Radiation Dose in CT held on February 2011 (McCollough et al., 2012).
In this study, we explored the potential of using the spectral density images for MC
dose simulation. The absorbed doses simulated were at a single axial rotation without
taking into account helical rotation. From figure 6.14, it is clear that the absorbed dose
on the Gd contrast agent is greater than the soft tissue absorbed dose. The reason
is that the Gd has a higher mass energy absorption coefficient compared to the the
soft tissue (see figure 5.10). This makes Gd receives more absorbed dose compared
to the soft tissue. A more detailed related study was conducted by (Sahbaee et al.,
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2017). Our results had several shortfalls that need to be taken into account before any
interpretation could be given to the dose difference between the soft tissue and the
Gd contrast agent. First, the absorbed dose was scored on the Gd only without the
presence of soft tissue. In the future, the absorbed dose to contrast agent should be
assessed in the presence of soft tissue. Secondly, the absorbed doses to the soft tissue
and Gd contrast agent were unrealistic since the mouse body and skeleton system were
not taken into account. Thirdly, the use of cadaver mice material image as a true
representation of a live mice material image. Hence, the measured Gd concentration in
the bladder may be different for a live mice material image thereby providing different
dose results. A complete study of the effect of contrast agents due to radiation dose
should take into account scanning of a live mouse with or without contrast agent. Lastly,
the physiological states of the mouse were not accounted for even though healthy mouse
was selected for this study.
In summary, in spite of this study limitations, we have shown the possibility of using
spectral material images obtained from contrast-enhanced CT examination for MC
dose simulation. Our study seeks to propose new ways of optimising CT scan settings
and contrast agent injection protocols taking into account dose due to contrast agents.
However, we edge that our contrast agent dose simulation studies should only be seen
as the first step towards the role of contrast agents on radiation dose. This is an area
requiring further studies.
The verification of the water mesh volume absorbed dose was done by comparing
with the absorbed dose due to the water vial (from the Gd/HA calibration phantom)
and the TLD-100s and the mouse size phantom taken from the chapter 5 table 5.15.
The absorbed dose scored by the water vial is 1.21 and 1.24 times less than that of
the mouse size phantom and water mesh volume, respectively. This could be explained
by the high statistical deviation associated with the dose scored by the water vial.
Also, the neighbouring material vials in the Gd/HA calibration phantom could have
attenuated some of the X-ray photons travelling to the water. However, the percentage
dose difference between the mouse size phantom and the water mesh volume were within
3%. This close dose estimates could be explained by the close size estimated for the
mouse size phantom and the water mesh volume.
Lastly, in table 6.7 the huge absorbed dose difference between the TLD-100s and
the rest (the water vial, the mouse size phantom and the water mesh volume) could be
due to the attenuation caused by the phantom body in which the TLDs are inserted.
Generally, thermoluminescence dosimeters are limited to scoring dose at specific points
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or position in phantoms. This makes them not to truly account for all the radiation
deposition in them. In addition, at standard atmospheric temperature and pressure,
exposed TLDs may loose some of the trapped excited electrons to the ground state
(Cember and Johnson, 2008). This may account for the least dose recorded. However,
all the absorbed dose values recorded are within the typical clinical imaging settings
dose range of 10-100 mGy (Pernicka et al., 2007) and below typical small animal imaging
radiation dose range of (100-300 mGy) (Boone et al., 2004).
In summary, this study has established a novel methodology for using the spectral
material image for MC dose simulation. This method will be used with the method
established in chapter 3 to optimise MARS scan settings for preclinical studies and
the MARS human clinical trials. This study as a proof of concept has demonstrated
spectral material image dosimetry. However, this study serves as a baseline for future
material dose investigations. The method developed in this chapter is translatable to
the MARS large-bore and body-parts scanners. The work presented in this chapter
aligns with the MARS project goal (providing economic and health benefits to New
Zealand). This is to ensure the MARS scan settings provides a minimum radiation dose
with good material differentiation quality for research and clinical health care use.
6.7 Summary
A summary of the key ideas in this chapter are presented:
 This study seeks to demonstrate the potential of using the spectral material
decomposed image for the MC dose simulation. Furthermore, we seek to provide
a solution to the challenges raised in using the spectral CT energy images for MC
dose simulation and contrast agents dosimetry.
 As a proof of concept, the use of the material image as input into MC dose
simulation has been demonstrated.
 Finally, the potential of contrast agent dosimetry has been shown.
 A novel methodology for the using spectral material image for MC dose simulation





This chapter summarises the results of this thesis with respect to the study aims. The
aim of this thesis was to establish methods to optimise MARS scan settings and conduct
a novel material-specific dosimetry simulation using the MARS small-bore scanner.
The importance of optimising the MARS scan settings is to produces images that
reveal as much detail as possible with reduced radiation dose. In addition, MARS
spectral computed tomography (CT) is at a stage of conducting human clinical trials.
Hence, obtaining optimal scan settings prior to the trial is imperative. Moreover,
different spectral systems material decomposition (MD) algorithms performance could
be compared using this method. Lastly, the method in this thesis serves as a guideline
in optimising different MARS scan settings in the MARS small-bore and large-bore
scanners.
Although previous MARS dosimetry studies were useful in understanding the
radiation dose distribution in the MARS scanner (Lu, 2016; Lu et al., 2017; Ganet
et al., 2015; Ganet, 2014; Zainon et al., 2012), none of them fully characterised the
MARS system dosimetry. The realisation of my thesis aims has brought us closer to
achieving the ultimate goal of the overarching project. The overarching project seeks to
fully characterise the MARS scanner radiation dose leading to personalised dosimetry.
The dosimetric methods established in this thesis could be used to estimate dose for
MARS imaging procedure and spectral technology in a whole. Another benefit is the
ability to scale the method up to human-size spectral dosimetry. The work presented
in this thesis provides economic and health benefits to New Zealand by ensuring robust





The research in this thesis demonstrates the progression of my thesis aims through
various stages. Each chapter represents a different stage, which follows on from the
previous stage.
In chapter 3, a method to optimise the MARS spectral CT scan settings was
presented. This study aims to use the As Low As Reasonably Achievable (ALARA)
principle of the radiation protection (Valentin, 2007; OECD, 2011) to determine absorbed
dose for spectral imaging of small animals that have sufficient image quality and material
differentiation to meets clinical needs.
The results in this chapter may suggest the inability of standard image quality
indicators (signal-to-noise and spatial resolution investigated in this thesis) to evaluate
the performance of current MD algorithm developed for the MARS spectral imaging.
Furthermore, it was observed that the assessment of material identification can be used
as an additional quality control tool to characterise any material concentrations in
spectral CT. Moreover, the results show that the energy-resolving capability of photon
counting CT maintains image quality, with correct material identification at reduced
radiation dose. The tube current deduced in this chapter can be used to further optimise
the MARS scan settings. The established method could also be used to evaluate the
MD algorithm performance. Lastly, a method for optimising MARS spectral CT scan
settings has been developed. This method is used to optimise MARS scan settings for
preclinical studies and the MARS human clinical trials.
Chapter 4 demonstrates the initial steps taken for a full dosimetry simulation package
for the MARS imaging system based on the Geant4 application for Tomographic
Emissions (GATE) Monte Carlo (MC) simulation toolkit. These initial steps are
important to ensure accurate dose verifications on the MARS image datasets (the
spectral energy images and the MD density images). The MARS simulation package
will be used with the method established in chapter 3 to optimise MARS scan settings
and perform material-specific dose simulation.
The verifications of the simulated MARS scanner were done with physical
measurements. The overall CTDI dose measured in air and the CTDI phantom results
in differences lower than 5% and 10%, respectively, between the simulation and the
physical measurement for all the scan settings. The CTDI dose differences in this study
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are found to be in agreement with other small animal dose difference reported (Deak
and Kalender, 2009; Lee et al., 2013, 2016).
The findings of this study imply the simulated MARS scanner can be used with
the method established in chapter 3 to optimise MARS scan settings during imaging
and conduct material-specific dose simulation. Also, it provides the license to use the
simulated MARS scanner for material-specific dosimetry (discussed in the chapters 5
and 6).
Currently, no established concepts exist to demonstrate how spectral CT image can
be used for MC dosimetry simulation. Hence, chapter 5 presents a method to show the
potential use of spectral CT attenuation image as input for MC dose simulation.
The study results have demonstrated that the average spectral energy images can be
used as an import into MC simulation platform for 3D dose scoring. Hence, we do not
require to conduct 3D dose scoring on individual spectral energy images. A step by step
procedure for preparing a spectral CT data to be imported into a GATE MC toolkit
simulation has been established. Furthermore, the shortcoming of the Schneider et al.
stoichiometric material conversion method to conduct contrast agents dosimetry was
demonstrated. The average spectral energy image (water vial of the Gd/HA calibration
phantom) absorbed dose was verified by comparing with the absorbed dose due to the
thermoluminescence dosimeters and the modelled mouse size phantom.
As of today, no established methods exist for spectral CT material image dosimetry.
Chapter 6 seeks to establish a method to explore the potential of using the spectral MD
image (density image) for the MC dose simulation. Furthermore, we seek to provide
a solution to the challenges raised in using the spectral CT energy images for MC
dosimetry and contrast agents dosimetry simulation.
The findings in this study suggests that the material images can be used for MC dose
simulation as well as contrast agent dosimetry. Our study provides the backbone for a
novel way of conducting spectral CT dosimetry. Also, it answers the questions raised in
other related studies (Lu, 2016; Lu et al., 2017). More importantly, the achievements
in this study have brought us closer to the realisation of the overarching project goal.
7.3 Future outlook
The MARS overarching project goal is to characterise the MARS system radiation
dose towards safe, fast and robust human scanning, and personalised dosimetry. The
attainment of this goal implies that there will finally be an advanced dose monitoring
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tool to fully assess radiation dose information during imaging for any scan settings.
The tool is also expected to retrospectively simulate 3D spatial dose maps from MARS
spectral images, as demonstrated in this thesis.
The work in this thesis is a continuation of the work done by Lu. This thesis work
has demonstrated the potential of personalised dosimetry. It is expected that in the
future where clinical procedures and scan settings are well defined, the work done in
this thesis will help in formulating MARS radiation protection guidelines.
Even though, the methods developed in this thesis are translatable to the MARS
large-bore and body-parts scanners and can be applied to other spectral imaging systems.
Some areas in the methods can be improved to ensure the full realisation of the MARS
overarching project goal.
A shortfall in chapter 3 studies could be due to using only tube current to optimise
the effect of material identification, standard image quality indicators and radiation
dose. Further studies should extend the work by assessing additional scan settings
such as the number of projection frames and exposure time to fully deduced optimise
scan setting at reduced dose while maintaining the material differentiating performance.
Lastly, more work is required to fully understand the relationship between the standard
image quality indicators and the material identification for photon-counting spectral
systems.
In chapter 4, several shortfalls of this study were observed. The observed difference
between the simulation and the physical measurements could be due to the use of the
simulated MARSpec spectrum. The simulated MARSpec spectrum was defined as a
point source to represent a true X-ray tube source. Finally, no helical dose simulation
was implemented.
In future studies, I would recommend the use of the actual X-ray spectrum simulated
in the GATE toolkit. This could help reduce the difference observed between the
simulation and the physical measurement results. In addition, implementing helical
dosimetry simulation would be a great benefit moving to personalised dosimetry. Lastly,
the high absorbed dose difference (between the simulation and physical measurements)
increasing with the number of projection frames is an area requiring further investigation.
Chapter 5 fails to compare the absorbed dose of the average spectral attenuation
image to the arbitration counter data of the MARS spectral system and the standard
CT scanner data. The importance of this comparison will help to decide which spectral
system data is a good representation of a standard CT scanner data to be used for dose
simulations. I recommend this investigation for further studies.
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However, in the future, the established method in this chapter can be applied to other
spectral data for 3D dose distribution map assessment. The use of high specification
computers should be considered in order to simulate more source particles to improve
the accuracy of the dose scoring.
A shortcoming of the study in chapter 6 is the use of cadaver mice material image
as a true representation of a live mice material image. Hence, the measured Gd
concentration in the bladder may be different for a live mice material image thereby
providing different dose results. Also, the dose was scored on the Gd contrast agent
molecules only without the presence of soft tissue. In the future, the dose to contrast
agent should be assessed in the presence of soft tissue. A complete study of the effect
of contrast agents on radiation dose should take into account scanning of a live mouse
with or without contrast agent.
The mesh volume localisation is an area that may need further investigation. Future
studies should look at making the process of deriving the mesh volume from the material
image simple and easy. The MARS vision image processing software (Chernoglazov,
2016; Mandalika et al., 2018) has inbuilt mesh volume component. I recommend further
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Rajendran, K., Löbker, C., Schon, B. S., Bateman, C. J., Younis, R. A., de Ruiter, N.
J. A., Chernoglazov, A. I., Ramyar, M., Hooper, G. J., Butler, A. P. H., Woodfield,
T. B. F., and Anderson, N. G. (2017). Quantitative imaging of excised osteoarthritic
cartilage using spectral CT. European Radiology , 27 (1), 384–392.
Rajendran, K., Murthy, N. S., Frick, M. A., Tao, S., Unger, M. D., LaVallee, K. T.,
Larson, N. B., Leng, S., Maus, T. P., and McCollough, C. H. (9000). Quantitative
Knee Arthrography in a Large Animal Model of Osteoarthritis Using Photon-Counting
Detector CT. Investigative Radiology , Publish Ahead of Print.
Rajendran, K., Voss, B. A., jie Zhou, W., Tao, S., DeLone, D. R., Lane, J. I., Weaver,
J. M., Carlson, M. L., Fletcher, J. G., McCollough, C. H., and Leng, S. (2019). Dose
Reduction for Sinus and Temporal Bone Imaging Using Photon-Counting Detector
CT With an Additional Tin Filter. Investigative Radiology , 55, 100 – 91.
Rajendran, K., Walsh, M. F., de Ruiter, N. J. A., Chernoglazov, A. I., Panta, R. K.,
Butler, A. P. H., Butler, P. H., Bell, S. T., Anderson, N. G., Woodfield, T. B. F.,
Tredinnick, S. J., Healy, J. L., Bateman, C. J., Aamir, R., Doesburg, R. M. N.,
Renaud, P. F., Gieseg, S. P., Smithies, D. J., Mohr, J. L., Mandalika, V. B. H., Opie,
A. M. T., Cook, N. J., Ronaldson, J. P., Nik, S. J., Atharifard, A., Clyne, M., Bones,
P. J., Bartneck, C., Grasset, R., Schleich, N., and Billinghurst, M. (2014). Reducing
beam hardening effects and metal artefacts in spectral CT using Medipix3RX. Journal
of Instrumentation, 9 (03), P03015.
Reuillon, R., Hill, D., Gouinaud, C., El Bitar, Z., Breton, V., Buvat, I., al Monte
Carlo, Reuillon DRC Hill Gouinaud, R. C., and El Bitar Breton, Z. V. (2008). Monte
Carlo Simulation With The GATE Software Using Grid Computing Simulation With
The GATE Software Using Grid Computing. 8ème Conférence Internationale sur les
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